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   Dear Colleagues,  
   On behalf of the Executive Council of the Bulgarian 
Scientific Pharmaceutical Society and of the Organizing 
Committee I am pleased to cordially welcome You at the 
7
th
 Congress of Pharmacy with International Participation 
“Pharmaceutical Altitudes” in the lovely resort of Borovetz 
(Rila Hotel), Bulgaria (21-24 November 2019).  
   We are organizing the Congress as an exciting venue, whereby leading 
internationally acknowledged experts in the fields of pharmacy and allied sciences 
will meet to debate the state-of-the-art scientific advances, and to face the 
evolving challenges and opportunities in the fast-changing world of Pharmacy, as 
an integral part of healthcare. Special emphasis is focused on drug design, 
phytopharmaceuticals, biotechnological drugs and biosimilars, pharmaceutical 
nanotechnologies and biopharmaceutics, pharmaco-economics and health 
technology assessment. 
   Esteemed colleagues, we welcome You to present your own research, to learn 
from prominent experts, network with key-opinion leaders, enjoy hearing high 
level lecturers reporting their latest scientific projects or sharing their vision over 
the evolving challenges in the pharmaceutical science and practice. The agenda 
of the Congress also includes specialized expert panels with prominent Bulgarian 
clinical key-opinion leaders, intended to discuss the state-of-the-art advances and 
the challenges of modern pharmacotherapy. 
  
 
Cordially Yours, 
Prof. Georgi Ts. Momekov, PhD 
President of the Bulgarian Scientific Pharmaceutical Society 
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ARE THE POLYMERIC NANO-CARRIERS ALTERNATIVE TO 
CANCER THERAPY? 
Tsvetanov Ch. 
 
Cancer remains one of the hardest for treatment diseases. Each year, over 10 
million people worldwide are affected by cancer. Cancer therapy involves: surgery, 
radiation therapy, chemotherapy, immunotherapy, stem cell therapy, etc. The use of 
chemotherapy can lead to the death of healthy cells as well as to body toxicity. The 
use of nano-carriers in chemotherapy offers the following advantages: 
- prevents preliminary drug degradation; 
- prevents drug pre-interaction with the biological environment; 
- provides effective drug absorption into the tumor tissue; 
- controls the location of the drug; 
- improves drug penetration into the cell. 
The following problems with the use of polymeric drug nano-carriers will be 
discussed: 
- active and passive drug targeting; 
- targeting agents; 
- types of nano-carriers – their advantages and disadvantages; 
- overcoming the membrane protein barrier – resistance of the cells by 
ejecting the drug; 
- the possibility of finding the so-called “magic bullet” – the drug that 
selectively attacks only the diseased tissue. 
 
 
CHALLENGES AND OPPORTUNITIES IN PHARMACY PRACTICE 
AND PROFESSION 
Angelovska B. 
Faculty of Medical Sciences, ,”Gotse Delchev” University, Shtip,  
Republic of North Macedonia 
 
Pharmaceutical care is a patient-centered, outcomes oriented pharmacy 
practice that requires cooperation of pharmacists with patients and other healthcare 
professionals in order to promote health, to prevent disease, and to assess, monitor, 
initiate, and modify medication use to assure that drug therapy regimens are safe 
and effective. The aim of pharmaceutical care is to optimize patients‟ health-related 
quality of life (HRQoL), and also to achieve positive clinical outcomes, within realistic 
economic expenditures. The requirements for providing safe and effective 
personalized care are becoming more and more important, taking into account the 
differences in the socioeconomic structure and demographic specifics. 
Despite the constant changes in health care systems, pharmacies still remain 
an integral part of the health care system. Their unique position in healthcare system 
is related to the fact that pharmacies are the last place for interaction between 
patients with healthcare professionals. Preservation of professional independence of 
back to 
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the pharmacist in order to maintain their independence from commercial pressure is 
of paramount importance for the further development of pharmaceutical practice. 
In order to accept the current and future challenges, we want to create a future 
with highly qualified and independent pharmacists able to give continuous support of 
every individual patient, of public health and also of the healthcare system. 
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CYTOCHROME P450 METABOLISM IN BRAIN: ROLES AND 
IMPLICATIONS IN NEURODEGENERATIVE DISEASES 
Dragoni S., Chiaino E., Frosini M., Fernandez-Abascal J., Valoti M. 
Dipartimento di Scienze della Vita, 
Università di Siena, 2 Via Aldo Moro, 53100 Siena, Italy 
 
The cytochrome P450 (CYP) family is involved in different steps of therapy 
from drug efficacy and dose requirement to adverse drug reactions and direct 
toxicity. Most of the studies have been conducted in the liver which is the major 
organ involved in drug metabolism due to the high concentration of CYPs in the 
endoplasmic reticulum of hepatocytes. However, the CYP families involved in 
xenobiotic metabolism are also expressed in extrahepatic tissues (i.e., intestines, 
brain, kidney). Since the expression of the majority of the isoforms appears to be low 
compared to the predominant expression in the liver, and their role in the overall total 
body clearance is lower, the basal expression and up-regulation in peripheral tissues 
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can significantly affect local disposition of drugs or endogenous compounds and thus 
modify the pharmacological/toxicological effects or affect the distribution of 
xenobiotics in the human body. In the brain, the overall level of CYP is ∼0.5 – 2% of 
that in liver microsomes and could play a role in tissue- and/or cell-specific sensitivity 
to certain drugs or xenobiotics (Ferguson and Tyndale, 2011). There have been a 
number of suggestions that environmental toxins may play a role in the pathogenesis 
of neurodegenerative disorders by directly damaging neurons or through 
bioactivation of some toxic compounds via CYPs. This can be an important aspect as 
the mechanisms involved in Parkinson‟s disease are thought to be multifactorial in 
nature and elucidation of how CYP may predispose the brain to subsequent damage 
caused by exogenous toxins is important. CYP isoforms are generally associated 
with the endoplasmic reticulum however, some CYP enzymes have been found in 
the mitochondria of a number of different brain areas including the substantia nigra. 
Therefore CYP and CYP-induction will result in neurotoxicity/neuroprotection due to 
enhanced metabolism of exogenous substrates. In our experiments, we have 
demonstrated that CYPs is inducible in vivo and in vitro models (Marini et al, 2007, 
Fernandez-Abascal et al., 2018). Moreover, in SH-SY5Y cells the induction of CYPs 
was able to reverse the damage of mitochondria complex I and the apoptosis 
promoted by the neurotoxin MPP+. These data suggest that cytochrome P450 can 
play an important role in the regulation of molecular mechanisms involved in 
neurodegeneration. 
Ferguson CS, Tyndale RF. Cytochrome P450 enzymes in the brain: emerging 
evidence of biological significance. Trends Pharmacol Sci. 2011:708-14. 
Marini S, Nannelli A, Sodini D, Dragoni S, Valoti M, Longo V, Gervasi PG. 
Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in 
brain regions from control and phenobarbital-treated rabbits. Life Sci. 2007;80910-7. 
Fernandez-Abascal J, Ripullone M, Valeri A, Leone C, Valoti M. β-
Naphtoflavone and Ethanol Induce Cytochrome P450 and Protect towards MPP⁺ 
Toxicity in Human Neuroblastoma SH-SY5Y Cells. Int J Mol Sci. 2018; 19. pii: 
E3369. 
 
 
CURRENT PHARMACOLOGY AND PHARMACOTHERAPY OF 
MULTIPLE SCLEROSIS 
Danchev N., Kostadinova I. 
Faculty of Pharmacy, Department of Pharmacology, Pharmacotherapy and 
Toxicology, Medical University of Sofia, Bulgaria 
Corresponding author: nikolai.danchev@gmail.com 
 
Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous 
system, characterized by demyelination of the axons. It affects many young people in 
active age between 30-35 years. There are four main clinical forms of MS and the 
most common is the relapsing-remitting form. The disease requires expensive 
treatment, making it a socially significant disease. Over the last 15-20 years, many 
first- and second-line therapies have been developed. The first-line therapy includes 
application of interferons Interferon beta1b and Interferon beta 1a and the copolymer 
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of the four amino acids - lysine, alanine, tyrosine and glutamic acid (INN glatiramer 
acetate). There are presented the pharmacodynamics, pharmacokinetics, clinical 
application and adverse effects of drugs for multiple sclerosis used in Bulgaria. The 
monoclonal antibodies Natalizumab and Alemtuzumab used as a novel therapy 
approach to multiple sclerosis are also discussed. There are presented the results of 
our own investigations of peptide derivatives of 4-aminopyridine. 
 
 
ALZHEIMER’S DISEASE – OPPORTUNITIES OF 
PHARMACOTHERAPY 
Kostadinova I., Danchev N. 
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
Corresponding author: Ivanka Kostadinova, PhD 
e-mail: i.kostadinova@pharmfac.mu-sofia.bg 
 
Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disease, in 
which the combination of various risk factors and mechanisms leads to a 
deterioration of brain cortical functions, memory deficits, learning and also 
behavioural changes. AD is the most common cause of dementia in people over 65 
years of age, representing 50-60% of all cases of dementia. There are many 
hypotheses about AD, including abnormal deposit of amyloid β (Aβ) protein in the 
extracellular spaces of neurons, formation of twisted fibers of tau proteins inside 
neurons, cholinergic neuron damage, inflammation, oxidative stress. Approved 
medicines for AD are mainly related to the cholinergic hypothesis. In this regard, first-
line drugs are inhibitors of the acetylcholinesterase enzyme - Galantamine, 
Rivastigmine and Donepezil. For moderate to severe AD, N-methyl-D-aspartate 
receptor antagonist Memantine is used. Due to the large number of side effects, new 
drugs are currently being studied, some of which are in Phase 3 of clinical trial such 
as the beta secretase inhibitor Elenbecestat. 
 
 
PHARMACOLOGIC INFLUENCE ON HYPERTHERMIC REACTION IN 
EXPERIMENTAL SEROTONIN SYNDROME MODELS 
Koleva K., Bogdanov G., Nikolov R. 
Department of Pharmacology, Pharmacotherapy and Toxicology,  
Faculty of Medicine, Medical University, Sofia 
 
Aim of the study: Serotonin syndrome is observed as a result of an overdose of 
serotonergic drugs or interactions with the combined administration of two or more 
drugs that increase the intrasynaptic concentration of serotonin (5-
hydroxytryptamine). The aim of the present study is to establish the effects of 
diazepam, vigabatrin, olanzapine and risperidone on the hyperthermic reaction in a 
serotonin syndrome in rats. 
Materials and methods: The animal models of serotonin syndrome used in our 
experiments were induced by сo-administration of both 5-hydroxy-L-tryptophan and 
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clorgyline or fluoxetine and tranylcypromine. Body temperature experiments were 
conducted at ambient temperature of 24 ± 1° C. The body temperature of the animals 
was measured with thermistor probes (TX-8) and monitored on a multichannel 
recorder Iso-Thermex 16. The thermistor probes were lubricated and inserted rectally 
to a depth of 6 cm. 
Results: Pretreatment with diazepam (5 mg/kg, i.p.) or vigabatrin (300 mg/kg, i.p.) 
decreased hyperthermia in an experimental model of the serotonin syndrome. 
Pretreatment with olanzapine (5 mg/kg, i.p.) or risperidone (1 mg/kg, i.p.) diminishes 
or blocks the development of hyperthermic response in a serotonin syndrome model. 
Conclusion: Pretreatment of rats with the GABA ergic drugs or 5-HT2 receptor 
antagonists prevents hyperthermia in an experimental serotonin syndrome. The 
results obtained in present study suggest involvement of interactions between 
GABAergic and serotoninergic systems in the processes of thermoregulation. 
 
 
THE SYNERGISTIC EFFECTS OF CANNABIDIOL AND EPIRUBICIN 
ON HL-60 CELL LINES AND FREE RADICAL DAMAGES 
Zhelyazkova M.1, Baltadzhieva K.2, Momekov G.2, Hristova-Avakumova N.2, 
Hadjimitova V. 
1Bulgarian Drug Agency, Sofia, Bulgaria 
2Medical University of Sofia, Bulgaria 
 
Aim: Chemotherapy is one of the successful therapeutic approaches for cancer but 
still there is an urgent need for novel treatment in relation to drug resistance and 
toxicity. Interest in the anticancer properties of Cannabidiol (CBD) - the main non-
psychoactive cannabinoid received from hemp of the Cannabis plant has been 
renewed. We hereby present our novel results for its potential interactions with 
cytostatic drugs where data has been limited. 
Materials and methods: The anticancer properties of CBD in combination with 
epirubicin were assessed by a standard MTT-test and the Chou Talalay method. 
Evaluation of the effect of CBD on the chemiluminescent response in hypochlorite 
containing system has been done. A spectrophotometric estimation of CBD influence 
on the “% of molecular damage” under experimental conditions of ferrous induced 
oxidative molecular damage of deoxyribose was accomplished. 
Results: CBD has anti-proliferative effect on sensitive and resistant to doxorubicine 
HL-60 cell lines (IC50 = 6,6 and 7.5 mmol/L), and it induces a concentration-
dependent cell death. The combination realizes a more pronounced anti-proliferative 
effect (combination index more than 1). In the samples containing CBD has been 
observed higher CL-signal and absorbance at 532 nm compared to the controls, 
which indicate prooxidant effect and increased “% of molecular damage”. It was 
demonstrated that CBD-driven increase in ROS production is needed for realizing the 
programmed cell death. 
Conclusion: The highlighted data suggest the possibility for simultaneous 
application of CBD and conventional cytostatic treatment which may be a beneficial 
option for lympho-proliferative or resistant cancer. 
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TREATMENT OF DYSLIPIDEMIAS WITH A FOCUS ON 
ATHEROSCLEROTIC DISEASE 
Georgiev B. 
National heart hospital 
 
Dyslipidemia is defined as changes in lipid parameters - elevated total and LDL-
cholesterol (hypercholesterolemia), only elevated triglycerides (hypertriglyceridemia) 
or elevated total LDL-cholesterol and triglycerides - mixed dyslipidemia. Isolated low 
HDL-cholesterol can also be observed. 
Hypercholesterolemia is a major risk factor for atherosclerotic disease, which is the 
first one for myocardial infarction and in the top three of the risk factors for stroke and 
peripheral arterial disease. 
The drug treatment of dyslipidemia includes statins, fibrates, nicotinic acid, inhibitors 
of dietary cholesterol absorption like ezetimibe, which can be small molecules, 
antibodies, antisense drugs, etc. 
 
 
BENEFICIAL INFLUENCE OF CHRONIC AGOMELATINE 
TREATMENT ON DESYNCHRONIZED DIURNAL RHYTHMS OF 
HORMONAL RELEASE, BEHAVIOR AND SLEEP ARCHITECTURE IN 
A RAT MODEL OF MELATONIN DEFICIT 
Tchekalarova J., Kortenska L., Ivanova N., Atanasova M., Stoynova T., 
Nenchovska Z., Mitreva R., Marinov P. 
 
Aim: The aim of the study was to explore the effects of agomelatine on 
desynchronized circadian rhythms of different hormones, behavior and sleep/wake 
cycle in a rat model of melatonin deficit. 
Materials and methods: Wistar rats, kept under either basal conditions (12:12 LD 
cycle+vehicle), chronic constant light CCL+vehicle and CCL+agomelatine (40 
mg/kg/day for 21 days) were exposed to a battery of behavioral test for anxiety and 
depressive-like behavior or equipped with electroencephalographic (EEG) and 
electromyographic (EMG) electrodes. The expression of plasma melatonin, 
corticosterone levels and BDNF in the hippocampus and frontal cortex (FC) was 
tested by ELISA test. 
Results: The CCL induced depressive-like (anhedonia and hopelessness) 
responses during the subjective dark/active phase were positively affected by 
agomelatine. In addition, this melatonin analogue restored the impaired circadian 
patterns of plasma melatonin and decreased the level of BDNF in the hippocampus 
but not that of corticosterone. The CCL-exposed rats were characterized by impaired 
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sleep/wake cycle with reduced slow-wave sleep (SWS) and delta power but 
increased rapid eye movement (REM) sleep and theta power. Agomelatine restored 
the diurnal rhythm of sleep/wake cycle and sleep architecture. 
Conclusion: The potential beneficial effect of this novel atypical antidepressant to 
resynchronize the diurnal rhythms of comorbid depression, sleep/wake cycle and 
sleep architecture accompanying melatonin deficit suggests the key role of the 
hormone melatonin and BDNF in the mechanism of action of agomelatine. 
Acknowledgement: This research was supported by the National Science Fund, 
Bulgaria (grants No. DN 03/10/2016; No. DN 12/6). 
 
 
HEART FAILURE THERAPY ACCORDING TO THE LATEST 
CLASSIFICATION FOR EUROPE 
Georgiev B. 
National heart hospital 
 
Heart failure is a syndrome, not a disease that is characterized by fatigue, shortness 
of breath, congestive symptoms in an effort or rest, as a result of heart disease. The 
latest classification of heart failure includes diseases with or without ventricular 
pumping dysfunction. However, in order to be clasified as patients with heart failure, 
patients should exhibit symptoms or signs of heart failure reduced by less than 40% 
left ventricular (LV) ejection fraction (EF) or fraction over 40% with elevated 
natriuretic peptides and at least structural heart disease or diastolic dysfunction. 
Therapies have undergone a change in recent years, and in some of the phenotypes, 
not all is clear about the effects of different therapeutic strategies. 
In heart failure with reduced LVEF (<40%) therapy is initiated with a drug that 
suppress the renin-angiotensin-aldosterone system (PAAS) - ACE-inhibitor or 
angiotensin-receptor blocker, beta blockers and, if symptoms persist, a 
mineralocorticoid receptor antagonist. The diuretics are administered concomitantly 
in the presence of congestive symptoms and the dose is adjusted according to the 
clinical manifestation. It should be noted that only some ACE-inhibitors have an 
indication for use in left ventricular systolic dysfunction - captopril, enalapril, lisinopril, 
ramipril, trandolaril, only 3 ARBs have this indication - candesartan, valsartan, 
losartan and from MPA - both spironolactone and eplerenone can be used. Of the 
beta-blocker group, only cardioselective beta-blockers bisoprolol, metoprolol 
succinate, nebivolol, and carvedilol (not selective but with additional vasodilator 
properties) are used with reduced LVEF. In the next step, ivabradine or aRNI (after 
stopping the ACE-inhibitor or ARB) can be added to conventional therapy. Many 
other drugs such as digoxin, nitrates have no place in conventional therapy of heart 
failure with suppressed LVEF. 
In heart failure patients with LVEF > 40% or with a normal fraction, many of the 
medications administered are free of clinical evidence of benefit. With adequate 
treatment for underlying cardiovascular disease, their prognosis can be improved. 
 
 
back to 
contents 
 29 
 
AGRIMONIA EUPATORIA L. LOWERS LIPID ACCUMULATION IN 
DIFFERENTIATED HUMAN ADIPOCYTES 
Vasileva L.1, Koycheva I.1,2, Balcheva-Sivenova Z.1,2, Aneva I.3, Georgiev M.1,2 
1Center of Plant System Biology and Biotechnology, Plovdiv, Bulgaria 
2Group of Plant Cell Biotechnology and Metabolomics, Institute of Microbiology, 
Bulgarian Academy of Sciences, Plovdiv, Bulgaria 
3Institute of Biodiversity and Ecosystem Research,  
Bulgarian Academy of Sciences, Sofia, Bulgaria 
 
Aim: Excessively increasing numbers of overweight and obese individuals are 
reported worldwide. The research interest in plant-derived natural compounds as 
potential drug candidates revives [1]. Agrimonia eupatoria L. (AGE) is reported in 
Bulgarian ethnobotanical herbal combinations for weight reduction. In the present 
study we hypothesized that the extract of A. eupatoria would modulate the processes 
of differentiation and lipogenesis in human Simpson-Golabi-Behmel syndrome 
(SGBS) pre-adipocytes cell line. The SGBS cells serve as an in vitro model of 
adipocytes differentiation and metabolism [2]. 
Materials and methods: Differentiation was induced in SGBS pre-adipocytes upon 
confluence. After initiation of differentiation the SGBS cells were repeatedly treated 
with AGE extract in doses of 6.25, 12.5, 25, 50 and 100 µg/mL. Staining with Oil Red 
O was performed in mature adipocytes to quantify total lipid content. Total cell 
lysates were extracted for determination of certain protein levels by Western blotting. 
Additionally, the phytochemical profile of AGE extract was analyzed by NMR-based 
metabolomics. 
Results: The application of doses below 25 µg/mL AGE extract markedly lowered 
the lipid content in SGBS adipocytes compared to the control samples. 
Conclusion: The obtained data indicate that the extract of A. eupatoria is worth 
further exploration as a potential source of bioactive leads that interferes with the lipid 
storage functions of mature adipocytes. 
Acknowledgements: This project for establishment of CPSBB has received funding 
from the European Union's Horizon 2020 research and innovation programme under 
grant agreement № PlantaSYST – SGA/CSA: 739582 – under FPA: 664620. The 
SGBS cell line was kindly provided by Prof. Dr. Martin Wabitsch (University of Ulm, 
Germany). 
References: 
1.Vasileva L., Marchev A., Georgiev M. (2018) Causes and solutions to “globesity”: 
The new fa(s)t alarming global epidemic. Food and Chemical Toxicology 121: 173-
193. 
2.Klusoczki A., Vereb Z., Vamos A., Fischer-Posovszky P., Wabitsch M., Bacso Z., 
Fesus L., Kristof E. (2019) Differentiating SGBS adipocytes respond to PPARγ 
stimulation, irisin and BMP7 by functional browning and beige characteristics. 
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IMBALANCE OF ESSENTIAL AND TOXIC METALS IN CHILDREN 
WITH AUTISTIC PECTRUM DISORDERS 
Ciurinskiene S., Savcheva M. 
 
Autism is a neuro-developmental syndrome, with symptoms‟ manifestation as early 
as the first year, which affects 1 out of 68 children (WHO, 2016). A good number of 
researchers (Yasko, Amy, 2009; Walsh, William, 2011) have proven the relation 
between autism and the inability of the organism to excrete toxic metals, due to 
disturbances in the methylation cycle. During the last 10 years, a great deal of 
attention has been paid to the theory of metabolic deficiencies/detoxification. 
According to this theory, autism is a result of disturbed detoxification, due to lack of 
antioxidants, glutathione, metallothionein. 
Objective of the study: 1. To identify the predominant toxic metals, most common in 
Bulgarian children with autism spectrum disorders (ASD). 
2. To find out whether there are increased toxic metals in children with ASD, different 
from mercury and aluminium. 
Materials and methods: The study spans over 53 children at the age of 1 – 13. 47 
boys and 6 girls, were tested for toxic metals overload, from January 1st 2017 to 
March 30th 2018. 
The level of toxicity was identified, using a hair metal elements test. 
The behavioural symptoms were tested with CARS2. 
Results: 53 out of 53 children with developmental disorders turned out positive for 
increased level of one or more toxic metals. The severity of the autistic symptoms, 
however, correlated not with the extent of increase, but with the numbers of the 
detected metals – the more the number of the different metals were, the heavier were 
the symptoms. 
Conclusions: Our study supports the metabolic deficiency theory, which occurs as a 
result of disturbed detoxification, caused by variations of several genes like GPX1, 
GSTP1, SOD2 etc., which in turn leads to intoxication with metals and bad 
metabolites, accompanied by gut and brain inflammation. 
Key words: autism, toxic metals, detoxification 
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EFFECTS OF LEPTIN ON NADPH-DIAPHORASE ACTIVITY IN THE 
NUCLEUS PARAVENTRICULARIS AND NUCLEUS ARCUATUS OF 
THE HYPOTHALAMUS IN RATS 
Hristov M.1, Landzhov B.2, Yakimova K.1 
1Department of Pharmacology, Pharmacotherapy and Toxicology,  
Faculty of Medicine, Medical University, Sofia 
2Department of Anatomy, Histology and Embryology,  
Faculty of Medicine, Medical University, Sofia 
 
Aim of the study: To investigate reduced nicotinamide adenine dinucleotide 
phosphate (NADPH)-diaphorase activity in the nucleus paraventricularis and nucleus 
arcuatus of the hypothalamus after systemic administration of leptin in rats. 
Materials and methods: The study was carried out on 6 male Wistar rats with body 
weight 350 g, divided into 2 groups of 3 rats each: first group - injected i.p. with leptin 
(0.5 mg/kg) and second group (control group) - injected with saline (0.2 ml/100g). 
The animals were anesthetized 45 minutes later with thiopental (40mg/kg) and 
transcardial perfusion was performed using 4% paraformaldehyde. Serial coronal 
sections were cut on a freezing microtome (Reichert-Jung) at a thickness of 40 μm. 
Sections were then stained with the NADPH-d-technique using 0.1–0.2 mg/ml of 
nitroblue tetrazolium, 1 mg/ml β-NADPH and 0.3–0.5 % Triton X-100 in 0.1 M TRIS– 
HCl buffer (pH 7.4) at 37° C for 30 – 60 min. Data were statistically assessed by one-
way analysis of variance (ANOVA) and presented as mean ± standard error of the 
mean (SEM). 
Results: Systemic administration of leptin resulted in a significantly higher NADPH-d 
positive cell number in nucleus paraventricularis compared to that observed in the 
control animals. In contrast to saline-treated rats, where nucleus arcuatus was 
unstained, leptin-treated rats have shown a few NADPH-d positive neurons and 
many NADPH-d positive tanycytes with well visible basal processes, that make 
contact with blood vessels and neurons in nucleus arcuatus. 
Conclusion: We have shown that systemic administration of leptin resulted in an 
increased NADPH-diaphorase activity in the nucleus paraventricularis and nucleus 
arcuatus of the hypothalamus in rats. We suggest that nucleus paraventricularis and 
nucleus arcuatus may be important centers in the hypothalamus for the leptin action, 
mediated by increased NO synthesis. 
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COMPARATIVE STUDY OF THE PROTECTIVE EFFECTS OF 
NIGELLA SATIVA OIL, CURCUMIN, AND HYDROXYTYROSOL 
AGAINST DEXTRAN SULFATE SODIUM-INDUCED COLITIS IN MICE 
Simeonova R.1, Zheleva-Dimitrova D.2, Balabanova V.2, Benbassat N.2,  
Savov I.3, Gevrenova R.2 
Faculty of Pharmacy, Medical University, Sofia 
 
Aim: This study aimed to investigate the possible protective role of Nigella sativa oil 
(NSO) vs curcumin (CUR) and hydroxytyrosol acetate (HTA) against Dextran Sulfate 
Sodium (DSS) induced oxidative damage and impairment of colons from mice. 
Materials and methods: High-resolution gas chromatography-mass spectrometry 
(GC-HRMS) was used for the analysis of the NSO. Colitis was induced by a 5-day 
oral DSS (2.5%) administration. The levels of nitric oxides (NO), C-reactive protein 
(CRP), malondialdehyde (MDA), reduced glutathione (GSH), the activity of catalase 
(CAT), superoxide dismutase (SOD), glutathione peroxidase (GPX), as well as the 
activity of myeloperoxidase (MPO), were measured spectrophotometrically. IL-6 
levels were analyzed using electrochemiluminescence immunoassay “ECLIA”. 
Results: Palmitic, linoleic, and oleic acids were detected. Colitis was discerned by a 
reduction in body weight, presence of blood in the stools, reduced colon weight and 
length. Colon inflammation was also manifested by an increased level of 
inflammatory markers IL-6, CRP, NO, MPO activity, and disturbed oxidative stress 
markers GSH, antioxidant enzymes activity (CAT, SOD, and GPx), and MDA 
quantity. All the investigated compounds markedly attenuated colonic inflammation 
by inhibiting MPO activity and by decreasing the augmented levels of IL-6, NO and 
CRP. The compounds improved colon anti-oxidant defence machinery by decreasing 
the quantity of MDA, a marker of lipid peroxidation and increasing the level of GSH 
and antioxidant enzymes activity. The investigated compounds ameliorated colon 
injury and inflammatory signs as visualized by histopathological examination. 
Conclusion: Results revealed that NSO produced a comparable therapeutic effect 
as the positive controls CUR and HTA. 
 
 
URIC ACID IS A RISK FACTOR FOR IN INCIDENT AN PATIENTS 
WITH UREMIA 
Zylbeari L., Haxhirexha K., Haxhirexha A., Dika-Haxhirexha F., Bexheti Z., 
Ahmeti-Lika S., Zylbeari G., 
Faculty of Medical Sciences, University of Tetovo, Tetovo 
 
Low serum uric acid (SUA) is a mortality risk factor in incident hemodialysis patients 
with a high comorbidity burden and hypoalbuminemia. Hyperuricemia is also 
common in uremic patients where it has been reported in up to 60-75% of patients. 
Studies performed in hemodialysis (HD) patients confirmed that hyperuricemia is also 
associated with a significantly increased mortality risk in the uremic patients. In this 
study we hypothesized that a low serum uric acid level is a mortality risk factor 
associated with clinical markers of MIA syndrome, inflamatio-oxidative stress, in a 
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cohort of patients treated with long-term hemodialysis. We found low uric acid levels 
conferred a greater than 2-fold risk for death, whereas elevated uric acid was not 
associated with increased mortality risk. We therefore undertook a detailed analysis 
to better understand the potential mechanism by which a low uric acid level might 
confer increa-sed risk in this population. We found that in our patients, low uric acid 
levels were associated with markers of malnutrition and a high comorbidity burden, 
which is consistent with the hypothesis that oxidative stress might contribute to the 
increased mortality in these patients. Twice a week every month, pre- and 
postdialysis blood samples from each of the patients was collected. The core 
indicators were urea reduction rate (URR), serum hematocrit and S-albumin levels. 
The target value for URR was ≥68%, that of serum hematocrit was ≥36 g% and that 
of S-albumin was ≥3.5 g/dl. For patients that had core indicator values that fell below 
the target values, the appropriate laboratory test was repeated on the following 
Monday or Tuesday. Prescription adjustments were made following NK/DOQI 
(National Kidney Disease Outcome Quality Inititatve) guidelines through a 
Continuous Quality Improvement program, using established protocols. The mean 
values of the core indicators for each patient over the entire period of study were 
employed for final analysis. In conclusion, our results suggest that uric acid is similar 
to other cardiovascular risk factors in that there is a reverse epidemiology pattern in 
HD patients. This relationship is largely explained by the association of low uric acid 
levels with comorbid conditions and markers of protein energy wasting that are 
suggestive of higher oxidative stress. A reverse epidemiology of classic 
cardiovascular risk factors was observed in hemodialysis patients with a high 
comorbidity burden. Further studies are necessary to understand if the low serum 
uric acid level is the cause or consequence of these conditions. In conclusion, our 
results suggest that uric acid is similar to other cardiovascular risk factors in that 
there is a reverse epidemiology pattern in HD patients. This relationship is largely 
explained by the association of low uric acid levels with comorbid conditions and 
markers of protein energy wasting that are suggestive of higher oxidative stress. 
Keywords: hypoalbuminemia, hemodialysis, serum uric Acid (SUA) 
 
 
MANAGEMENT OF RENAL ANEMY 
Zulbeari L., Haxhirexha K., Haxhirexha F., Bexheti Z., Ahmeti-Lika S. 
Medical Faculty, University of Tetove 
 
Аbstract: One of the most common complications in uraemic patients treated with 
chronic hemodialysis (HD) is the anemia that is still wound up in the early stages of 
the disease. National Kidney Foundation (NKF) and KDOQI-Kidney Disease 
Outcomes Quality Initiative renal anemia is treated when concentrations of Hb for 
women e <12 g/dl whereas in men e <13.5 g/dl. (1,2). Chronic renal disease 
according to NKF and KDOQI is separated into 5 different phases based on the 
glomerular filtration rate (Glomerular Filtration Rate-GFR (3,4). According to the 
recommendations of NKF and KDOQI, about 90% of patients with ESRD with 
glomerular filtration GFR, below 25-30 ml/min, has anemia with low concentrations of 
Hb <10 g/dl (5). The most common cause of this type of anemia is the lack of 
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erythropoietin (EPO) which is produced principally in the bubble - the cuts and is the 
basic factor for the stimulation of erythropoiesis. The introduction of erythropoiesis 
stimulating agent (ESA) for the treatment of renal anemia at the end of 1980 was a 
major breakthrough in the field of medicine (6). In our work, all anemic patients were 
treated with ESA at a dose of 2000-4000 IU subcutaneously (s.c.) after the end of the 
HD session. Out of the total number of 120 patients at 100 (83%) there was anemia 
that showed a high sensitivity to the ЕSA preparation, while 20 (17%) patients had 
normal Hb, Er, Htc values and were not treated with ESA. 
Material and methods: In the cross-sectional study, the GH cells included N0=240 
examiners of which 120 were HD treated patients while 120 were healthy individuals 
serving as a control group. Of the 120 patients treated with HD-54 (45%) were 
women while 64 (55%) were males with an average median of 59.50 ± 14/30 years 
old, treated over 12 in the Nephrology Clinic in Skopje and in Tetovo Hospital Clinic. 
The control group of healthy examiners (volunteer blood donors) was also 54 (45%) 
female and 64 (55%) males, and was similar to the group of patients according to 
age (58.0 ± 13.80 years), gender and national relevance. Statistical analysis: The 
statistical methods used were: average arithmetic value and standard deviation: X ± 
SD, Studentov t test, Anonova Two-Factor. The results obtained from the Hb, Er, Htc 
examinations were processed and presented in the form of charts, tabulations and in 
the knowledge-grams processed in a standard statistical program (Statistic for 
Windows, version 6.0A, Stat. Softinc Tulsa, OK USA. 
Results: Before starting ESA therapy, the mean values of Hb in the examined 
female females were: 5.20±1.15 mmol/l, while male male patients were = 5.60 ± 1.10 
mmol/l, the Er number of females was: 2.90 ± 0.86 x 1012/l, while masculine were = 
in 
males-0.28 ± 0.06. After treatment with ESA the desired target for Hb ("target 
Hgb≥6.80mmol/l") was postponed after the sixth week of 46 female patients out of 
the total number of 54 females with Hb> 6.80 mmol/l, while male target Hb> 6.80 
mmol/l reached 58 patients in the total number of 66 meshes, number Er females 
reached: 3,50 ± 0.86 x 1012/l, while masculine was 3.80±0.90 x 1012/l. Htc values in 
females reached up to 0.30 ± 0.02 while in males 0.32 ±0.04. The sFe deficiency was 
compensated by applying the Amp.Ferri (III) Oxidum Sa-ccharatum intravenously in 
150 ml NaCl. Comparison of the winning values of patients with psoriatic treatment 
with ESA and after treatment showed a statistically significant difference for p 
<0.0001.  
Conclusion: Our results have shown that the application of ESA therapy is the most 
comprehensive and effective way of correcting and treating renal anemia and timely 
preventing left ventricular hypertrophy. 
Key Words: renal anemy, Erythropoesis stimulating agent (ESA), Hemodialysis 
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MOLECULAR GENETIC ANALYSIS OF TOXIC MICRO-DERIVATIVES 
IN DRINKING WATER 
Ilieva V.1, Georgieva T.2, Kondeva-Burdina M.1 
1Faculty of Pharmacy, Medical University, Sofia 
2GMO Laboratory, National Center of Publish Health and Analysis 
 
The aim of the study: The aim of the researches is to evaluate the risk of 
cyanobacteria‟s toxicity and toxins in samples of the above-mentioned Bulgarian 
dams. Goals are to be discovered potentially toxic or pathogenic micro-organisms in 
order to protect the health of the population. 
Materials and methods: For the research are used molecular-genetic methods such 
as polymerase chain reaction in real time (RT-PCR). Initially, bacterial DNA was 
isolated by DNA extraction with pre-set lysis-buffer for isolating bacterial DNA from 
the food matrices, processed for water samples, followed by RT-PCR. From multiply, 
genes are determined the amount and toxicity of cyanobacteria in the available 
samples. RT-PCR allows being observed the change of the fluorescence in each 
cycle in real time. 
Results: In this research, samples were tested from the following dams: Studena, 
Ptchelina, Uzungerel, Mandra, Durakulak, Vaia, Bistrista and Iskar. Those dams are 
the main water source, so they are important for the population. In the result of the 
conducted experiments is found that positive results for the presence only of 
cyanobacteria in Vaya dam and Durankulak dam – the presence of cyanobacteria 
and the toxin produced by them microcystin B; for Mandra dam are found only 
positive samples for cyanobacteria. 
Conclusion: RT-PCR is an important tool for the control of drinking water. Blue-
green algae are an important indicator of drinking water, and this requires more 
rigorous control and the introduction of molecular-genetic methods for this as 
reference. 
Correspondent author: Viktoria Ilieva, viki.ilieva1991@gmail.com; 0896828312 
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BONE REMODELLING EFFECTS OF SOPHORAE FRUCTUS 
EXTRACT AND CURCUMIN (CURSOL
®
) ON GOSERELINE-INDUCED 
OSTEOPOROSIS IN RATS 
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Introduction: Numerous natural compounds present in dietary and medicinal plants 
have been proven useful in the prevention and treatment of osteoporosis (OP). 
Sophora japonica L. (Fabacaeae) is a source of natural isoflavones as genistein and 
daidzein that could help alleviate the risk of fracture in osteoporotic patients. 
Curcumin is known for its anti-inflammatory action. 
Aim: The aim of the present study was to investigate the effects of Sophorae fructus 
extract (SFE) combined with highly soluble form of curcumin (Cursol®) on the skeletal 
system of rats with estrogen deficiency induced by subcutaneous implantation of a 
gonadtropin releasing hormone (GnRH) analogue goserelin (GR) (Zoladex®). 
Materials and methods: The experiments were carried out on 3-months-old Wistar 
rats, divided into four groups: control, estrogen deficient rats (ED), ED and 
supplemented with the combination of SFE (100 mg/kg/day) and Cursol® 2 g/kg/day, 
orally for 30 days, ED and supplemented with the positive control estradiol (EST) (40 
µg/kg/day). Serum and urine bone turnover markers, bone radiological and 
histopathological changes were studied. 
Results: GR treatment has a dramatic impact on the biochemical biomarkers and on 
the cancellous bone at the proximal tibia. The combination of SFE and Cursol® 
restored the biochemistry and histopathological changes in the chemically castrated 
animals. These effects were commeasurable with EST. 
Conclusion: These findings provide information about the bone protective effects of 
these natural substances against GR-induced bone loss, which could be developed 
as candidates for prevention of drug induced osteoporosis. 
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NEUROPSYCHIATRIC COMORBIDITIES IN EPILEPSY AND THE 
POSSIBLE BENEFICIAL EFFECT OF MELATONIN –THE EVIDENCES 
FROM META-ANALYSES 
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In one third of patients with epilepsy the antiepileptic treatment is without success. A 
possible reason for this could be the high neuropsychiatric comorbidity. Melatonin is 
an endogenous indoleamin with chronobiological, antioxidant and neuroprotective 
properties. It is registered in Europe both as a food supplement and as a medication 
for short-term treatment of insomnia in adults and for treatment of children with 
autism or Smith-Magenis syndrome. 
Our aim was: (1) to analyze the literature for the possible involvement of the 
melatonin system in the comorbidity in epilepsy, and (2) to analyze data from 
evidence-based medicines about efficacy and safety of melatonin. 
Materials and methods: Searching in data-bases Medline and Google Scholar, we 
identified and analyzed qualitatively meta-analyses published until May 2019 about 
neurological and psychiatric comorbidity of epilepsy with focusing on the melatonin 
co-medication. 
Results: The most common neuropsychiatric comorbidities in epilepsy are autism, 
depression with suicide, dementia, chronic pain, psychogenic nonepileptic seizures 
and multiple sclerosis. High level of evidence exists only for data about the efficacy of 
melatonin co-medication in cases with desynchronized biorhythms and insomnia. 
Some of the planned meta-analyses could not be realized due to the insufficiency of 
information. In general, data about the safety of melatonin are favorable. 
Conclusion: Conduction of well-planned clinical trials with patients with epilepsy and 
neuropsychiatric co-morbidity, evaluating the role of melatonin is needed. Usage of 
melatonin by children imposes more detailed evaluation of the safety profile. 
Acknowledgment: Supported by Bulgarian Science Fund DN 13/16 21.12.2017. 
 
 
SIGNIFICANCE OF ANTIBIOTIC RESITANCE IN CLINICAL 
PRACTICE AND MEASURES FOR LIMITING IT TO HOSPITALS 
Hristova M., Eneva-Dimitrova M. 
“Nadezhda” MHAT for Women’s Health 
 
According to the World Health Organization antibiotic resistance is one of the biggest 
threats for human health. Globally it is related to longer hospital stay, increased 
medical cost and increased morbidity and mortality. A multidisciplinary approach is 
necessary in hospital practice in order to limit antibiotic resistance including 
prevention of infection, rational prescribing of antibiotics after isolation of the 
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microorganism and determination of its sensitivity and antibiotic stewardship. Every 
hospital has to create antibiotic policy which corresponds to the national and 
international guidelines for treatment of bacterial infections as well as the scope of 
activities of the hospital. The aim of the current work is to determine the impact of the 
introduction of an antibiotic policy in a hospital on the frequency and severity of 
bacterial infections. A number of clinical cases of the emergency and progress of 
antibiotic resistance in hospital settings were reviewed. Based on the WHO 
recommendations on antibiotic resistance and the antimicrobial prescribing guideline 
of NICE, a hospital antibiotic policy was made. The policy aims at insuring proper 
antibiotic use and limiting antibiotic resistance. The changes in the prescription and 
application of antibiotics and the spread of resistant bacteria were examined before 
and after the implementation of the antibiotic policy. The results are presented as 
reduction of the prescription of antibiotics, reduction of the cost of treatment and 
influence on the spread of resistant microorganisms. 
 
 
NANOCOMPOSITE CRYOGEL CARRIERS FOR THE DELIVERY OF 
POORLY WATER-SOLUBLE DRUGS 
Petrov P.1, Momekova D.2 
1Institute of Polymers, Bulgarian Academy of Sciences, 103 A “Akad. G. Bonchev” 
Str., 1113, Sofia, Bulgaria; e-mail:ppetrov@polymer.bas.bg 
2Faculty of Pharmacy, Medical University, 2 “Dunav” Str., 1000, Sofia, Bulgaria 
 
Aim: The present study aims at developing nanocomposite cryogels comprising 
polymeric core-shell micelles for loading and sustained release of hydrophobic drugs. 
Materials and methods: Hydroxypropyl cellulose; hydroxyethyl cellulose; Pluronic 
P65; Pluronic F127; pentaerythritoltetraacrylate; (4-benzoylbenzyl) 
trimethylammonium chloride; N,N′-methylenebisacrylamide; curcumin; canabidiol; 
photo-crosslinking. 
Results: Polysaccharide cryogels comprising either stabilized or dynamic polymeric 
micelles were fabricated by combination of cryogenic treatment and photo-
crosslinking. The effect of micelle content on gel fraction yield, swelling degree, 
cryogel morphology and mechanical properties were evaluated. Two different 
methods of loading of poorly water-soluble drugs into nanocomposite cryogels were 
studied. Finally, the encapsulation efficiency and drug release profile of cryogel 
carriers were determined. 
Conclusions: Novel nanocomposite carriers were developed by embedding 
stabilized or dynamic core-shell micelles into polysaccharide cryogels. The tested 
systems exhibited sustained release profile and excellent physicochemical 
characteristics which make them applicable for topical delivery of hydrophobic drugs. 
Acknowledgments: This work was supported by the Bulgarian Ministry of Education 
and Science (Grant DО1-217/30.11.2018) under the National Research Programme 
“Innovative Low-Toxic Bioactive Systems for Precision Medicine (BioActiveMed)” 
approved by DCM # 658 / 14.09.2018 
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THERMORESPONSIVE POLY (N-ISOPROPYLACRYLAMIDE) 
COPOLYMER NETWORKS FOR GALANTAMINE HYDROBROMIDE 
DELIVERY 
Georgieva D.1, Kostova B.1, Ivanova-Mileva K.2, Ivanova S.2, Rachev D.1, 
Christova D.2 
1Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of 
Pharmacy, Medical University, 2 “Dunav” Str., 1000 Sofia, Bulgaria 
2Institute of Polymers, Bulgarian Academy of Sciences, “Akad. G. Bonchev” Str., Bl. 
103-A, 1113 Sofia, Bulgaria 
 
Aim of study: The aim of the present study was to synthesize poly (N-
isopropylacrylamide) (PNIPAAM) copolymer networks and evaluate their potential as 
drug carriers for galantamine hydrobromide (GH) delivery. 
Materials and methods: PNIPAAM copolymer networks were synthesized using two 
methods: free radical polymerization and redox polymerization. Poly (ethylene glycol) 
di-acrylate (PEGDA) was used as a crosslinker. The obtained networks were 
characterized by Fourier Transform Infrared Spectroscopy (FTIR), X-ray diffraction, 
the swelling kinetics were studied and in vitro drug release experiments were 
conducted. 
Results: PNIPAAM copolymer networks were synthesized and it was established 
that there was a difference in swelling kinetics of the networks obtained by the two 
methods. Networks prepared by redox polymerization swell in a bigger extent than 
those obtained by free radical polymerization. This affects GH-loading, which is 
higher for the first ones. GH release was monitored, revealing that the networks 
released up to 100% of the active substance within 4 hours. This rapid release was 
due to the increased solubility of GH, which was in amorphous state in the networks, 
which was proven by X-ray diffraction. 
Conclusions: PNIPAAM copolymer networks were synthesized and their potential 
as GH delivery systems was investigated. The studies conducted suggest that the 
networks have potential as GH drug delivery systems. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
back to 
contents 
 40 
 
IN VIVO STUDY OF ANTINOCICEPTIVE AND ANTI-INFLAMMATORY 
ACTIVITY OF KETOPROFEN BIGEL FOR DERMAL APPLICATION 
Peneva P.1, Apostolova E.2, Kassarova M.1 
1Department of Pharmaceutical Sciences, Faculty of Pharmacy,  
Medical University, Plovdiv 
2Department of Pharmacology and Drug Toxicology, Faculty of Pharmacy,  
Medical University, Plovdiv 
Corresponding author: Petya Peneva, tel. 0886358683,  
e-mail: pharmpeneva@abv.bg 
 
Aim of the study: The aim of the present study was to determine in vivo the 
antinociceptive and anti-inflammatory activity of carbopol hydrogel/sorbitan 
monostearate-almond oil bigel with ketoprofen for dermal application. 
Materials and methods: The bigel formulation was prepared from a carbopol 
hydrogel and sorbitan monostearate-almond oil oleogel in a 70/30 ratio. In vivo 
experiments were performed with 82 male Wistar rats (weighing 180 to 400 g). A test 
for acute dermal toxicity was conducted, antinociceptive activity was determined by 
hot plate test, anti-inflammatory activity was recorded with carrageenan induced 
edema. The animals with which the anti-inflammatory activity has been detected 
have been tested for anti-hyperalgesia effect. The obtained results were compared to 
a commercial product. 
Results: The bigel formulation with ketoprofen exhibits a well-expressed 
antinociceptive effect. It shows better anti-inflammatory activity and anti-hyperalgesia 
effect in the first hour of the study compared to a market product hydrogel. The test 
for acute dermal toxicity showed that the bigel formulation could be considered as 
safe. 
Conclusion: As a result of the in vivo experiments, it was found that the bigel 
formulation could be considered as safe and effective dosage form for dermal 
application. 
 
 
SOLUBILITY OF FENOFIBRATE IN HUMAN GASTRO-INTESTINAL 
MODEL 
Katev V., Vinarov Z., Radeva D., Tcholakova S., Denkov N. 
Faculty of Chemistry and Pharmacy, Sofia University, Sofia, Bulgaria 
e-mail: vk@lcpe.uni-sofia.bg 
 
Aim: Many new drug candidates are poorly water soluble, which results in low and/or 
variable intestinal absorption. One of the modern approaches to solve this problem is 
by using lipid-based drug delivery systems (LBDDS). The LBDDS contain lipids, 
surfactants and co-solvents. The aim of the study is to clarify the effect of natural 
surfactants which are encountered in the food, GI-tract or they are lipolysis products, 
on the fenofibrate solubility by using a GIT in-vitro model. 
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Materials and methods: We studied fatty acids, phospholipids and monoglycerides 
with different hydrophobic chain length and saturation. The solubility of fenofibrate 
was determined by high-performance liquid chromatography (HPLC). 
Experimental results: A maximum in the fenofibrate solubility was observed with 
increasing chain length and in the presence of double bond in the molecule. Highest 
solubility was achieved when a phospholipid was used. We measured intermediate 
solubility when we used monoglycerides and lowest when using fatty acids. 
Conclusion: The relationship between the structure of natural surfactants and 
fenofibrate solubility was clarified by using an in-vitro digestion model. 
References: 
1. Z. Vinarov, V. Katev, D. Radeva, S. Tcholakova, N. Denkov. Drug. Dev. Ind. 
Pharm., 44 (2018) 677-686. 
2. Z. Vinarov, V. Katev, N. Burdzhiev, S. Tcholakova, N. Denkov, Molеcular 
Pharmaceutics, 15 (2018), 5741−5753. 
 
 
IMPACT OF SURFACTANT-BILE INTERACTIONS ON THE 
SOLUBILITY OF HYDROPHOBIC DRUGS 
Vinarov Z., Tcholakova S., Denkov N. 
Department of Chemical and Pharmaceutical Engineering, 
Faculty of Chemistry and Pharmacy, Sofia University 
e-mail: zv@lcpe.uni-sofia.bg 
 
Aim: Up to 90% of the new molecular entities have poor aqueous solubility, which 
leads to low oral absorption. One of the solubility enhancement techniques is 
solubilization in surfactant solutions. 1-4 However, surfactant micelles can interact with 
the bile salts in the intestines, thereby changing drug solubility. 5 The aim of our study 
is to clarify how the drug and surfactant structure determines drug solubilization, and 
to demonstrate the impact of bile salts on micellar drug solubility. 
Materials and methods: We studied a total of 17 surfactants and 6 hydrophobic 
drugs. Drug solubility was determined by HPLC. The size of colloidal aggregates and 
the surfactant-bile interactions were investigated by DLS and DOSY 1H NMR. 
Results: The solubility of all studied drugs increases with the increase of the 
surfactant hydrophobic chain length. Very high solubilization was determined for 
pairs of oppositely charged surfactant and drug molecules, due to the electrostatic 
attraction. Drug precipitation was observed when drug-loaded ionic surfactant 
micelles were introduced in bile solutions. In contrast, the drugs remained solubilized 
in mixtures of nonionic surfactants + bile. 1H DOSY showed that mixed bile salt + 
surfactant micelles with low drug solubilization capacity were formed for the ionic 
surfactants, whereas separate surfactant-rich and bile salt-rich micelles were found 
to coexist in the nonionic surfactant + bile mixtures. 
Conclusion: The relationship between surfactant and drug structure, and the 
solubilization capacity was clarified. It was shown that surfactant-bile interactions can 
have a dramatic effect on drug solubility, which can affect the oral drug absorption. 
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CALORIMETRIC STUDY ON SOLVENT MEDIATED INTERACTIONS 
OF INDOMETHACINE WITH POLY(N-ISOPROPYLACRYLAMIDE)-
GRAFT-POLY(ETHYLENE OXIDE) COPOLYMER 
Valkova I.1*, Michailova V.2 
1Department of Chemistry, Medical University, Sofia 
2Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of 
Pharmacy, Medical University, Sofia 
Corresponding autor: Tel: +359 2 9236 599, e-mail: ivalkova@abv.bg 
 
The application of NSAID indomethacine (IMC) has been limited because of its 
hydrophobicity. This limitation can be overcome by associating it with a delivering 
carrier. Thermoresponsive poly(N-isopropylacrylamide)-graft-poly(ethylene oxide) 
(PNIPAM-g-PEO) is attractive for such applications as it forms core-shell 
nanostructures close to physiological temperature. It can also micellize in aqueous 
ethanol solutions and that can be used to enhance drug solubilization and loading 
within PNIPAM chains. 
Isothermal titration calorimetry (ITC) is one of the most reliable techniques that permit 
direct thermodynamic characterization (standard free energy, enthalpy and entropy) 
of associative processes in complex media. То examine the effect of the organic 
solvent on the IMC-PNIPAM interaction we conducted ITC measurements in 
phosphate buffer (PBS) pH 7.4 and its mixtures with ethanol. 
It is found that in PBS the interaction between IMC and PNIPAM is mainly 
hydrophobic since the entropy changes are all positive and the contribution of − T∆S° 
to ∆G° is larger in magnitude than that of ∆H°. 
The picture completely changes when PBS solutions of PNIPAM are titrated with 
ethanol and IMC/ethanol solutions. The interactions are accompanied by large 
negative changes in enthalpy and a significant entropy decrease, suggesting that the 
hydrogen binding of ethanol to PNIPAM energetically dominates the hydrophobic 
IMC-PNIPAM interactions. We also noticed that the heat flow is larger for the IMC-
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containing systems that could be attributed to the ability of IMC to promote ethanol 
accumulation within the PNIPAM chains. This finding is also confirmed by the 
negative values of ∆H° and ∆S° from the IMC/ethanol-PNIPAM/ethanol titration in 
which the IMC and PNIPAM solvation shells are in equilibrium with the tested solvent 
composition. Combining all the above results, the most likely contribution to such 
enthalpy and entropy changes is the mutual synergistic effect of IMC and ethanol on 
their complexation with PNIPAM. 
Acknowledgements: This research was carried out with the financial support of 
Medical University of Sofia, Grant-Project 8273/21.11.2018, Financial contract D-
77/23.04.2019. 
 
 
IN VITRO CARDIOPROTECTIVE EFFECTS OF DOXORUBICIN 
ENCAPSULATED IN CHITOSAN-ALGINATE PARTICLES 
Yordanov Y.1, Tzankov B.2, Tzankova V.1, Frosini M.3, Valoti M.3, Yoncheva K.2 
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3Department of Life Sciences, University of Siena, Siena, Italy 
Corresponding author: Yordan Yordanov 
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Aim: Doxorubicin (DOX) is a potent and widely used chemotherapeutic drug, but its 
application is often related to severe dose-dependent cardiotoxicity by oxidative 
stress mediated mechanisms. Encapsulation of DOX in nanoparticulate drug delivery 
systems could reduce the side effect of doxorubicin. The aim of the present study 
was to compare the cytotoxic effects of free and encapsulated in chitosan alginate 
particles doxorubicin on two cell lines in vitro. The effects of encapsulated DOX on 
glutathione (GSH) antioxidant system were also evaluated. 
Materials and methods: The cytotoxic effects of free and encapsulated doxorubicin 
were evaluated on H9c2 cells (cardioblasts) and on L5178 MDR1 (multidrug resistant 
lymphoma cells). The cytotoxic effects were evaluated by means of the MTT – test 
and Alamar blue metabolic assays. The effects on the levels of total glutathione and 
the GSH/GSSG ratio were investigated by means of a modification of Tietze‟s 
enzymatic-recycling assay. 
Results: The encapsulated DOX showed decreased cytotoxicity on H9c2 
cardioblasts, while the cytotoxic effects were retained on lymphoma L5178 MDR1 
cells. The treatment with encapsulated DOX (sub cytotoxic concentrations) caused 
reduction in GSH oxidation compared to free DOX. The GSH/GSSG ratio was 
optimal in cells, treated with non-loaded chitosan-alginate particles, which shows the 
lack of pro-oxidant activity and a positive safety profile of the drug carrier. 
Conclusion: Chitosan-alginate nanoparticles are a promising drug carrier that 
effectively encapsulated doxorubicin retained its cytotoxic effects on multidrug 
resistant L5178 lymphoma cells and exerted an in vitro cardioprotective effect on 
H9c2 cells. 
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MEMBRANE PERMEABILITY OF FENOFIBRATE SOLUBILIZED IN 
SURFACTANT MICELLES 
Krastev D.1, Vinarov Z.1, Müllertz A.2, Tcholakova S.1 
1Department of Chemical and Pharmaceutical Engineering, Faculty of Chemistry and 
Pharmacy, Sofia University, Bulgaria 
2Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark 
 
Aim of the study: The main factors governing the oral bioavailability of 
pharmaceuticals are their solubility and permeability. In previous articles we have 
showed [1-2] that the solubility of fenofibrate can be enhanced significantly (over 100 
times) in aqueous solutions with the help of surfactants. In continuation of this 
research, the main goal now is to determine the effect of surfactant type on the 
permeation rate of fenofibrate. 
Materials and methods: To measure these effects we have used a cell-free in vitro 
permeability system µFlux (Pion Inc.), with continuous in situ optical fiber monitoring 
of the drug concentration in both the donor and the acceptor compartment during the 
experiment. 11 surfactants with different hydrophobic chain length (from C-10 to C-
18) and different charge of the hydrophilic head group were studied. 
Results: The results show that there are significant differences between ionic and 
non-ionic surfactants. After the end of the experiment, the drug concentrations in the 
acceptor compartment were three to four times higher with ionic surfactants (SDS 
and TTAB) compared to nonionic surfactants (Tween and Brij). 
Conclusion: The obtained results demonstrate that the permeation rate depends 
significantly on the type of surfactant used for drug solubilization. Additional 
experiments with broader selection of surfactants and permeation experiments with 
phospholipid bilayers are planned, in order to clarify the main mechanism that 
governs the transmembrane transport of drugs solubilized in surfactant micelles. 
References: 
1. Z. Vinarov, V. Katev, D. Radeva, S. Tcholakova, N. Denkov. Drug. Dev. Ind. 
Pharm., 44 (2018) 677. 
2. Z. Vinarov, V. Katev, N. Burdzhiev, S. Tcholakova, N. Denkov, Mol. Pharm. 
559 (2018) doi: 10.1021/acs.molpharmaceut.8b00884. 
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IN VITRO SAFETY AND ANTIOXIDANT ACTIVITY EVALUATION OF 
CAFFEIC ACID PHENETHYL ESTER LOADED COPOLYMER 
MICELLES 
Aluani D.1, Tzankova V.1, Yoncheva K.2, Bankova V.3 Atanasova M.4, 
Grancharov G.4, Petrov P.4 
1Department of Pharmacology, Pharmacotherapy and Toxicology,  
Faculty of Pharmacy, Medical University of Sofia, Bulgaria 
2Department of Pharmaceutical Technology and Biopharmaceutics,  
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
3Institute of Organic Chemistry with Center for Phytochemistry,  
Bulgarian Academy of Sciences, Sofia, Bulgaria 
4Institute of Polymers, Bulgarian Academy of Sciences, Sofia, Bulgaria 
Caffeic acid phenethyl ester (CAPE), one of the components of propolis, possesses 
broad biological activities as antioxidant, anti-inflammatory, anticancer, etc. However, 
the higher lipophilicity of CAPE limits its in vivo applications, since the low water 
solubility hinders both the formulation of stable drug dosage form and its 
bioavailability. 
 
Aim: Safety evaluation and antioxidant activity of a newly developed CAPE loaded 
poly (ethylene oxide)-b-poly (ε-caprolactone)-b-poly (ethylene oxide) (PEO-PCL-
PEO) micelles in vitro. 
Methods: In vitro toxicity screening of the newly developed PEO-PCL-PEO 
copolymer micelles on human endothelial Ea.hy926 cells. The viability of the cells 
was assessed by MTT assay and lactate dehydrogenase (LDH) leakage. The 
antioxidant properties of pure and micellar CAPE were determined in a model of 
H2O2-induced oxidative damage in Ea.hy926 cells. 
Results: The treatment of Еa.hy926 cells with empty micelles showed slight cell 
viability decrease at the highest studied concentrations (125 and 250 µg/ml). In 
contrast, the treatment with pure CAPE (17 and 34 µg/ml) caused a statistically 
significant decrease of cell viability by 38% and 50% (***p<0.001) vs untreated 
control group. LDH release was increased by 32% and 41% (***p<0.001) vs 
untreated controls at both tested concentrations. A similar trend was observed with 
the CAPE-loaded micelles on endothelial cells. The results from H2O2-induced 
oxidative damage showed similar antioxidant effects of pure and micellar CAPE. 
Conclusion: The presented data showed a beneficial safety profile of PEO-PCL-
PEO micelles and suggested that the CAPE loading in copolymer micelles preserved 
its antioxidant properties in vitro in human endothelial cells.  
Acknowledgments: The financial support from the National Science Fund of 
Bulgaria (Contract DN-09/1-2016) is greatly acknowledged. 
Corresponding author: Denitsa Aluani  
email: denitsa.aluani@gmail.com tel: 359888869426 
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PREPARATION AND CHARACTERIZATION OF DOXYCYCLINE 
LOADED NIOSOMES FOR OCULAR DELIVERY 
Gugleva V.1, Momekova D.2, Titeva S.1, Rangelov S.3 
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Aim of the study: Niosomes are vesicular systems, formed from the self-assembly 
of non-ionic surfactants and cholesterol in aqueous media. In ocular therapeutics 
doxycycline is known to be effective in management of matrix metalloproteases-
mediated ocular surface diseases. The aim of this study was to prepare and evaluate 
niosomes for ophthalmic drug delivery of doxycycline hyclate. 
Materials and methods: Niosomes were prepared using various surfactants (Span 
20, Span 60, Span 80, Tween 60) and cholesterol in different molar ratios by thin film 
hydration method followed by extrusion and reverse phase evaporation method. 
Niosomes were characterized by transmission electron microscopy, dynamic light 
scattering, Fourier-transform infrared spectroscopy, doxycycline entrapment 
efficiency and in vitro release performance. Ocular irritation test was also conducted. 
Results: Niosomes composed of Span 60 and cholesterol at 6:4 molar ratio 
prepared by thin film hydration and extrusion method are characterized with diameter 
163 nm, monomodal size distribution and entrapment efficiency of 52%. Niosomes 
prepared by reverse phase evaporation method from Span 60 and cholesterol in 
molar ratio 7:3 are characterized with larger size (720 nm) and higher entrapment 
efficiency (app.59%). In vitro drug release studies indicated sustained doxycycline 
release up to 20th hour. Both niosomal formulations were non-irritant and excellently 
tolerated by the eye. 
Conclusion: On the ground of the excellent physicochemical characteristics, in vitro 
release studies and occular irritancy test can be concluded that the elaborated 
niosomes are promising nanocarriers for ocular delivery of doxycycline hyclate. 
 
 
DEVELOPMENT OF ADVANCED DRUG DELIVERY SYSTEMS 
BASED ON MESOPOROUS SILICA NANOPARTICLES 
Popova T., Tzankov B., Voycheva C., Spasova I., Avramova K., Kovacheva D., 
Yoncheva K., Lambov N. 
Faculty of Pharmacy, Medical University, Sofia 
 
The aim of the study: Bicalutamide (BLT) is one of the most widely used agents in 
androgen ablation therapy. Due to its low aqueous solubility BLM is included into 
class II of biopharmaceutic classification system (BCS). Considering this the aim of 
the present study is to develop mesoporous silica nanoparticles as drug delivery 
systems with improved therapeutic outcomes. 
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Materials and methods: For the need of the present study the active substance was 
included into two different types mesoporous silica nanoparticles – MCM-41 and 
SBA-16 characterized with good potential for the functionalization, high drug loading 
capacity as well as improved stability. FTIR, N2-physisorption, XRD, TGA and TEM 
were used for physico-chemical characterization of obtained formulations. In-vitro 
dissolution studies were also performed in order to determine the release kinetics of 
bicalutamide. 
Results: The results from performed analysis confirmed no changes in mesoporous 
structure after drug loading procedure. Moreover, the obtained nanoparticles had 
negative surface charge and average diameter less than 500 nm. In-vitro dissolution 
tests demonstrated differences into release kinetics of an active substance from 
obtained mesoporous silica nanoparticles compared to the dissolution behavior of a 
pure substance. 
Conclusion: In the current study mesoporous silica nanoparticles were successfully 
obtained and loaded with model active substance with low aqueous solubility and 
pronounced cytostatic effect. The changes of the release kinetics of bicalutamide 
were probably due to the high surface area and changed crystallinity of an active 
substance, owing to the inclusion into mesoporous silica nanoparticles. 
 
 
ANALYSIS OF THE STRUCTURAL AND FUNCTIONAL 
CHARACTERISTICS OF ADVANCED THERAPY MEDICINAL 
PRODUCTS 
Shopov G., Hristov E. 
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“Sveti Kliment Ohridski” Sofia University, Bulgaria 
Corresponding author: George Shopov 
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Introduction: Nowadays of rapid development of biotechnology and genetic 
engineering, advanced therapy medicinal products are emerging as a new class of 
innovative medicinal products. Advanced therapy medicinal products are divided into 
three main types: tissue engineering medicinal products, gene therapy medicines 
and somatic cell therapy. Aim: In a comparative perspective, we analyze 
mechanisms of action of the various types of advanced therapies, evaluate their 
structural and functional characteristics, with an emphasis on viruses as vectors and 
carriers of therapeutic effect of the so-called “oncolytic viral therapies”. 
Materials and Methods: Through graphic analysis, static and dynamic 2D and 3D 
models we will present cellular and tissue constructs involved in building this type of 
medicinal products as well as their mechanisms of action.  
Results and Conclusion: In the development of this area of medicinal products, 
science is a matter of the future and enormous hopes for the treatment of severe 
traumas, rare diseases, genetic and oncologic diseases. 
Key words: Medicinal products, advanced therapy, oncolytic viruses 
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IMMUNOGENICITY PREDICTION OF BACTERIAL PROTEINS BY 
RANDOM FOREST ALGORITHM 
Zaharieva N., Doytchinova I., Dimitrov I. 
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
tel.: +359 2 9236537 
 
Immunogenicity is defined as the ability of a substance to produce an immune 
response in the host. Bacterial proteins are the most common substances associated 
with the etiology of infectious diseases. The in silico prediction of protein 
immunogenicity is the first step in the process of vaccine design and development. 
Ten years ago, a server for immunogenicity prediction of proteins of bacterial, viral, 
fungal, parasite and tumor origin, named VaxiJen (http://www.ddg-
pharmfac.net/vaxijen/VaxiJen), was developed in our Lab. The models for 
immunogenicity prediction were derived by partial least square (PLS) discriminant 
analysis on sets of known immunogenic and non-immunogenic proteins. The primary 
structures of proteins were encoded by z-descriptors and transformed into uniform 
vectors by auto- and cross-covariance (ACC) calculations. 
Recently, the set of bacterial immunogens was updated and now it contains 317 
proteins from 47 species (http://www.ddg-pharmfac.net/vaxijen/ VaxiJen/database. 
fasta). A mirror set of non-immunogenic proteins from the same species was 
collected. The amino acids in the primary structure of each protein were represented 
by five E-descriptors. The first descriptor (E1) reflects the hydrophobicity of amino 
acid; the second (E2) – size; the third (E3) – helix propensity; the forth (E4) 
correlates with the relative abundance of amino acid; and the fifth (E5) is dominated 
by β-sheet propensity. The resulting protein strings were transformed into uniform 
vectors by ACC. 
The new dataset was used to derive models by PLS discriminant analysis and by 
random forest algorithm (RF). The predictive ability of the derived models was 
assessed by receiver operating characteristics curves (ROC-statistics) after 10-fold 
cross-validation. The RF model showed better overall performance than the PLS 
model. The area under the ROC curve (AUC) and the prediction accuracy are 0.834 
and 0.752, respectively, for the RF model vs 0.702 and 0.732 for the PLS model. 
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PROSPECTIVE STUDY OF ADVERSE DRUG REACTIONS IN THE 
BULGARIAN POPULATION OF PATIENTS WITH INFLAMMATORY 
JOINT DISEASES TREATED WITH BIOLOGICAL MEDICINAL 
PRODUCTS 
Parvova I.1, Rangelov A.2, Hristov E.2, Rashkov R.1, Getov I.3, Ognianov S.2 
1Department of Internal Medicine, Clinic of Rheumatology, 
 “Sveti Ivan Rilski” University Hospital, Medical University, Sofia, Bulgaria 
2Faculty of Chemistry and Pharmacy,  
“Sveti Kliment Ohridski” Sofia University, Bulgaria 
3Department of Social Pharmacy, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
Corresponding author: Iva Parvova MD, PhD, Fepartment of Internal Medicine, Clinic 
of Rheumatology, “Sveti Ivan Rilski” University Hospital”,  
Medical University, Sofia, Bulgaria 
13 “Urvich” str., 1612 Sofia, Bulgaria 
e-mail: ivaparvova@mail.bg 
Tel: 00 359 894 463 171 
 
Aim: To analyze Adverse Drug Reactions (ADRs) in patients with inflammatory joint 
diseases eligible to treat with biological medicinal products (BMP). Materials and 
Methods: A single-center, observational, open-label, prospective, non-interventional, 
pharmacoepidemiological study of clinical cases of ADRs in the Bulgarian population 
of patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic 
arthritis (PsA), treated with BMP between March 2015 and October 2016. The study 
was conducted on a protocol basis and after signed informed consent. Patients are 
treated with: Etanercept, Adalimumab, Golimumab, Certolizumab, Rituximab. The 
statistical analysis was made with SPSS version 16.0.  
Results: 53 patients were screened, 5 did not meet the inclusion criteria; 47 enrolled, 
5 - withdrawn from the study, 42 - analyzed. Disease distribution: RA-40.5% (n=17), 
PsA-19% (n=8), AS-40.5% (n=17). Women - 52% (n=22), male - 48% (n= 0). 76% of 
patients was treated with Adalimumab and Etanercept. 17% of patients (n=7), 
biological treatment was discontinued due to serious ADRs. 3 of them were 3rd 
grade of severity, 4 – 4th grade. The largest relative share occupied by ADRs with 
grade of severity 1 and 2, as 1 being 63%. The total number of reported and 
confirmed ADRs is 160. 3 ADRs meet the definition of SUSAR; 30 was unexpected; 
127 - suspected. The total incidence of ADR was measured at 4.37 ADR/patient. 
Discussion: We have established a very high incidence of ADRs that is 
inappropriately higher than pre-authorization data for the analyzed BMP. The most 
common cause of discontinuation of biological therapy in patients with inflammatory 
joint disease is the onset of ADR. 
Keywords: inflammatory joint diseases, adverse drug reactions, biological treatment, 
prospective study 
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MONOCLONAL ANTIBODIES PATHWAY 
Marinov L., Nikolova I. 
Faculty of Pharmacy, Medical University, Sofia 
 
Monoclonal antibodies (mAbs) are one of the most important classes of therapeutic 
proteins that are used for the treatment of various oncological, inflammatory and 
autoimmune diseases. Their development began more than 40 years ago. The first 
authorized mAb, in 1986, was muromonab-CD3, followed by chimeric (Abciximab) in 
1995 and the first fully human antibody – Necitumumab, registered in 1999. 
During the period 2005-2017, around 880 monoclonal antibodies have started clinical 
trials, of which more than 80 have a marketing authorization. There is a tendency to 
increase their number in each subsequent year - from 12 in the early 1990-s to 70 in 
2014. In 2015-2017, there has been an increase in the number of molecules that 
have started clinical trials to over a 100 per year. In 2013, the first biosimilar mAb, 
Infliximab, was registered in Europe. Approximately 20% of all registered mAbs have 
an oncological indication, 17% haematological, 13% dermatological, 11% 
rheumatologic, 10% gastroenterological and pulmonary, 7% are related to 
orthopedics, 4% to cardiology, 3% to ophthalmology and immunology, 1% with 
nephrology and lymphology. In 2018, 12 new mAbs have been authorized for use in 
Europe and US; 9 of them have indications different from cancer, including three for 
migraine prevention and one for HIV treatment. 
Monoclonal antibodies market is expected to almost double in 2023 compared to 
2018 and reach over 63 billion USD. In addition to cancer and autoimmune diseases, 
new fields for the development of mAbs include obesity, diabetes, Alzheimer's 
disease, bacterial infections and skin diseases. 
 
 
OUR CONTRIBUTION IN DEVELOPING OF INNOVATIVE 
POLYBACTERIAL IMMUNOSTIMULATORS FOR IMMUNOTHERAPY 
AND IMMUNOPROPHYLAXIS 
Schekerdjiiska S., Georgiev N., Schekerdjiiski R. 
NATSTIM Ltd 
 
Aim: Creation and production of polybacterial immunostimulators - products of 
natural or synthetic origin, resulting from the development of modern biotechnology 
with different chemical characteristics and mechanism of action. 
Developing of low-dose polybacterial immunostimulators based on the established 
and widely used in medical practice - Respirax, Urostim. 
Creation and implementation of products for immune-prophylaxis to enhance the 
body's natural resistance to various bacterial and viral infections, to support the 
treatment of other pathogenetically related diseases such as malignancies. It is also 
known the negative effect on the immune system of the increasing pollution of the 
environment and especially of the air, the increasing radiation, which further directed 
our efforts in the creation of products related to immunostimulation and immune-
prophylaxis. 
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Materials and methods: The detailed and extensive clinical trials conducted with 
Respivax, Urostim, in the last years and their positive impact on the various 
mechanisms of the immune system, as well as the long-standing experience of their 
uses, have led to the creation of various so-called "Target" polybacterial 
immunostimulators for oral administration to stimulate the natural mechanisms of the 
immune system and to assist in the prophylaxis of infections of the respiratory and 
urogenital systems. 
Results: Based on the long-standing experience in creation of combined 
antioxidants and immunomodulator products, we developed a new formula which 
contains a patented immunosupporting complex and a specific list of essential 
antioxidants and micronutrients (Respisim, Pharynostim, Immuno-Uroprostanorm, 
etc.). 
Conclusion: IMUNOSTIMULATORS are particularly suitable for the prophylaxis and 
treatment of: 
• Influenza and other viral respiratory infections and subsequent secondary bacterial    
  infections; 
• Infections of different organs and systems induced by antibiotic and  
  chemotherapeutic resistant strains; 
• Infections with different localization in patients with hypersensitivity reactions to  
  antibiotics and other antibacterial agents used; 
• Lack of antibiotics for specific treatment of viral infections; 
• In the complex therapy of malignancies; 
• In the control of diseases and conditions associated with suppressed immune  
  system resulting from the action of harmful factors in the working environment. 
*The products quoted above are commonly developed with NCIPD, BUL BIO-NCIPD 
and NATSTIM Ltd 
. 
 
JOINT EUROPEAN LEGISLATION ON HEALTH TECHNOLOGIES 
ASSESSMENT – WHERE THE COUNTRIES COULD COLLABORATE 
Petrova G. 
Faculty of Pharmacy, Medical University, Sofia 
 
Introduction: The Proposal for a Regulation on health technology assessment and 
amending Directive 2011/24/EU for joint health technologies assessment (HTA) 
raised a numerous discussions in society. 
Goal: The current work presents the results from the study of the historical 
development of the collaboration between the European countries in the area of HTA 
and the possibilities of its further enlargement. 
Methods: Historical analysis of the development of European legislation and 
regulatory projects in the area of HTA during 1994-2019. 
Results: Collaboration in the area of HTA is 20 years old and starts with the 
financing of the project EUR-ASSESS of the European commission in 1994-96, 
followed by other projects as ECHTA/ECHAHI and tree years lasting EU Joint Action 
project EUnetHTA. The objectives of these projects were to create a joint framework 
for effective creation and development of joint HTA, which further to be used from the 
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European regulatory institutions. During the latest 3 years some countries developed 
regional collaboration in medical and health technologies, pricing and reimbursement 
areas as are the BeNeLuxAIr, Valletta, FINOSE and Visegrad initiatives. The HTA 
Network was created with art. 15 of the Directive 2011/24/EU. In 2019 the European 
commission approved the new project HTx (Next generation HTA) which gathers 
together 16 European universities and governmental institutions. The Medical 
university of Sofia is part of this project. 
Conclusion: Having in mind the successful initiatives, the joint assessment of the 
efficacy and safety of new health technologies is more recommendable. 
Endorsement of joint standard for evaluation will increase the requirements towards 
the HTA at national level; decrease the duplication of work and eliminate the doubling 
ad collection of data. This will increase the objectivity and transparency of decision-
making for public finding of new technologies. At national level will remain the cost-
effectiveness and budget impact evaluation of new health technologies. 
 
 
ANALYSIS OF THE CHANGES IN REGULATORY POLICY OF 
PRICING AND REIMBURSEMENT OF MEDICNAL PRODUCTS IN 
BULGARIA 
Savova A., Nikolova I., Terezova S.,  Zidarova B., Vasileva M., Apostolova D., 
Danchev N. 
Faculty of Pharmacy, Medical University of Sofia; National Council on Pricing and 
Reimbursement of Medicinal Products 
 
Goal: To analyse the recent changes in the regulatory basis of pricing and 
reimbursement of medicinal products in Bulgaria. 
Materials and methods: Regulatory analysis of two normative documents – Law on 
medicinal products in human medicine (Law) and Regulation on conditions, rules, 
and order for regulation, and registering of the prices of medicinal products for 
human use (Regulation) in 2019. 
Results: Based on the changes in the Law the Regulation on pricing and 
reimbursement new procedures have been introduced, namely for health technology 
assessment (HTA) and therapeutic effect monitoring for advanced medicinal 
products included in the Positive Drug List (PDL). The requirement for at least one 
positive HTA evaluation from governmental institutions in UK, France, Germany, and 
Sweden is also introduced for applying for inclusion into the PDL. 
The order for conditions and criteria for monitoring of the therapeutic effect of 
advanced therapies, as well as the authorized health care establishments is defined. 
Number of reference countries for external prices comparison is decreased from 17 
to 10 and they all became obligatory. With the changes in the Tariff for taxes 
according to the Law for medicines new governmental taxes are endorsed for HTA 
process funding. As the Annex to the Regulation are explained in details instructions 
for preparation and evaluation of HTA dossiers. 
Conclusion: The changes in the Regulation on pricing and reimbursement of 
medicinal products aimed at optimising the decision making process for listing into 
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the PDL. They introduce one new contemporary European approach for health 
technologies assessment and prices control of medicinal products in Bulgaria. 
 
 
METHODOLOGICAL AND TECHNOLOGICAL APPROACH TO 
IMPROVING THE STATISTICAL ACCURACY OF DIAGNOSTIC TEST 
AND METHODS 
Mitov K., Tachkov K. 
Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, 
Medical University, Sofia 
 
Goal: To develop a methodologic and technological approach for reducing the risk of 
errors when diagnosing patients with reference intervals, which are not fixed and can 
change with time. 
Methods: A cyclical, stepwise, programming approach and recommendations on its 
implications on an individual and laboratory level has been proposed. This approach 
is based on the development of a register for systemic collection, accumulation and 
analysis of data from clinical tests. 
Results: Establishing reference intervals for a given diagnosis, although useful, hide 
risk of several statistical errors, not always considered – errors in poor laboratory 
data, errors due to a lack of a representative sample of measurements on an 
individual level, errors attributable to the sensitivity and specificity of the applied 
method, errors due to a change in a reference interval. To objectify the diagnostic 
process, tree types of data are required, which guidelines do not offer: data on mean 
value, data on variation and data on variability of clinical markers. An individual level 
solution would be the automatization of data collection and creation of control 
diagram, comprising an individual‟s clinical parameters and tendencies for a given 
time period. On a laboratory level, the creation of a register with all tests carried out, 
stratified by type of test would allow calculation of a population interval and 
variations. On a national level this would improve diagnosis by calculating well-
defined, population-based reference intervals. 
Conclusion: In the field of diagnostics, modern electronic technologies for 
continuous collection, accumulation and analysis of clinical records, offer possibilities 
for improving early diagnosis of high-risk individuals. 
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COST-EFFECTIVENESS ANALYSIS OF THERAPY FOR 
ACROMEGALY – A CASE WITH PEGVISOMANT 
Kamusheva M.1, Rusenova Y.1, Vandeva S.2, Mitov K.1, Petrova G.1 
1Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, 
Medical University, Sofia, Bulgaria 
2Clinical Center of Endocrinology and Gerontology, Medical University, Sofia 
Corresponding author: Maria Kamusheva,  
e-mail: mkamusheva@pharmfac.mu-sofia.bg, Tel. Number: 0886428154 
 
The aim of the study: To assess the cost-effectiveness of pegvisomant in 
comparison to octreotide for patients with acromegaly in Bulgaria. 
Materials and methods: Cost-effectiveness analysis is performed from the 
perspective of National Health Insurance Fund (NHIF) and includes: determination of 
effectiveness expressed as change in the levels of insulin-like growth factor 1 (IGF-1) 
(nmol/l) on the basis of real-world data extracted from existing acromegaly patients 
registry in Bulgaria, calculation of the annual costs for each alternative (octreotide 
and pegvisomant), estimation of incremental cost effectiveness ratio (ICER), 
application of one-way sensitivity analysis and presentation of the results through the 
Tornado diagram. 
Results: The ICER is 18 438.38 BGN per 1nmol/l reduction in IGF-1, which 
expresses the additional money that should be paid per one additional unit of result. 
The incremental ratio is lower than the threshold of 3xGDP (gross domestic product 
per capita) defined by the World Health Organization. The key parameters are varied 
within the intervals +/-5% for effectiveness and +/-5%, +/-15% and +/-30% for the 
cost. The increase of pegvisomant effectiveness with 5% leads to most significant 
change in ICER as it receives the lowest possible ICER value of 9 089,07 additional 
money per 1nmol/l additional reduction in IGF-1 in comparison with octreotide. 
Conclusion: Pegvisomant leads to better therapeutic outcomes and higher 
pharmacotherapy costs for acromegaly patients. It is a cost-effective alternative from 
the NHIF perspective. The reduction of pegvisomant annual expenditures with 30% 
and 15% and the increase of its effectiveness with 5% have significant impact on 
ICER value. 
 
 
BREAST CANCER LANDSCAPE MAPPING IN BULGARIA 
Dimitrova M., Petrova G. 
“Organization and Economy of Pharmacy” Department,  
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
Corresponding author: Maria Dimitrova, 
e-mail: mdimitrova@pharmfac.mu-sofia.bg, 02 9235 568 
 
Aim of the study: To evaluate the screening, diagnostic, health care services and 
therapy practices in breast cancer (BC) and their availability in Bulgaria. 
Materials and methods: Demographic, epidemiological, clinical, therapeutic and 
economic profile of the disease was created using the publically available data bases 
of the National Cancer Register, National Health Insurance Fund and National 
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Council of Prices and Reimbursement of Medicines. Data were processed through 
descriptive statistics. 
Results: BC is the most common cancer among women in Bulgaria (26.8%) and 
according to expert data about 65% are diagnosed in I-II stage, however, there is no 
mechanism for controlled action of early detection yet. The average 5-year survival 
rate is 72% for stage I-II and 27% for the advanced breast cancer (ABC) but is still 
under the average for the European Union. The applied methods for diagnosis and 
monitoring of BC follow the international guidelines with the majority of them covered 
with public expenditures. The pharmaco-therapeutic guideline complies with the 
ESMO and NCCN recommendations and patient access to therapy is relatively fast 
through the inclusion of medicines in the Positive Drug List (PDL). Currently only one 
CDK 4/6 inhibitor (ribociclib) for ABC has no market access granted yet but it has 
positive HTA decision and is about to be included in PDL. 
Conclusion: BC continues to place substantial economic and social burden. Stricter 
follow of the international guidelines and some improvements in the health policies 
should be placed in order to increase the early detection. 
 
 
ANALYSIS OF PRIMARY OUTPATIENT DATA FOR OFF-LABEL USE 
OF MEDICINES IN NEUROLOGY 
Drenska M.¹, Elitova S.¹, Grigorova V.², Naseva E.³, Getov I.¹ 
¹Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
2Acibadem City Clinic Cancer Center, Sofia, Bulgaria 
3Faculty of Public Health, Medical University Sofia, Bulgaria 
Corresponding author: Drenska Maria;  
e-mail: maria.drenska@gmail.com 
 
Objective: The off-label use of medicines is a common practice that covers a wide 
range of therapeutic areas in both adults and children. So far, the extent of the off-
label use among the Bulgarian population has not been studied. The aim of this 
nested, retrospective, non-interventional, single center study is to provide data on the 
frequency, type and the most common situations in which off-label medicines are 
prescribed in daily neurology practice in Bulgaria. 
Methods: The data on prescriptions of 360 neurology outpatients, treated in one-
year period, were recorded and provided for analyses. The Summaries of Product 
Characteristics (SmPC), published on the Bulgarian Drug Agency website, were used 
as reference documents for assessment of prescriptions. Descriptive statistics, with 
absolute frequencies, means and standard deviation, were used to analyses the 
processed data. 
Results: The results from this study show that most neurology patients (63%) were 
exposed to off-label use. Most of the medicines prescribed off-label (90%), were 
used for another therapeutic indication then the one listed in the authorized product 
information. Certain medicines were found to be used off-label in 100% of 
prescriptions. 
Conclusion: Although the study is limited to one center, it deserves attention as it 
reveals many different aspects of the off-label use in neurology patients in Bulgaria. 
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Further studies based on a larger number of medical centers are needed to establish 
more accurate data on off-label prescribing in neurology patients on national level. 
 
 
RISK-MINIMIZATION MEASURES IN THE EU: REVIEW AND 
ANALYSIS 2017-2018 
Getova V.1, Staynova R.2, Getov I.3 
1Bulgarian Drug Agency 
2Department of Pharmaceutical Sciences, Faculty of Pharmacy,  
Medical University, Plovdiv 
3Faculty of Pharmacy, Medical University, Sofia 
 
Aim: The current study aims to research, systemize and analyze the 
pharmacovigilance referral procedures which took place in the EU for two years‟ 
period 2017-2018. The purpose of the study is to point out the qualitative 
characteristics of the procedures and to summarize future development and practical 
aspects of pharmacovigilance. 
Materials and methods: For the purpose of the study PRAC decisions and minutes 
for all procedures which started and completed within 2017-2018 were extracted and 
systemized. The systemization was based on several criteria including legal basis of 
procedure, scope, proposed risk-minimization measures and whether Bulgaria is 
concerned or not. 
Results: The results from the study showed that the scope of the majority of referrals 
included medicinal products available on the Bulgarian market. PRAC‟s 
recommendations are most frequently focused on narrowing patient population and 
therapeutic indications and enhancing safety monitoring during the use of medicines. 
National competent authorities play major role both as initiators of referrals and 
national safety monitors. 
Conclusion: The conducted analysis shows that conducting PRAC safety referral 
procedure is a complex and dynamic process where real-life clinical data is valuable 
source of information. The suggested risk-minimization steps are mainly focused on 
the enforcement of measures already existing in the risk-management plan of the 
products. They also require a constant follow-up monitoring for efficacy. National 
competent authorities are leading participants in organizing the work and composing 
the agenda of the committee. 
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COST-EFFECTIVENESS OF PHARMACOLOGIC TREATMENT IN 
PRIMARY OPEN-ANGLE GLAUCOMA AND “DRY EYE” SYNDROME 
IN REAL THERAPEUTIC CONDITIONS 
Tashkov K., Vasilev A., Kostova S. 
 
Aim: The goal of this study is to assess the level of disease control with conventional 
therapies, prescription habits, and evaluate the cost-effectiveness of therapy in 
Primary Open-Angle Glaucoma (POAG). 
Materials and methods: A prospective, observational study was carried out in the 
Ophthalmology clinic in “Alexandrovska” Univeristy Hospital. Data collected included 
type of therapy, control of POAG, and measurements of control of “dry-eye” through 
TMS, NIBUT Ave, and ST). Therapy costs were calculated based on retail prices for 
both reimbursed and non-reimbursed products. A “decision tree” model was 
constructed with the probabilities of prescribing a particular product and the cost-
effectiveness of treatment was evaluated. Deterministic sensitivity analysis was 
conducted to test robustness. 
Results: The probability of prescribing a formulation with preservatives was two-
times higher than preservative-free products (p=0.69, and p=0.31). In the 
monotherapy group, lower costs were observed in the preservative containing 
products, whereas in the combination group, preservative-free products had a lower 
yearly cost of therapy. Both preservative-containing and preservative-free products 
were equally prescribed as combination products (p=0.5, p=0.46, respectively). The 
highest incremental cost-effectiveness ratio (ICER) was for NUBIT (8318,9 BGN), 
whereas for TMS and ST the ICER was 75.40, and 115.38 BGN, respectively. 
Varying the parameters within ±30% showed that all values were below the threshold 
of 20 000 BGN, thus are cost-effective. 
Conclusion: Using products with preservatives hides a risk of developing “dry-eye” 
syndrome. Treatment with preservative-free products is cost-effectives, thus, 
physicians should carefully monitor patients and choose the appropriate medication 
carefully. 
 
 
ASSESSMENT OF MEDICINAL THERAPY IN NEONATOLOGY 
Petkova V., Antova V. 
Faculty of Pharmacy, Medical University, Sofia 
tel. 029236593, e-mail: vpetkova@pharmfac.mu-sofia.bg 
 
Aim of the study: Study of prescription drugs in the Department of Intensive 
Neonatology of “Maichin Dom” SHATOG for 2018. 
Materials and methods: A retrospective study was carried out by type and quantity 
of the medicines prescribed in the Department of Intensive Neonatology of “Maichin 
Dom” SHATOG for 2018. An analysis was performed on the following criteria: the 
licensing status, pharmacological groups, which have in SPC indications and dosage 
for use in newlyborns, number and type of prescription drugs specially formulated for 
neonatal therapy. 
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Results: The total number of prescribed medicinal products for 2018 is 98. Of these, 
only three were specifically designed to treat neonates. The largest proportion of 
prescribed medicinal products were antibiotics - 22 or 22.45% of all prescribed 
medicinal products. In the current study, the percentage of drugs with off-label use 
was 59.18% in total. 
Conclusion: Although there are already legislative initiatives in the US and the EU to 
promote drug use studies in neonates, the proportion of off-label drugs used in this 
group remains high. 
 
PILOT STUDY AND ASSESSMENT OF PHARMACIES’ SERVICES 
AND PATIENTS' SATISFACTION IN BURGAS REGION 
Burgazliev H.1, Krumov S.2, Luizov A.3, Getov I.4 
1 Medical College, University „Prof Assen Zlatarov“ Burgas 
2National Center of Public Health and Analyses 
3Burgas Free University 
4Medical University Sofia, Faculty of Pharmacy 
 
Aim of the study: This study aims to investigate and measure the satisfaction of 
visitors in community pharmacies in the Burgas region, Bulgaria from the provided 
pharmaceutical activities and services, and the expectations for improvement. 
Material and methods: A methodical approach used was indirect individual 
anonymous poll with questionnaire file card of pre-trained field interviewers (in 30 
community pharmacies on the territory of Bourgas region) during the period 01.5 - 
30.6.2019. The questions are closed, incl. with more than one response and Likert 
Scale assessment, basic demographic information was also collected. Participation 
of respondents - visitors to the pharmacy is voluntary, and written consent is not 
required due to the nature of the study, such as medical-social, non-interventional 
and anonymous. A nested population based non-systematic sample was formed on 
the basis of the total number of visitors and the SPSS v.24.0 statistical software was 
used to process the primary information. 
Results: The total number of respondents is expected to be over 500, with a high 
degree of validity of completed questionnaire file cards. Data is in the process of 
collection and processing, but preliminary results show a high level of satisfaction, 
expectations and specific guidelines for improving the range of activities, services 
and service organization in community pharmacies. 
Conclusion: Consumer satisfaction and expectations are the focus of marketing 
research and are particularly important for community pharmacies in the strong 
market competition. In addition, data using a standardized study approach may be 
useful at macro, micro and regional level. 
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ANALYSIS OF THE REGULATORY CHANGES AND PREPARATION 
OF THE INDIVIDUAL PRESCRIPTIONS IN THE HOSPITAL 
PHARMACIES 
Georgieva S. 
Medical University of Sofia, Medical College; “Alexandrovska” University Hospital  
 
Goal: To analyse the changes in the regulatory framework in the area of hospital 
pharmacy in Bulgaria and related changes in the preparation of the individual 
prescriptions for inpatients. 
Methods: Regulatory analysis of the Law for medicinal products for human medicine; 
Regulation of the order, rules and organization of work in the pharmacies; Regulation 
on prescription and dispensing of medicines, and Guidelines for good pharmaceutical 
practice. Retrospective analysis of the individual prescriptions for inpatients in 
“Alexandrovska” University Hospital for the period 2016-2019. 
Results: Significant changes in the LMPHM and related regulations led to changes 
in the type and volume of the individual prescriptions for inpatients. A drastic 
decrease is observed for the classic magisterial prescriptions, mainly dermatological 
ones, and increase in the number of individual prescriptions for direct application for 
patients with malignant diseases. In recent years is also observed an increase in the 
number of prepared radiopharmaceuticals following pharmacopeia prescriptions. On 
average 400-450 patients per month receive radiopharmaceuticals while the classic 
forms are around 20 per month. 
Conclusion: The regulatory changes necessitate new knowledge from the hospital 
pharmacists, as well as reorganization of the work, and new equipment to comply 
with the requirements of the good pharmaceutical practice. 
 
 
POSSIBILITIES FOR OPTIMIZING THE EDUCATION OF PHARMACY 
STUDENTS BY USING A SPECIALIZED ELECTRONIC PLATFORM - 
SWOT ANALYSIS BASED ON THE EXPERIENCE IN MU-VARNA 
Todorova A.1, Grigorov E.1,2, Petrova G.1, Kolev J.1, Kumanov I.1, Naydenova D.1 
1„Organization and Economics of Pharmacy“ Department, 
 Faculty of Pharmacy, Medical University, Varna 
2National Center of Public Health and Analyses 
 
Introduction: The Blackboard Learning platform has been introduced in 2014 and 
plays an important role in the training and education of the students from the Medical 
University, Varna. The main priority is not to shift the attendance classes, but to 
provide new opportunities for teachers and students to use digital content and 
additional educational resources. 
Objective: To analyze from the point of view of the Pharmacy specialists the 
strengths and weaknesses, the prospects and the difficulties that accompany the 
training of the students with the help of the electronic platform. 
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Methods: Using the classic technique of building a SWOT table, we show and 
address the individual elements of this type of analysis - strengths and weaknesses, 
opportunities and threats. 
Results: The Blackboard electronic platform provides additional educational 
opportunities to improve communication with students, facilitating access to learning 
resources. It also has innovative options for presenting the material through videos 
and interactive exercises, enhancing the learner's knowledge and skills, increasing 
motivation and active participation in traditional lectures and seminars. 
On the other hand, for teachers, it is an effective tool for tailoring the learning process 
and taking into account the specificities of organizing the training in each discipline, 
as well as tracking the success rate. Requires training and improvement of the 
teachers' digital competences. A drawback may be the risk of a possible collapse and 
the associated loss of information. 
Conclusion: Rapidly developing information and communication technologies pose 
a number of challenges to education related to the pedagogical and organizational 
aspects of their application. Public needs and expectations in the context of their 
widespread penetration of life are increasing, which requires them to be introduced 
into the learning process to optimize training. 
Keywords: training, pharmacists, SWOT analysis, lecturers 
 
 
STUDY OF THE ATTITUDE OF PHARMACISTS IN BULGARIA 
TOWARD THE REMUNERATION OF VALUE-ADDED PHARMACY 
SERVICES 
Balkanski S.1, Simeonova J.², Gitev I.1, Getov I.1,3 
1Bulgarian Pharmaceutical Union 
2Faculty of Pharmacy, Мedical University, Pleven 
3Faculty of Pharmacy, Мedical University, Sofia 
 
Aim: The aim of the study is to evaluate and analyse the current state of the value-
added pharmacy services (VAPS) offered in the community pharmacies in Bulgaria 
and the pharmacists‟ attitude toward their remuneration. 
Materials and methods: A cross-sectional study was carried-out in 2018. А web-
based questionnaire was developed consisting of 15 questions and sent to all 
members of Bulgarian Pharmaceutical Union. Data was processed by SPSS v.24.0. 
The number of cases falling in each range of categorical variables and percentage 
were displayed. 
Results: Over 51% of the pharmacies in Bulgaria offer VAPS but mainly measuring 
of blood pressure (67.4%) and of blood glucose (12.9%). About 60% of community 
pharmacists in the country are willing to perform other VAPS. Most pharmacists 
(98.3%) support the idea of introducing a remuneration fee for VAPS. According to 
49.8%, the fee should be over BGN 10 and 30.9% - up to BGN 5. With the increase 
in the number of patients in the pharmacy, the share of pharmacists who are 
disapproving of the idea of introducing a remuneration fee for blood sugar measuring 
- from 9.3% in pharmacies serving up to 50 patients on average per day up to 52% at 
pharmacies serving over 500 patients / day (χ2=12.127; df=6; p=0.059). 
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Conclusion: The study shows that the pharmacy can offer other services, different 
from consultation and dispensing of medicinal products. Such additional services in 
the pharmacy would have added value from societal, healthcare and economic point 
of view. 
 
 
THE FIRST FEMALE PHARMACISTS IN BULGARIA - WHAT DOES IT 
MEAN TO BE AMONG THEM? DREAMS OR REALITY? 
Stoyanova S.1, Hristov E.1, Andreevska K.1, Delyiski T.1, Ognyanov S.1, 
Dimitrova Z.1, Burgazliev H.2 
1Faculty of Chemistry and Pharmacy,  
“Sveti Kliment Ohridski” Sofia University, Bulgaria 
2College of Pharmacy, "Prof. Assen Zlatarov" University, Bourgas, Bulgaria 
Corresponding author: Stefka Stoyanova, Faculty of Chemistry and Pharmacy,  
“Sveti Kliment Ohridski” Sofia University, 1 “James Bourchier” blv., 1164 Sofia, 
Bulgaria; e-mail: stefkasd@mail.bg 
 
For many years, a pharmacist has been a typical male profession and has been 
practiced by women exceptionally. However nowadays, the pharmacy becomes one 
of the most preferred women‟s specialties for professional realization. Have we 
considered who are the first Bulgarian ladies who have managed to fight for the right 
to be pharmacists, assistant pharmacists and master pharmacists in times of full 
patriarchy? Even in the textbooks of the History of Pharmacy in Bulgaria there are 
not enough verifiable data and reliable information about the first Bulgarian women 
who have been practicing in the field of pharmacy. 
Aim: To investigate who are the first female pharmacists in the history of 
pharmaceutical science and practice of Bulgarian origin and practiced in the 
Bulgarian lands. 
Materials and methods: We conducted extensive search and analysis of historical 
information and documents by reviewing electronic sources, literary data, searching 
in historical museums in the country, the Archives State Agency, the Institute of 
History at the Bulgarian Academy of Sciences, the “Sveti Kiril I Metodii” National 
Library and personal archives. 
Results and conclusion: We have found data on three worthy Bulgarian women, an 
example of women who have made their dream a reality - to be a Master of 
Pharmacy and have contributed to the development of pharmacies in a number of 
Bulgarian cities - Raina Aleksova, Anna Belizarova Yakovova and Penka Hristova 
Sarafova. Despite the few sources and the lack of living witnesses of that distant and 
romantic historical period, we believe that the three worthy Bulgarian ladies 
described as the first Bulgarian women made a professional breakthrough in 
pharmacy in its various practical applications! Their names, lives, deeds, efforts and 
achievements must not fall into oblivion, just the opposite - they must be 
remembered and respected! 
Key words: Master pharmacist, pharmacist student, first Bulgarian woman Master of 
Pharmacy 
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COMPARATIVE ANALYSIS OF THE PRICING AND 
REIMBURSEMENT SYSTEMS BETWEEN ITALY AND BULGARIA 
Cannavale C.1, De Rosa A.1, Yordanov E.2, Hristov E.2 
1Department of Pharmacy, “Federico II” University of Naples, Italy 
2Faculty of Chemistry and Pharmacy,  
“Sveti Kliment Ohridski” Sofia University, Bulgaria 
Corresponding author: Emanuyl Yordanov, Master of Pharmacy, Faculty of 
Chemistry and Pharmacy, “Sveti Kliment Ohridski” Sofia University,  
1 “James Boucher” blv., 1164 Sofia, Bulgaria 
e-mail: emanuil.iordanov@gmail.com 
 
Introduction: The pricing and reimbursement approaches in the EU Member States 
are unified by Directive 89/105 / EEC of 21 December 1988. The Directive lays down 
common principles such as - time limits for taking a decision, legal remedies, 
disclosure of information, introducing tacit consent, etc. However, specific 
mechanisms are the subject of purely national measures, making the pricing and 
reimbursement picture of the various Member States extremely varied. 
Aim. To make a comparative analysis of the regulatory measures for pricing and 
reimbursement of medicinal products applied by the governments of Bulgaria and 
Italy. 
Materials and methods: Of all commonly agreed pricing and reimbursement 
measures that regulate and control the cost of pharmaceuticals at macro and micro 
levels, we looked at four main: positive drug lists, internal reference pricing, health 
technology assessment, and innovative schemes such as risk sharing agreements. 
We used documentary method, analysis and synthesis, comparative method and 
statistical methods. 
Results and discussion: The pricing and reimbursement systems of the two 
countries are fundamentally different. In the period since 2000, legislation (laws, 
regulations, guidelines), representation and composition of different types of bodies 
and commissions, switching to the NHIF system and other measures concerning the 
system of pricing and reimbursement of medicinal products and patient access to 
them in Bulgaria have been amended and supplemented more than 35 times, which 
characterizes Bulgarian pricing and reimbursement policies as permanently 
regulatory unstable and volatile. Unlike Bulgaria, Italy's pricing and reimbursement 
system has long traditions, based on well-established principles and guarantees 
stability in the availability and affordability of medicinal products to the population. 
Key words: Medicinal products, prices of medicnes, reimbursement. 
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INFLUENCE OF PHARMACEUTICAL CARE AND PROFESSIONAL 
PHARMACIST’S CONSULTATION ON THE PATIENT  
Kachulev K.1, Simova T.2, Enchev D.1 
1Faculty of Public Health, Medical University, Sofia 
2TSC Directorate, Bulgarian Drug Agency 
For correspondence: Konstantin Kachulev, +359 878 287 705,  
e-mail: kkachulev@gmail.com 
 
Aim of the study: To investigate and assess the impact on the patient of the 
decision to introduce an electronic (e) recipe and e-dossier, through the expert 
assessment of the pharmacists (Phs) working in the pharmacy and through the 
subjective assessment of the patients. 
Materials and methods: 
Patient poll 
From 10.2016. until 01.2017. a cross-sectional study of patients was conducted 
through a survey (609 questionnaires). 
A qualitative criterion for selecting respondents in the study is to meet the definition 
of a patient or to use prescription or OTCs purchased in the pharmacy. 
Pharmacists‟ Survey 
A cross-sectional study was conducted using a rapid data collection method - 15 
days across the country through one of the drug distributors in Bulgaria. 
Results: 71% of the patients consider e-carrier data storage to be safer, and this 
would facilitate pharmacy work by 59%, according to the Phs. 
68.3% consider safer storage of their personal data and their disease data, and 
agree this to be done by introducing e-dossier and e-recipe. 
Relatively large is the proportion of people who cannot assess the risks and benefits 
of the proposed policies. 
The question "Do you approve the introduction of an e-dossier and an e-
prescription?" 436 (72%) of the patients and 322 (87%) of the MF respond with 
"Yes". 
Conclusion: The institutions responsible for implementing these policies need to be 
more proactive in informing healthcare users. 
Patients have confidence in e-dossier and e-recipe, and according to the Phs putting 
them into practice would make pharmacy work easier. 
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HEALTH RELATED QUALITY OF LIFE – A PILOT STUDY IN 
HEALTHY VOLUNTEERS 
Asipova N.1, Hristov E.1, Delyiski T.1, Parvova I.2, Yordanov E.1, Andreevska K.1, 
Ognianov S.1, Burgazliev H.3 
1Faculty of Chemistry and Pharmacy,  
“Sveti Kliment Ohridski” Sofia University, Bulgaria 
2Department of Internal Medicine, Medical University, Sofia, Bulgaria 
3College of Pharmacy, "Prof. Dr. Assen Zlatarov" University, Bourgas, Bulgaria 
Corresponding author: Nasie Asipova, Faculty of Chemistry and Pharmacy, “Sveti 
Kliment Ohridski” Sofia University, 1 “James Bourchier” blv., 1164 Sofia, Bulgaria  
e-mail: nasi_12@abv.bg 
 
Key words: HRQoL, SF-36v2, domains, health status, healthy volunteers. The broad 
definition of health proposed by the WHO more than 50 years ago states: "Health is a 
state of complete physical, mental and social well-being and not merely the absence 
of disease or infirmity." Most healthcare providers and professionals have adapted 
this broad view of health and now include measures for the overall impact of the 
disease and its treatment. The most common tool used is Short Form-36. SF-36 
consists of 36 questions for a multi-purpose study of the patient's overall health 
status developed by the WHO. 
Aim of study: The aim of the study is to create experimental conditions for selection 
of healthy volunteers by assessing the health status of pharmacy students through 
self-assessment of their condition, refracted through the HRQoL tool SF-36, in four 
main domains: physical, social and behavioral functioning, mental health, and 
general perceptions of health. 
Materials and methods: We interviewed pharmacy students from the Faculty of 
Chemistry and Pharmacy at “Sveti Kliment Ohridski” Sofia University using SF-36v2 
Questionnaire. The research included 26 students aged between 22 and 25, 
distributed equally between men and women, after they duly signed an informed 
consent form and were informed of the conditions for completing the questionnaires. 
Data is processed statistically with the specified program. 
Results and discussion: The results obtained showed serious deviations from the 
norms of the functioning of the “healthy volunteers” in the four functional domains 
and posed a number of questions as to how to select control groups of healthy 
volunteers for randomized controlled clinical trials. 
 
 
 
 
 
 
 
 
 
 
 
back to 
contents 
 65 
 
ANALYTICAL STUDY OF PRODUCTS CONTAINING CANNABIDIOL 
Andonova L.1, Ivanov E.2, Pencheva I.1, Konstantinov S.2 
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical Univercity-
Sofia, 2 “Dunav” str., Sofia 1000, Bulgaria 
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Pharmacy, Medical University, Sofia, 2 “Dunav” str., Sofia 1000, Bulgaria 
Corresponding author: Lily Andonova, PhD 
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Cannabidiol (CBD) is the major, biologically active, but psycho-inactive component of 
the glandular hairs of Cannabis sativa. CBD exhibits diverse pharmacological 
activities such as anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory 
and neuroprotective. 
Aim: With respect to quality control optimization solutions the aim of this study is to 
develop a simple, precise, accurate and reproducible HPLC method for assay of 
CBD obtained with certain forms of extractions and purifications in food supplements.  
Matherials and methods: HPLC method with isocratic elution and UV detection, 
supplements containing CBD. 
Results: Analytical parameters reproducibility, linearity, accuracy, LOD, LOQ, 
specificity and system suitability test were developed and optimized. 
Conclusion: The proposed method could be applicable for identification, purity and 
assay tests of food supplements containing CBD extract according to EU regulation 
concerning food authorizations. 
 
 
APPLICATION OF HIGH PERFORMANCE LIQUID 
CHROMATOGRAPHY FOR STATINS ANALYSIS IN BIOLOGICAL 
MEDIA 
Maslarska V., Smerikarova M., Bozhanov S. 
Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
 
Purpose of the study: Statins are widely used to treat hypercholesterolemia in 
patients with established cardiovascular disease as well as those with a high risk of 
developing atherosclerosis. The aim of the present study is to summarize the 
information in the available literature as well as to systematize the main approaches 
in the analysis of statins in biological media by high performance liquid 
chromatography. 
Materials and Methods: Sample preparation methods, optimal chromatographic 
conditions and various types of detectors were considered. 
Results: High Performance Liquid Chromatography has been successfully applied in 
analyzing statins in various biological fluids such as plasma, serum and urine. Most 
methods allow quantitative determination of statins at level of ng/ml, making them 
suitable for therapeutic monitoring. 
back to 
contents 
 66 
 
Conclusion: There is a continuing interest in the development of new bioanalytical 
methods for the separation and quantification of statins in biological media. The 
characteristic specificity and sensitivity, as well as the variety of chromatographic 
columns and detectors, make high performance liquid chromatography a method of 
choice for statin assay in biological samples. 
 
 
SYNTHESIS AND PRELIMINARY SCREENING FOR CYTOTOXICITY 
AND BIOLOGICAL EFFECTS OF SERIES PYRROLE HYDRAZONES 
Tzankova D., Aluani D., Peikova L., Georgieva M. 
Department of Pharmaceutical Chemistry, 
Faculty of Pharmacy, Medical University, Sofia 
Department of Pharmacology, Pharmacotherapy and Toxicology,  
Faculty of Pharmacy, Medical University, Sofia 
 
The aim of the study: The applicability of newly synthesized molecules as potential 
drugs and prototypes for future optimizations of the structure was evaluated with 
theoretical in silico approaches, predicting their pharmacokinetics and drug-like 
properties. The obtained values were compared to Lipinski‟s criteria, recommending 
the following boundary conditions for some molecular parameters: hydrophobic 
parameter Log P < 5, molecular weight MW < 500, number of proton acceptors n (O, 
N) < 10 and number of proton donors n (OH, NH) < 5. In addition the evaluated 
structures were subjected to an attempt to predict the possible pharmacological 
effect against included in the web based software Molinspiration Cheminformatics 
drug targets, divided into the following six classes: GPCR ligands, ionic channels 
modulators, kinase inhibitors, nuclear receptor ligands, protease inhibitors and 
enzyme inhibitors. 
Materials and methods: Series evaluated N-pyrrolyl hydrazide-hydrazones was 
subjected to a preliminary in silico evaluation of their hepatootxicity through the 
predicting software ProTox II. The obtained results were further compared to the 
results of in vitro evaluation on the cell viability against HepG2 cell line of the tested 
compounds, determined through a МТТ-test. 
Results: The performed theoretical evaluation on drug likeness is clear, that the 
investigated molecules violate Lipinski‟s Rule on 2 parameters – hydrophobicity and 
molecular weight, which is a prerequisite of impaired pharmacokinetics. As most 
probable pharmacological effects was predicted, that the newly synthesized 
compounds would have high effects as enzyme inhibitors and GPCR ligands. 
Conclusion: The in silico evaluation of the hepatotoxicity determined the target 
compounds as low toxic. These predictions were confirmed by the results from the 
performed in vitro experiments. 
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IN VITRO INTERACTION OF 5-AMINOOROTIC ACID AND ITS 
GALLIUM(III) COMPLEX WITH THE SUPEROXIDE RADICAL, 
YIELDED BY POTASSIUM SUPEROXIDE AND XANTHINE/XANTHINE 
OXIDASE MODEL SYSTEMS 
Todorov L.1*, Kostova I.1 
1 Pharmeceutical Faculty, Medical university – Sofia 
*lozantodorov@yahoo.com 
 
Aim of the investigation: The superoxide radical (O2
-) is involved in many normal 
and pathological bioreactions in living organisms. Gallium(III) salts and complexes 
are known for their anticancer properties. The Gallium(III) complex (GaAOA) with 5-
aminoorotic acid (HAOA) has demonstrated better in vitro antioxidant properties than 
the ligand itself. The aim of the current investigation is to assess the interaction of 
HAOA and GaAOA with O2
-. 
Materials and methods: The effects of HAOA and GaAOA on the in vitro 
accumulation of superoxide and free radicals were estimated using potassium 
superoxide (KO2) and xanthine/xanthine oxidase (X/XO) as model systems. Luminol-
dependent chemiluminescence (LDCL) was utilized to estimate the radicals 
scavenging activity. The specific activity of xanthine oxidase was estimated by way of 
UV spectrophotometric measurement. 
Results: Both HAOA and GaAOA, reduced the LDCL in presence of KO2-generated 
O2
- in a concentration-dependent manner. Within the experimental error limits, both 
compounds were scavengers of superoxide radical generated by the model system 
X/XO. 
Conclusions: Data suggested better antioxidant effect of GaAOA than that of 
HAOA. Evidently all three ligands of GaAOA participated in the scavenging of 
superoxide. The effects in rat blood plasma were more complex, considering the 
chemical and biochemical complexity of this model system. 
Acknowledgement: The authors gratefully acknowledge the financial support of the 
Grand Commission in the Medical University of Sofia (Grant No. Д-130/2019). 
 
 
DETERMINATION OF Cd AND Pb IN PRODUCTS OF BULGARIAN 
OIL-BEARING ROSE (ROSA DAMASCENA MILL) 
Bozhanov S.1, Smerikarova M.1, Maslarska V.1 
1Chemistry Department, Faculty of Pharmacy, Medical University, Sofia 
 
Aim of the study: Determination of Cd and Pb in rose oil, rose water and rose 
concrete of Bulgarian oil-bearing rose (Rosa damascena Mill.) 
Materials and methods: Direct Electrothermal Atomic Absorption Spectrometry 
(ETAAS) was applied after minimum sample pretreatment - dissolution in a suitable 
organic solvent. 
Results: The optimal parameters (atomizers, modifiers, temperature programs) as 
well as the detection limits of the elements (Cd - 0.08 ng/g and Pb - 1.2 ng) were 
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determined. The relative standard deviation was within 2-9%. Samples from the 
areas of Pavel Banya and Zelenikovo were analyzed. 
Conclusion: Further researches are needed to clarify the sources of trace elements 
as well as to track their content at the different stages of the production process. 
 
 
INTRODUCTION OF THE QUARZ CRYSTAL MICROBALANCE 
METHOD IN THE PHARMACEUTICAL ANALYSIS: DETERMINATION 
OF DRUG CONTENT IN POLYMERIC CARRIERS 
Kolev I.1, Ivanova N.1, Marinov M.2 
1Faculty of Pharmacy, “Prof. Dr. Paraskev Stoyanov” Medical University, Varna, 84 
“Tzar Osvoboditel” Blvd., 9000, Varna, Bulgaria 
2Freelance Electronics and System Design Engineer, 54 “Chajka” str., 9000, Varna, 
Bulgaria 
 
Aim of the study: The quartz crystal microbalance (QCM) method provides a wide 
range of possibilities for tracking chemical or physical phenomena occurring with a 
mass variation in nanoscale order. In this study, we propose a version of the QCM 
method with application in the pharmaceutical analysis, and in particular regarding 
drug assay in polymeric matrix-type carriers. 
Materials and methods: A series of polymeric mixtures of drugs with increasing 
concentrations were applied to a sensitive quartz resonator in the form of solutions. 
Evaporation was initialized to obtain homogeneous layers suitable for calibration of 
the analytical method. Homogeneous solutions of drug-delivery micoparticles, 
synthesized with known drug concentrations, were used as test analytes. A variation 
in the sample mass was initiated by passing acidic gas into a pressurized system 
storing the loaded resonator. The drug content analysis was based on the 
occurrence of irreversible changes (related to chemisorption of the irradiating gas) in 
the analyte mass. 
Results: The proposed method demonstrated better accuracy when compared to a 
conventionally used pharmacopoeial spectral assay. 
Conclusion: The QCM method was proven to be accurate and precise and thus 
according to our research, possess the potency for the routine pharmaceutical 
control. 
 
 
VIRTUAL SCREENING AND HIT SELECTION OF NATURAL 
COMPOUNDS AS ACETYLCHOLINESTERASE INHIBITORS 
Atanasova M*., Dimitrov I., Doytchinova I. 
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
*corresponding author: matanasova@ddg-pharmfac.net; phone: +359 2 9236 599 
 
Acetylcholinesterase (AChE) is one of the classical targets in the treatment of 
Alzheimer‟s disease (AD). AChE is a serine protease that catalyzes the hydrolysis of 
acetylcholine (ACh) to choline and acetate in neuromuscular and brain synapses. 
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Loss of cognitive abilities, a typical symptom in patients with AD, is due to prolonged 
loss of Ach because of hyperactivity of AChE and hyperactive N-methyl-D-aspartat 
(NMDA) glutamate receptors. Inhibition of AChE slows down the hydrolysis of ACh 
and increases its levels. Thus, the cognitive abilities are improved. 
The AChE inhibitor galantamine (GAL), an alkaloid from Galanthus genus with 
multitarget mechanism of action, is the most appropriate drug for treatment of AD. 
GAL inhibits AChE and interacts with nicotine receptors leading to improvement in 
the cognitive brain function. Additionally, it increases phagocytose and clearance of 
amyloid-β peptides in the brain in rats and rodent models. 
In the present study, 12 ZINC databases of natural compounds (almost 150 000 
compounds) were screened virtually for affinity to AChE by molecular docking with 
GOLD v.5.2.2 at the following settings: ChemPLP scoring function, rigid protein and 
flexible ligand. Next, the compounds were screened for blood brain barrier (BBB) 
permeability, drug-likeness and lead-likeness by SwissADME tool. The complexes 
with ChemPLP score > 70 were inspected visually. Finally, the synthetic feasibility or 
the available vendors were assessed and 20 hits were selected for in vitro tests. 
 
 
DESIGN AND DOCKING OF CURCUMIN-GALANTAMINE HYBRIDS 
AS ACETYLCHOLINESTERASE INHIBITORS WITH DUAL-SITE 
BINDING 
Lukarski A.1, Atanasova M., Stavrakov G., Philipova I., Doytchinova I. 
1Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of 
Science, Sofia, Bulgaria 
*Corresponding author: e-mail: nasko_lukarski@abv.bg; phone: 02 9236599 
 
Alzheimer's disease (AD) is the leading cause of dementia in the elder people (> 65 
y.o.) affecting more than 25 million people worldwide. The major pathological 
changes caused by AD are amyloid-beta (Aβ) peptide plaques, formation of 
neurofibrillary tangles, loss of cholinergic neurons and oxidative stress. For this 
reason, there is an increased demand for new drug candidates, aimed at reduction of 
both the oxidative stress and the formation of amyloid plaques. 
Curcumin is a natural polyunsaturated phenol compound which has antioxidant and 
anti-inflammatory properties. An inhibitory activity of curcumin against the 
acetylcholinesterase (AChE) and Aβ formation has also been demonstrated, making 
it an ideal candidate for design of its hybrids with galantamine. 
In the present study 192 galanthamine-curcumin and curcumin-like compounds were 
designed to bind to the active site of AChE (CAS) and the peripheral anionic site 
(PAS). The aim was to increase the binding affinity to AChE and the inhibition of the 
formation of Aβ plaques. The hybrids were docked with state-of-the-art GOLD 
software, using a protocol previously optimized for affinity prediction of galantamine 
derivatives. With two web-based servers, the blood-brain barrier (BBB) permeability 
of the hybrids was predicted, which is a prerequisite for their activity. 
All structures theoretically display a higher affinity towards the enzyme in comparison 
to galantamine, used as reference. For 156 of them was predicted good BBB 
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permeability. A synthetic strategy was considered for the preparation of 17 selected 
representatives for which in vitro tests are foreseen. 
 
 
DEVELOPMENT OF RP-HPLC METHOD FOR IDENTIFICATION OF 
THE PRODUCTS OF HYDROLYSIS OF PROPANEHYDRAZONE, 
CONTAINING A XANTHINE FRAGMENT IN ITS STRUCTURE 
Peikova L., Dineva A., Georgieva M., Zlatkov A. 
Department of Pharmaceutical Chemistry, Faculty of Pharmacy,  
Medical University, Sofia 
 
Hydrazones and oximes are well known derivatives, containing the double carbon-
nitrogen bond, characterized with its liability to hydrolysis. 
An important functionality of a given molecule, containing such liable groups, 
determining its biological activity is their stability during storage, their chemical 
stability and their stability under close to physiological conditions. 
The aim of the study: The purpose of this study is to identify the hydrolysis products 
through a developed RP-HPLC method. For this reason the following parameters of 
the chromatographic system were varied: column type, mobile phase contents, 
column temperature and flow rate, as factors determining the efficiency of the 
chromatographic procedure. The change in the discussed parameters affected 
mainly the retention times and the chromatographic peak‟s symmetry. 
Materials and methods: As most appropriate were determined the listed 
chromatographic conditions: flow 1.0 ml/min; temperature of the column 25ºC; 
Column Purospher®STAR RP-18 endcapped (125x 4.0mm), 5µm; UV-detector with 
fixed wavelength at 272 nm; mobile phase: methanol : water : acetonitril: glacial 
acetic acid = 52:46.5:1:0.5 v/v/v/v and injection volume of 20 µl. 
Results: The developed chromatographic procedure was validated according to 
guidelines as expressed in European Pharmacopoeia 7.0 and ICH and applied for 
determination of the hydrolytic stability of a model compound. The method was found 
to selective, linear and repeatable. 
Conclusion: With the validated RP-HPLC procedure were identified and isolated the 
products of degradation of the studied 2-(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-
purine-7(6H)-yl)-N'-(3-fluorobenzylidene)propanehydrazide under close to 
physiological conditions –рН of 2.0, 7.4 and 9.0 and temperature of 37оС. In addition 
the storing stability and chemical stability was also investigated in media of рН 13.0. 
The results show, that the tested compound is stable in neutral and weak alkali 
media of рН 7.4 and 9.0 and liable to hydrolysis in рН 2.0 and temperature of 37оС, 
as well as in strong alkali media of рН 13.0. 
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DEVELOPMENT OF CHYRAL RP-HPLC METHOD FOR 
IDENTIFICATION OF OPTICAL ISOMERS IN THE STRUCTURE OF 2-
(1,3-DIMETHYL-2,6-DIOXO-2,3-DIHYDRO-1H-PURINE-7(6H)-YL)-N'-
(3-FLUOROBENYLYDENE)PROPANHYDRAZIDE 
Dineva A., Peikova L., Georgieva M., Zlatkov A. 
Department of Pharmaceutical Chemistry, Faculty of Pharmacy,  
Medical University, Sofia 
 
The aim of the study: The development of methods for separation of enantiomers is 
a procedure which requires the application of powerful and specific techniques and 
methodologies, including the introduction of new highly selective and sensitive 
columns, which is a prerequisite of high costs and prolongs analysis. The application 
of chyral columns will lead to decrease in the costs and the time of the analysis. 
Materials and methods: In the current research we aimed to develop a single stage, 
easy, selective and precise RP-HPLC method for simultaneous separation and 
identification of geometrical isomers of a synthesized in our laboratory xanthine 
hydrazone, containing an asymmetrical center in its structure. 
Results: For development of the RP-HPLC method the influence of the type of the 
column, the mobile phase contents, the temperature of the column and the flow rate 
was investigated. The change in the followed parameters affected mostly the 
retention time and the shape of the obtained peaks. It was seen that the application 
of a hyral column gave best effectiveness of the chromatographic system. 
Thus the next experiments were performed on a chromatographic system containing: 
chyral column ACE®EquivalenceTM С18 (250x 4.6mm), 5µm; UV-detector with fixed 
wavelength 272 nm; mobile phase: methanol: water: phosphate buffer рН=7.4 = 
50:46:4 v/v; temperature of the column – 25 °С; flow – 1 ml/min and injection volume 
– 20 µl.  
Conclusion: The developed chyral RP-HPLC method was validated according to the 
European Pharmacopoeia 7.0 and ICH guidelines and used for the successful 
separation of the two enantiomers of the newly synthesized 2-(1,3-dimethyl-2,6-
dioxo-2,3-dihydro-1H-purine-7(6H)-yl)-N'-(3-fluorobenzylydene) propanehydrazide. 
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SESQUITERPENE LACTONES FROM SONCHUS PALUSTRIS L. 
(ASTERACEAE, CICHORIEAE) 
Shulha O.1, Çiçek S.1, Piccolella S.2, Rárová L.3, Strnad M.3, Pacifico S.2,     
Zidorn C.1 
1Pharmazeutisches Institut, Abteilung Pharmazeutische Biologie, Christian-Albrechts-
Universität zu Kiel, 76 Gutenbergstraße, 24118 Kiel, Germany 
2Department of Environmental Biological and Pharmaceutical Sciences and 
Technologies, University of Campania Luigi Vanvitelli,  
43 Via Vivaldi, 81100 Caserta, Italy 
3Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological 
and Agricultural Research, Institute of Experimental Botany ASCR & Palacky 
University, 27 Šlechtitelů, 78371 Olomouc, Czech Republic 
 
In our continuing search for new bioactive compounds in the Cichorieae tribe of the 
Asteraceae family, we have studied the formerly not investigated European species 
Sonchus palustris L. 
Standard chromatographic techniques were used for natural product isolation and 1D 
and 2D NMR, together with HRMS were used for structure elucidation. In addition, 
some of the pure compounds were assayed in vitro for cytotoxicity. 
Seven previously undescribed sesquiterpene lactones, three known sesquiterpene 
lactones (ixerin D, 15-p-hydroxyphenylacetyllactucin, and 15-p-
hydroxyphenylacetyllactucin-8-sulfate), and two known quinic acid derivatives (3-O-
feruloylquinic acid and 3,5-di-O-caffeoylquinic acid) were isolated from Sonchus 
palustris L. roots. Four formerly unknown compounds were elucidated to be 3β,14-
dihydroxycostunolide-3-O-β-D-gluco¬pyranosyl-(2-O-p-hydroxyphenylacetyl)-14-O-p-
hydroxyphenylacetate, 15-p-methoxyphenyl-acetyllactucin, 15-p-
methoxyphenylacetyllactucin-8-sulfate, and 8-p-hydroxyphenylacetyllactucin-15-
sulfate. Additionally, three undescribed conjugates of lactucin and a eudesmanolide 
type sesquiterpenic acid were characterized. Five compounds [3β,14-
dihydroxycostunolide-3-O-β-D-glucopyranosyl-(2-O-p-hydroxy¬phenylacetyl)-14-O-p-
hydroxyphenylacetate, ixerin D, 15-p-hydroxyphenylacetyllactucin, 15-p-
methoxyphenylacetyllactucin, and 15-p-hydroxyphenyl-acetyllactucin-8-sulfate] were 
additionally tested for their antiproliferative activity. 15-p-hydroxy-
phenyl¬acetyllactucin and 15-p-methoxyphenylacetyllactucin showed cytotoxicity 
against CEM, MCF7, and HeLa cells with IC50 values ranging from 3.9 ± 0.2 to 34.6 
± 2.8 µM, while 3β,14-dihydroxycostunolide-3-O-β-D-glucopyranosyl-(2-O-p-
hydroxy¬phenylacetyl)-14-O-p-hydroxyphenylacetate, ixerin D, and 15-p-hydroxy-
phenylacetyllactucin-8-sulfate were significantly less active (> 50 µM). 
Our new data supports previous observations that the Cichorieae are a group 
particularly rich in bioactive compounds, mainly from the class of sesquiterpene 
lactones. 
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HERBAL MEDICINE DEVELOPED AT THE ALL-RUSSIAN 
RESEARCH INSTITUTE OF MEDICAL AND AROMATIC PLANTS. 
ACHIEVEMENTS AND PERSPECTIVE 
Mizina P. 
Federal State Budgetary Institution "All-Russian Scientific Research Institute of 
Medical and Aromatic Plants" (FSBI VILAR) 
Moscow, 7 Grin str., e-mail: mizina-pg@yandex.ru; Tel.8 903 503 32 01 
 
FSBI VILAR turned 88 years. This is a multidisciplinary scientific institution, its 
structure includes 4 research centers: 
- The Center of Medical Plant Growing with two departments (natural resources, 
agrobiology and selection) and the Botanical Garden of medical plants; 
- Center of Chemistry and Pharmaceutical Technology with three departments 
(phytochemistry and standardization, experimental technology, biotechnology); 
- Center of Medicine (preclinical research center) with two departments (experimental 
and clinical pharmacology, toxicology) and a laboratory of microbiological research; 
- Research Center of Biomedical Technologies with two departments (biomedical 
problems, special works). 
During its 88-year history of development of FSBI VILAR, working on the principle 
“From plant to drug”, has created more than 100 medical herbal preparations of 
multidirectional pharmacological effect.  Many of them have no analogues to foreign 
drugs.  These are our drugs such as alapinin, flakozid, sanguirytrin, hyporamin, 
eukalimin, belacechol and others. 
However, the relevance of herbal medicines use in practical medicine is currently 
disputed, which cannot be considered justified.  Drugs created on the basis of 
medicinal plant materials, have softer effect on the human body and fewer side 
effects compared to synthetic drugs and can be successfully used in practical 
medicine along with synthetic drugs; their development is important, relevant, 
necessary and allows to solve many issues in providing the population with 
affordable, effective and safe medicines. 
It is advisable to include herbal medicines in different nosologies into clinical 
guidelines and treatment standards.  It is necessary to make wider use of information 
on herbal medicines, including it in educational processes at all stages of medical 
and pharmaceutical workers training. And in this aspect it is necessary to consolidate 
all scientific and practical workers in medicine and pharmacy. 
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ENZYME MODIFICATION OF POLYSACCHARIDES FROM HERBAL 
PLANTS AND THEIR BIOLOGICAL ACTIVITY AS PREBIOTICS 
Iliev I. 
Department of Biochemistry and Microbiology, Faculty of Biology, “Paisii Hilendarski” 
Plovdiv University, 4000 Plovdiv, Bulgaria 
*Correspondence: ilievini@abv.bg, 0888519288 
 
Aim: The aim of the present work is to investigate the correlation between the 
chemical structure and prebiotic potential of oligosaccharides from herbal plants 
Plantago major and Lycium barbarum after their enzymatic hydrolysis with different 
types of hemicellulases. 
Methods: The neutral sugars, uronic acid, total phenolic and protein content were 
analyzed spectrophotometrically. The monosaccharide composition of 
polysaccharides and oligosaccharides was studied by HPLC, with RI Detector and 
YMC Polyamine II (250×4.6 mm) column. Different probiotic strains of genus 
Lactobacillus were used to examine the prebiotic activity of the enzymatically 
hydrolysed oligosaccharides. 
Results: We present a principal sheme of technological process for production of 
prebiotic oligosaccharides by enzyme hydrolysis of different plant and and herbal 
polysaccharides, using original method of our laboratory. In the presence of different 
oligosaccharides and disaccharides as substrates the lactobacilli produce different 
glycohydrolase enzymes for their metabolism. The utilization of polysaccharide 
hydrolysates of Plantago major and Lycium barbarum were studied by measuring the 
cell growth, the production of different end products, and the activity of α-
galactosidase, α-glucosidase, and β-xylosidase from the tested probiotic strains. The 
results showed that L. plantarum strains specifically metabolized the carbohydrate 
composition when they were cultivated in mMRS medium in the presence of 2% 
hydrolysates. 
Conclusion: Health effects of prebiotics are evolving but currently include benefits to 
the gastrointestinal tract (for example, inhibition of pathogens, immune stimulation), 
cardiometabolism (for example, reduction in blood lipid levels, effects upon insulin 
resistance), mental health (for example, metabolites that influence brain function, 
energy and cognition) and bone (for example, mineral bioavailability), among others. 
 
 
INVASIVE ALIEN SPECIES – CHEAP SOURCES OF VALUABLE 
ESSENTIAL OILS 
Kozuharova E.*, Benbassat N., Ionkova I. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia 
 
Here we present data on the distribution and invasion level in Bulgaria of Ailanthus 
altissima (Mill.) Swingle, (Simaroubaceae), Amorpha fruticosa L. (Fabaceae), 
Ambrosia artemisiifolia L., Xanthium strumarium L., Erigeron canadensis L., and 
Dittrichia graveolens (L.) W. Greuter (Asteraceae). The high tolerance of various 
habitat conditions and potent propagation ability of these alien plants promote their 
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aggressive invasive behaviour. Additionally, they not only over-compete the local 
vegetation but suppress the seed development. In the newly invaded habitats they 
might not have suitable herbivores to control their populations. The aim of this review 
study is to attract the attention towards these plants and their potential to be used as 
cheap sources of valuable essential oils. 
A growing body of scientific literature points to the presence of essential oils with 
various compositions. The main components are limonene, borneol, caryophyllene 
oxid, α-pinene, germacrene D, β-caryophyllene. These essential oils possess 
different activities such as anti-inflammatory, antimicrobial, antifungal, antiviral, anti-
inflammatory, insect repellent, insecticidal and herbicidal activity. 
Due to the fact that these are aggressive invasive species, they can provide 
abundant and cheap resources. Additionally, exploitation of the biomass for 
extraction of essential oils might contribute to relieving the destructive impact of 
these species on the natural habitats. 
Key words: essential oils, pharmacological activity, management. 
Acknowledgements: This work has been carried out in the framework of the Grant Д-
79/23.04.2019, Project  8276/20.11.2019 CMS, MU-Sofia 
 
 
IN VIVO EVALUATION EFFECTS OF FLAVONOID MAURITIANIN, 
ISOLATED FROM ASTRAGALUS MONSPESSULANUS SPP. 
MONSPESSULANUS 
Kondeva-Burdina M.1, Krasteva I.2, Shkondrov A.2, Popov G.3, Manov V.3 
1 “Drug Metabolism and Drug Toxicity“ Laboratory, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
2Department of Pharmacognosy, Faculty of Pharmacy, 
Medical University, Sofia, Bulgaria 
3Department of Internal Uninfected Diseases, Pathology and Pharmacology,  
Faculty of Veterinary Medicine, University of Forestry, Sofia, Bulgaria 
 
In this study, we investigate the in vivo effects of flavonoid mauritianin, isolated from 
Astragalus monspessulanus spp. monspessulanus, administered alone and in 
carbon tetrachloride-induced toxicity. 
The effects of the flavonoid were evaluated by: complete blood count and 
biochemical parameters; malondialdehyde (MDA) production, level of reduced 
glutathione (GSH) and activity of ethylmorphine-N-demethylase (ENDM) (marker for 
the isoform CYP3A activity). Histopathological evaluation of the mauritianin effects 
was made on liver, kidney, brain and spleen. The effects were compared to those of 
the classical protector and antioxidant silymarin. 
The rats were treated 21 days with mauritianin and silymarin (dose 100 mg kg-1/p.o). 
Carbon tetrachloride (10 % solution) was given once (dose 1.25 mL/kg p.o). 
Administered alone, mauritianin didn‟t reveal statistically significant toxic effects, 
compared to the control (non-treated rats). In a model of carbon tetrachloride-
induced toxicity, mauritianin protects the exam parameters: decreased the MDA 
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production, prevent the GSH level and decreased the activity of EMND. The results 
were proved by histopathological examinations. 
We found that in vivo mauritianin revealed protective effects in carbon tetrachloride-
induced toxicity, which might be due to possible influence of the metabolism of the 
toxic agent. 
 
 
IDENTIFICATION AND MASS FRAGMENTATION ANALYZES OF 
STEROID ALKALOIDS AND PHENOLIC ACIDS FOUND IN SOLANUM 
SCHIMPERIANUM 
Voynikov Y.1, Zheleva-Dimitrova D.2, Balabanova V.2, Gevrenova R.2 
1Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
2Department of Pharmacognosy, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
 
Purpose: Phytochemical analyses of leaves extract of the plant Solanum 
schimperianum, Hochst were performed. High-performance liquid chromatography 
and high resolution mass-spectrometry (LC-HRMS) was utilized for the identification 
of several steroid alkaloids as well as 21 phenolic acids. 
Materials and methods: The leaves of S. Schimperianum were harvested in the 
region of Erkowit, East Sudan. After ultrasonic extraction with 5% acetic acid, the 
aqueous layer was alkalized and n-butanol was added. The organic phase was 
evaporated to dryness and reconstituted in methanol. Mass spectrometric analyzes 
were carried out on a Q Exact Plus mass spectrometer (ThermoFisher Scientific) 
equipped with an electrospray ionization probe (HESI-II) (ThermoScientific). 
Results: Based on accurate high-resolution mass measurements and analysis of 
isotope distributions and mass fragmentation analyses, several steroid alkaloids 
bearing spirosolane or solanidane type ring were identified. Furthermore, by targeted 
analysis, 21 phenolic acids were identified in the plant extract. 
Conclusion: The mass fragmentation behavior of steroidal alkaloids and phenolic 
acids was investigated which allowed their identification and characterization in the 
leaves extract of Solanum schimperianum, Hochst. 
Corresponding author: Yulian Voynikov 
mobile: 0 888 398 907; e-mail: y_voynikov@pharmfac.mu-sofia.bg 
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LIQUID CHROMATOGRAPHY–HIGH RESOLUTION MASS 
SPECTROMETRY - EFFECTIVE TOOL IN GYPSOPHILA SAPONINS 
ANNOTATION 
Gevrenova R. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia, 2 
“Dunav” str., 1000 Sofia, Bulgaria 
Corresponding author: Reneta Gevrenova, tel.+359898641361,  
e-mail: rgevrenova@gmail.com 
 
The aim of the study: The study aimed to develop a hyphenated platform liquid 
chromatography - high resolution mass spectrometry (LC-HRMS) for comparison of 
saponin profiles from Gypsophila roots and annotation and dereplication of 
glucuronide oleanane-type triterpenoid carboxylic acid 3,28-bidesmosides 
(GOTCABs). 
Materials and methods: Saponins were analyzed in a set of accessions including 
wild (G. trichotoma and G. glomerata) and in vivo cultivated (G.scorzonerifolia, G. 
acutifolia, G. altissima, G. paniculata, G. pacifica, G. oldhamiana, G. zhegualensis) 
plants. They were profiled and characterized by classical reverse phase and 
hydrophilic interaction (HILIC) chromatography coupled with hybrid quadrupole-
Orbitrap HRMS. 
Results: Fragmentation pathways evidenced from 15 saponin references, high-
accuracy MS and MS/MS data, elemental composition, isotopic peak profiles and 
database searching in an in-house library of GOTCABs were employed to 
characterize sapogenins and sugar chains. A total of 70 GOTCAB core structures 
were identified or tentatively elucidated in the assayed species, forming isobaric and 
positional isomers. They possess gypsogenin, quillaic,oleanolic and gypsogenic acid 
as sapogenin, substituted at C-3 with O-β-D-galactopyranosyl-(1→2)-[pentosyl-
(1→3)]-β-D-glucuronopyranoside. Possible fragmentation pathways for four groups of 
GOTCABs were suggested. Type I consisted of saponins with C-28 ester-bonded 
oligosaccharide substituted with acetyl or/and methoxycinnamoyl group(s); type II 
and III included sulphated, and acetylated and sulphated saponins, while type IV 
grouped compounds with С-28 unsubstituted tri- to hexa-saccharides. The wild 
species possessed sulphated GOTCAB, while cultivated accessions displayed a 
variety of mono- and di-acetylated GOTCABs. 
Conclusion: An in-depth depiction of the GOTCAB saponin composition of wild and 
cultivated Gypsophila species was achieved. 
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UHPLC-HRMS BASED STRATEGY FOR THE DEREPLICATION OF 
CAFFEIC ACID OLIGOMERS AND SAPONINS IN CLINOPODIUM 
VULGARE L. WATER EXTRACT 
Zheleva-Dimitrova D., Gevrenova R. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia, 2 
“Dunav” str., 1000 Sofia, Bulgaria 
 
The aim of the study: In this study we focused on a comprehensive characterization 
of Clinopodium vulgare lyophilized water extract (CVE) by ultra high-performance 
liquid chromatography coupled with high resolution mass spectrometry (UHPLC-
HRMS). A strategy for the dereplication of caffeic acid oligomers and saponins in 
CVE was developped. 
Materials and methods: CVE was analyzed by UHPLC-HRMS system equipped 
with a hybrid quadrupol-Orbitrap high resolution “Q-Exactive” mass spectrometer 
coupled with a heated electrospray ionization probe. The mass analyzer scanned 
over a mass range 100-1500 Da in Full MS-ddMS2/Top N scan type and negative ion 
mode. The identification of the studied compounds was based on the accurate 
masses, MS/MS data and comparison to fragmentation fingerprints observed for the 
reference standards, and literature data. 
Results: Dereplication represents a key step for rapidly identifying known secondary 
metabolites in complex biological matrices. In this context, UHPLC-HRMS was used 
via untargeted data-dependent MS/MS experiments; massive amounts of detailed 
information on the chemical composition of crude C. vulgare extract were generated. 
Two monomers, seven dimers, twenty-three trimers and nine caffeic acid tetramers, 
as well as five saponins were tentatively identified in CVE using the UHPLC-HRMS 
based strategy. A variety of clinopodic, salvianolic, isosalvianolic, yunnaneic acids 
and oleanane-type triterpenoid saponins were found in CVE for the first time. 
Conclusion: The obtained UHPLC-HRMS based strategy for the dereplication of 
secondary metabolites in Clinopodium vulgare extract highlights the studied species 
as a new rich source of water soluble caffeic acid oligomers. 
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PHYTOCHEMICAL AND BIOLOGICAL INSIGHT INTO TELEKIA 
SPECIOSA (SCHREB.) BAUMG. AND TANACETUM 
MACROPHYLLUM (WALDST. & KIT) SCHULTZ BIP. (ASTERACEAE) 
Balabanova V.1, Zengin G.2, Zheleva-Dimitrova D.1, Benbassat N.1,      
Gevrenova R.1 
1Department of Pharmacognosy, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
2Department of Biology, Science Faculty, Selcuk University, Konya, Turkey 
Corresponding author: Vessela Balabanova,  
e-mail: vessela.balabanova@gmail.com, Phone:+359 898 249 850 
 
The aim of the study: In this study we aim at investigating the phytochemical and 
biological profiling of Telekia speciosa (Schreb.) Baumg. and Tanacetum 
macrophyllum (Waldst. & Kit) Schultz Bip. (Asteraceae) grown on Vitosha Mt.  
Materials and methods: The flower heads of the studied species were assessed 
using spectrophotometric and ultra high-performance liquid chromatography - high 
resolution mass spectrometry (UHPLC-HRMS) techniques. The species' antioxidant 
and enzyme inhibitory activity was evaluated. 2,2-Diphenyl-1-picrylhydrazyl (DPPH), 
2,2'-azinobis-(3-ethylbenzothiazine-6-sulphonic acid) (ABTS) and ferric and cupric 
reducing power (FRAP and CUPRAC), metal chelating and phosphomolybdenum 
methods were used for antioxidant activity assays. In addition, cholinesterase, α-
amylase and α-glucosidase inhibitory ability of the extracts were tested. 
Results: The obtained results revealed that Flos Tanaceti has higher antioxidant, α-
glucosidase and α-amylase inhibitory activities in comparison with the anthodium of 
T. speciosa, while the later has prominent acetylcholinesterase inhibitory ability. 
Moreover, a variety of hydroxyisopropanoyl- and hydroxyisovaleryl-esters of caffeoyl- 
and feruloylhexosides, as well as caffeoyl- and feruloylquinic acids, dicaffeoyl- and 
caffeoylferuloylquinic acids were tentatively elucidated. 
Conclusion: In conclusion, the studied species have significant antioxidant and 
enzyme inhibitory capacity and could be used as a rich source of bioactive 
compounds. 
Acknowledgements: The study was supported by Grant D-222/12.12.2018 from the 
Medical Science Council at the Medical University of Sofia, Bulgaria. 
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IN VITRO EFFECTS OF SAPONINS’ MIXTURE FROM ASTRAGALUS 
GLYCYPHYLLOS ON ISOLATED RAT BRAIN SYNAPTOSOMES AND 
MICROSOMES 
Voynova M.1, Shkondrov A.2, Kondeva-Burdina M.1, Krasteva I.2 
1“Drug Metabolism and Drug Toxicity” Laboratory, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University, Sofia, 2 
“Dunav” str., Sofia, Bulgaria 
2Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia, 2 
“Dunav” str., Sofia, Bulgaria 
 
Astragalus glycyphyllos L. (Fabaceae) is used in folk medicine as an 
antihypertensive, diuretic, anti-inflammatory, anti-tumour, laxative, expectorant, etc. 
In our study, we investigate the effects of saponins‟ mixture, isolated from Astragalus 
glycyphyllos, a native plant in Bulgarian flora, in different models of neurotoxicity: 6-
hydroxydopamine (6-OHDA)-induced oxidative stress on isolated rat brain 
synaptosomes and non-enzyme-induced lipid peroxidation on isolated rat brain 
microsomes. The saponins‟ mixture revealed statistically significant neuroprotective 
and antioxidant effects in these models, by preservation the synaptosomal viability 
and GSH level (at synaptosomes) and decrease of malondialdehyde (MDA) 
production (marker for lipid peroxidation) (at microsomes). These effects might be 
due to possible scavenger activity of reactive oxygen species (ROS) and 
preservation of reduced glutathione level – a classical nucleophile, which is a ROS 
scavenger. 
 
 
BIOACTIVE COMPOUNDS FROM GARDEN SNAILS HELIX 
ASPERSA WITH APPLICATIONS IN PHARMACEUTICS INDUSTRY 
AND MEDICINE 
Dolashka P.1, Dolashki A.1, Velkova L.1, Atanasov V.1, Devreese B.2 
1Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of 
Sciences, Sofia, Bulgaria 
*Corresponding author: pda54@abv.bg 
2 Laboratory for Protein Biochemistry and microbiology,  
Department of Biochemistry and Microbiology, Ghent University 
 
The hemolymph and mucus of garden snails are a complex multi-component mixture 
comprising various biochemical and pharmacologically active substances with 
different masses and properties. Some of them exhibit antibacterial, antitumor 
activities and have antioxidant and immunomodulatory properties. 
The mucus was collected and purified from garden snails H. aspersa, grown in 
Bulgarian farms using patented technology without suffering any snail. The crude 
extract was separated using Millipore filters by ultrafiltration into different fractions. 
We have performed in vitro studies on the antimicrobial activities of different extracts, 
obtained from mucus, against Gram+ and Gram- bacteria, as well as fungal strains  
A. niger, A. fumigatus and C. albicans. Our results have shown that fractions 
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<10kDa, <20kDa and between 1-10kDa and possess strong antimicrobial activity 
against the tested pathogens. The fraction 10-50kDa possesses the most significant 
fungistatic activity on the mycelium growth of A. niger strain compared to other tested 
fractions. 
Using tandem mass spectrometry we identified the primary structures of many novel 
antimicrobial peptides. Most of them contain high level of glycine and leucine 
residues into the amino acid sequences and belong of a class of Gly/Leu-rich AMPs, 
but others, contain proline, tryptophan and valine residues which are typical for 
peptides with antimicrobial activity. 
Our results may be considered as basic information for further investigations on 
bioactive compounds from H. aspersa for creating new natural products with potential 
biomedical applications. 
Keywords: garden snails H. aspersa, H. aspersa hemocyanin, antimicrobial peptides 
(AMPs), anticancer activity 
Acknowledgments: This work was supported by the Bulgarian Ministry of Education 
and Science under the National Research Program “BioActivMed” approved by DCM 
№ 658/14.09.2018 and FWO VS.076.18N/2018-2020 
 
 
CLINOPODIUM VULGARE AND ITS MAJOR CONSTITUENT 
ROSMARINIC ACID, PROTECT AGAINST SCOPOLAMINE-INDUCED 
OXIDATIVE STRESS IN RAT BRAIN 
Nasar- Eddin G1., Simeonova R1., Zheleva D2., Gevrenova R2., Danchev N1. 
1Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia, 2 
“Dunav” str., 1000 Sofia, Bulgaria 
 
Introduction: One of the mechanisms involved in the brain toxicity, is the oxidative 
stress. Clinopodium vulgare L. (Lamiaceae) is a perennial herbaceous plant used in 
the Bulgarian folk medicine. 
Aim: The aim of the current study was to investigate the antioxidant and 
neuroprotective effects of C. vulgare extract (CVE) and its main constituent 
rosmarinic acid (RA), on scopolamine (SC) induced brain toxicity in Wistar rats. 
Materials and methods: The animals were divided into four groups: control; group 
treated with scopolamine (3 mg/kg, i.p., 7 days); animals treated simultaneously with 
SC and CVE (100 mg/kg, oral gavage for 14 days), and group four – animals treated 
with SC and RA (20 mg/kg i.p., 14 days). Acetylcholinesterase (AChE) activity, 
nitrites (NOx) concentration, and the following antioxidant enzymes: superoxide 
dismutase (SOD), catalase (CAT), glutathione-peroxidase (GPx), as well as the 
biomarkers of oxidative stress malondialdehyde (MDA) and reduced glutathione 
(GSH) were measured in the whole brain of the experimental animals. 
Results: Scopolamine repeated administration resulted in increased AChE activity 
and oxidative stress, discerned by an increased lipid peroxidation and formation of 
NOx, depletion of GSH levels, and impairment of the enzymatic antioxidant defense 
system measured in brain. 
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CVE and RA administered along with SC restored the GSH levels and antioxidant 
enzyme activities near control levels. Both substances reduced the increased AChE 
activity, MDA, and NOx brain concentrations and thus exerting neuroprotective action 
on the SC induced brain toxicity. 
Conclusions: Both substances possess antioxidant and neuroprotective activity and 
could be candidates for further investigations. 
The study was supported by Grant Young scientist - 147 / 23.04.2019 from the 
Medical Science Council at the Medical University of Sofia. 
 
 
BIOLOGICAL ACTIVITY OF YEASTS AND THEIR USE AS 
ANTINEOPLASTIC AGENTS 
Hristova D.1, Russinova-Videva S.2, Zaharieva M.2, Naidenski H.2,    
Konstantinov S.1 
1Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
2”Stephan Angeloff” Institute of Microbiology, Bulgarian Academy of Sciences, Sofia 
and Plovdiv, Bulgaria 
 
Studies on yeast show that they have a broad spectrum of biological activity - 
immunostimulating, antidiabetic and antineoplastic. Psychrophilic microorganisms 
need to possess adaptable metabolism thus producing bioactive components with 
attractive pharmacological properties. In this study we used methanol extracts of two 
strain yeasts- Sporobolomyces salmonicolor AL36 and Cryptococcus luarentii AL65. 
They were prepared in bioreactor and in flasks. By using method of growing yeast 
cells in a bioreactor it is possible to easily control conditions, being independent of 
geographic location and climatic features of the area, short time to carry out the 
fermentation processes and low value of the substrates used, are other advantages. 
Our study aimed to determine and compare the antineoplastic activity of the Antarctic 
yeast extract against different tumor cell lines: T-24 and CAL-29 (urinary bladder 
cancer), HuT-29 and MJ (cutaneous T-cell lymphoma), HD-MY-Z (Hodgkin 
lymphoma), RPMI-8226 (multiple myeloma). The cytotoxic efficacy was measured 
using the MTT-assay. Induction of apoptosis was ascertained by nuclear changes, 
DNA fragmentation, as well as by caspase activation. 
Concentration response curves showed IC50 values between 28,27µg and 219,60 
µg/ml for the different tumor cell lines. Highest sensitivity to the antineoplastic activity 
of the yeast extracts was registered in multiple myeloma RPMI-8226 cells. 
Along with these results with Antarctic yeast extracts we do not expect any toxic side 
effects. Taken together our data indicate that yeast extracts are very attractive and 
perspective sources of substances with valuable pharmacological and toxicological 
profile and could be used to ameliorate the complex treatment of human malignant 
diseases. 
Acknowledgments: A substantial part of the experimental work has been supported 
by the National Program BioActiveMed D01-217/30.11.2018, sponsored by the 
Bulgarian Ministry of Education and Science. 
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BIOACTIVE COMPOUNDS ISOLATED FROM MARINE SNAIL 
RAPANA VENOSA WITH POTENTIAL APPLICATION IN MEDICINE 
Velkova L.1, Konstantinov S.2, Dolashki A.1, Atanasov V.1, Dolashka P.1 
1Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of 
Sciences, Sofia, Bulgaria 
2Faculty of Pharmacy, Medical University of Sofia, Bulgaria 
Corresponding author: e-mail: lyudmila_velkova@abv.bg 
 
Aim: The priority for the next decades will be focused on discovers and investigation 
of alternative natural molecules with a new mechanism of action as medicaments for 
therapy. The object of our investigation is hemolymph of marine snail R. venosa, 
which is a complex mixture from various bioactive substances with potential 
application in medicine. The aim of this study was to investigate the anti -tumor effect 
of different fractions from hemolymph of R. venosa. 
Methods: The hemolymph from R. venosa, was separated into several fractions, by 
ultrafiltration using membranes with different pore sizes. The native molecule of R. 
venosa hemocyanin (RvH) and its two structural subunits RvH1 and RvH2 were 
isolated and purified from fraction >100 kDa. The isolated  components: RvH, RvH1 
and RvH2, fraction below 10 kDa and fraction between 10-50 kDa were  investigated  
in vitro for antitumor activity of human cell lines: bladder cancer (T-24) and cutaneous 
T-cell lymphomas (MJ, Mycosis fungoides and HuT-78, Sézary syndrome). 
Results: The results revealed a significant cytotoxic effect of structural subunit RvH2 
against bladder cancer (tumor cells line T-24). The most effective inhibition against 
cutaneous T-cell lymphomas (MJ, Mycosis fungoides) was observed after treatment 
with fraction, containing bioactive components with Mw between 10-50 kDa from 
hemolymph of R. venosa. 
Conclusion: The absence of toxic effects on R. venosa extracts makes them 
promising candidates for topical application in the bladder before and after 
transurethral resection. Our results may be considered as basic information for 
further investigations on bioactive compounds from hemolymph of R. venosa for 
creating new natural products with potential biomedical applications. 
Acknowledgments: This work was supported by the Bulgarian Ministry of Education 
and Science under the National Research Program “BioActivMed” approved by DCM 
№ 658/14.09.2018. 
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HOUSEHOLD AND PUBLIC SPENDING ON HEALTH 
Mitkova Z*., Petrova G. 
Faculty of Pharmacy, Medical University, Sofia 
*e-mail: sppmitkova@mail.bg 
 
Aim of the study: Between 2000 and 2016, global spending on health increased 
every year. Government and household health expenditures have risen in absolute 
terms as a result of economic growth. This study explores the trend of household and 
public health expenditures in Bulgaria during 2010-2017. 
Materials and methods: The study is observational and retrospective analysis on 
household and public expenditures for healthcare and medicines over the period 
2010-2017. National statistical Instituteand Annual reports of National Health 
Insurance Fund were used for data collection. Statistical significance in the changes 
was tested with t-test. 
Results: The results showed that health expenditures per household on average 
(BGN) haverisen from 447 in 2010 to 642 BGN in 2017. The health expenditure per 
person has increased from 181 to 280 BGN within the same period. The household 
costs for medicinal products growth up too (from 177 to 205 BGN per person during 
2015-2017). 
NHIF costs for reimbursed medicines, dietary foods for special medical uses and 
medical devices continue to grow latest years. Pharmaceuticals spending is 
increasing almost twice (from 365 to 798 million BGN) while the costs for medicines, 
dietary foods and medical devices is increasing from 384 to 821 million BGN 
between 2010-2017. T-test analysis shows statistically significant differences in costs 
(p ˂ 0.0029). 
Conclusion: Our study confirms the world trend of increasing household and public 
health expenditures observed last decade. This trend may be due to different factors 
as population aging, chronic diseases, healthcare system financing etc. 
 
 
PHARMACY STUDENTS’ OPINION REGARDING THEIR 
KNOWLEDGE OF BIOTECHNOLOGY MEDICINAL PRODUCTS 
Tamer D.1, Grozev J.1, Todorova A.2, Kamusheva M.1, Petrova G.1 
1Faculty of Pharmacy, Medical University, Sofia 
2Faculty of Pharmacy, Medical University, Varna 
Corresponding author: Djanet Tamer; e-mail: janitamer@gmail.com;  
Tel. 0885204137 
 
The aim of the study: To assess pharmacy students‟ opinion regarding their 
knowledge of biotechnological medicines (BM). 
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Materials and methods: An online questionnaire-based survey among pharmacy 
students in Bulgaria was carried out. Descriptive statistics, test for one proportion and 
comparison of proportions have been applied using the statistical program MedCalc.  
Results: The number of respondents is 172 out of all targeted 281 (CI 95%, margin 
of error 5%) pharmacy students from three Faculties of Pharmacy in Bulgaria – 
Medical University, Sofia (52.3% of all respondents), Sofia University (19.2%) and 
Medical University, Varna (28.5%). 76.7% of the respondents were women, with the 
predominance between 20 and 22 years old (67.4%). Statistically significant more 
students shared that they are familiar with BM legal definition (66.3% (p<0.0001)) 
and the difference between biosimilar and generics (59.9% (p<0.05)). However, 
71.5% deem that their knowledge of BM is insufficient to consult patients in real-life 
practice (p<0.0001). Therefore, most of them (83.1%) opined that more detailed 
education on BM is needed (p<0.0001) and 62.8% (p=0.0008) would consider to take 
up BM related elective discipline. Significantly more students from Sofia are familiar 
with BM definition (68.9% vs. 51.02% (p=0.0269)) but less of them shared that their 
level of knowledge is enough (18.6% vs. 51.02% (p<0.0001)) in comparison with the 
students from Varna. 
Conclusion: The survey revealed that most of the pharmacy students identify some 
gaps in their knowledge regarding BM. They obviously would like to become more 
experienced and fluent on the topic. Therefore, more training, elective disciplines and 
educational symposiums focusing on BM should be provided for pharmacy students. 
 
 
QUALITY OF LIFE OF ASTHMA PATIENTS 
Milushewa P., Doneva M., Petrova G., Najdenova K., Krusheva B., Usunov S., 
Dimitrov V. 
Faculty of Pharmacy, Medical University of Sofia 
 
Goal: The goal of this study is to analyse the quality of life and asthma control in 
elderly patients with mild, moderate, severe asthma and asthma with rhinitis. 
Materials and methods: Prospective study performed at the clinic of allergology at 
the “Alexandrovska” University hospital. The quality of life is accessed with 
unidimensional instrument (EQ5D), questionnaire for the evaluation of asthma 
therapy - Asthma Treatment Assessment Questionnaire (ATAQ) and test for asthma 
control (ACT). 30 patients with mild, moderate, severe asthma and asthma with 
rhinitis are inquired during their visit at the department. The results are processed 
with t-test and Kruskal Wallis test. 
Results: The age of the 30 participants is between 30-70 years. With moderate 
asthma were 7, 14 had severe and 5 asthma with allergic rhinitis. Patients with 
asthma above 5 year prevail (n=19), and between 1 and 5 years (n=8). Average 
quality of life is 0.74 (EQ5D3L). According to the answers of ATCQ 14 patients 
reported partial control, 9 control and 7 with poor control of their asthma. According 
to answers to АСТ 23 are with poor control (77%). There is a statistically significant 
relation between the duration of the disease and quality of life for patients with 
duration 1-5 and above 5 years; duration and control according to ATCQ, but not 
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according to АСТ. Statistically significant is the difference between the moderate and 
severe asthma and quality of life. 
Conclusions: Asthma control is insufficient, and the worst are the АТС values. The 
quality of life is somewhat lower in comparison to the general population in the same 
age group. Duration and type of asthma influenced negatively the control and quality 
of life. 
 
 
IN VITRO EFFECTS OF NEWLY SYNTHESIZED 
SEMICARBAZIDES/THIOSEMICARBAZIDES OF THEOPHYLLINE ON 
ISOLATED RAT BRAIN SYNAPTOSOMES 
Goliykov T.1, Kondeva-Burdina M.1, Mitkov J.2, Zlatkov A.2 
1“Drug Metabolism and Drug Toxicity” Laboratory, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
 
Aim: This study investigates the in vitro effects of newly synthesized 
semicarbazides/thiosemicarbazides on isolated rat brain synaptosomes. 
Materials and methods: The synaptosomes were obtained by multiple 
centrifugation, using Percoll gradient. The main parameters, characterized the 
functional status of synaptosomes: synaptosomal viability and depletion of reduced 
glutathione (GSH), were measured. The effects were compared to those of 
Theophylline. 
Results: Administered alone, all of the compounds (at concentration 100 µM) 
revealed statistically significant neurotoxic effects on the synaptosomes, compared to 
the control (non-treated synaptosomes). With higher toxic effects were compounds 
JE-5, JE-7 and JE-10. JE-5 decreased synaptosomal viability and GSH level, 
respectively with 51 % and 49 %; JE-7 – with 55 % and 50 %; JE-10 – with 53 % and 
51 %, compared to the control (non-treated synaptosomes). Theophylline, itself, 
decreased viability and GSH – with 42 % and 44 %, respectively, compared to the 
control (non-treated synaptosomes). 
Conclusion: The newly synthesized semicarbazides/thiosemicarbazides of 
theophylline show significant toxicity on rat brain synaptosomes. 
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INVESTIGATION AND ANALYSIS OF THE HTA PROCESS AMONG 
EXPERTS, MEMBERS OF WORKING GROUPS 
Nikolova A.1, Grigorov E.1, Getov I.2, Salchev P.1 
1National Center of Public Health and Analyses 
2Medical University, Sofia 
 
Aim of the Study: Analysis of the HTA process and related procedures on the basis 
of experience gained 2016-2019 and evaluation of the experts, members of working 
groups on the introduced regulatory changes. 
Materials and methods: An online anonymous questionnaire containing 19 
questions, addressed to respondents from two distinct groups was developed in two 
stages: 
a. First stage (24.04 - 10.05.2019) - experts, members of working groups and 
involved in the HTA process until 31.3.2019; 
b. Second Stage (15 May - 31 May 2019) – Physicions, Pharmacists, Patients, 
Industry Representatives, Patient Organizations, etc.; 
Results: The number of responses in the first stage is 89. All respondents have 
positively answered that they were familiar with the process, knew where they could 
find information about HTA and had experience in conducting. The evaluation of the 
experts, who participated in the working groups to the process, is largely positive. 
96% consider that HTA works in the public interest and evaluates the organization of 
work as very good (55%). Half of the experts surveyed are not aware or cannot 
assess the regulatory changes introduced by 01.04.2019 concerning the HTA 
process. 
Conclusion: From the survey data, it can  logically be concluded, that the HTA 
process is sufficiently well known to the experts who participated in working groups. 
The share of respondents, who take into account the positive aspects of the 
introduction of HTA in Bulgaria is high. There is a need for a broader explanation of 
the changes and their impact on the HTA process in the country. 
 
 
IN VITRO EFFECTS OF NEWLY SYNTHESIZED HYDRAZIDE-
HYDRAZONES BEARING INDOLE MOIETY ON ISOLATED RAT 
BRAIN MICROSOMES 
Yanakieva N.1, Kondeva-Burdina M.1, Angelova V.2 
1“Drug Metabolism and Drug Toxicity” Laboratory, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
2Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
 
The aim of the study: A series of new aroylhydrazones 3a–3g has been 
synthesized with the aim of evaluating their effect on isolated mouse microsomes. 
Materials and methods: The aroylhydrazone derivatives have been synthesized in 
high yields by direct reaction of substituted 5-C substituted indole-3-carbaldehyde  
1a-c with various hydrazides 2a-d. The synthesis was performed in ethanol at reflux, 
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using an established procedure. The structures of the newly synthesized hydrazones 
3a–3g were characterized by IR, 1H-NMR, 13C-NMR, HR-MS spectroscopic 
methods. 
The microsomes were obtained by differential centrifugation. As a marker of lipid 
peroxidation, the production of malondialdehyde (MDA) was measured. 
Results: All compounds revealed statistically significant pro-oxidant effects, 
compared to the control (non-treated microsomes). With highest pro-oxidant effects 
are compounds bearing Br- and benzyloxy- 5-substituted indole scaffold: 3a, 3e, 3f 
and 3g. The compound 3a increased the production of MDA with 65 %, 3e – with 60 
%, 3f – with 58 % and 3g – with 66 %. The other three compounds: 3b, 3c and 3d 
had lower pro-oxidant effects. 
Conclusion: From the results we can define the relation between the structure of the 
compounds and their toxicity. Three of the compounds with furyl, 4-chlorophenyl, 2,4-
dihydroxyphenyl fragments – 3b, 3c, 3d are convenient for further investigations. 
 
 
COST-UTILITY ANALYSIS OF HERNIA MESHES 
Doneva M.1, Sopotenski S.2, Gerassimov N.3, Kamusheva M.1, Petrova G.1 
1Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
2“Sv. Sofia” Hospital, Sofia, Bulgaria 
3”Subra” Pharmacy, Dobrich, Bulgaria 
 
Aim: The present study evaluates the quality of life in a conventional hernia 
operation where light or standard polypropylene hernia meshes were used. (TiO2, 
Pariettene, Surgimesh, Microval -PP, Surgipro). 
Materials and methods: A total of 68 patients were interviewed with a EuroQoL 5D 
questionnaire. Patient quality of life is compared one day and 3 months and one year 
after surgery. A cost-benefit analysis for economic assessment of the quality of the 
health score was applied. The costs are calculated in case of full reimbursement of 
hernia meshes by the public fund. Health improvement is measured in quality 
adjusted life years (QALY). 
Results: The results show that three months after the operation, patients did not 
report problems with motor activity, self-care, and usual activities, but only the 
presence of pain. 23% of patients with implanted standard meshes and 16% of 
patients with implanted light meshes experience severe pain. One year after surgery 
complains as pain, pulling and swelling are reported by 26.92% of patients with 
implanted standard meshes vs. 26.67% of patients with implanted light meshes. 
There is no statistically significant difference in the level of pain according to the used 
meshes and the feeling of a foreign body (p = 0.41). 
The utility index for both types of meshes increases from 0.53 to 0.904, with the 
value of QALY equal to 0.475 for light meshes vs. 0.469 for standard meshes. The 
incremental cost utility ratio is 2978 BGN which is far below the threshold defined as 
gross domestic product per capita in Bulgaria (7100 euro in 2018). 
Conclusion: Patient's quality of life depends on the used meshes but this trend 
decreases one year after surgery. At the end of the study period, patients assessed 
their condition as very good. The analysis of the results found that both types of 
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meshes offer good value for money for the Bulgarian healthcare system and could be 
used for implantation and paid by public funds. 
Corresponding author: Miglena Doneva 
tel. 02 92 36 584; e-mail: miglena_doneva@ abv.bg 
 
 
IMMUNOSTIMULATION IN CHILDREN. ROLE OF THE PHARMACIST 
Argilashki D., Hadzhieva B., Mihaylova A., Koleva N. 
Medical College, Medical University, Plovdiv, Bulgaria 
 
Purpose of the study: Study of the use of immunostimulants and the role of the 
pharmacist in choosing immunostimulating products. 
Materials and methods: Database review - Google Scholar, Pubmed and official 
sites. Instrumental method - survey. Statistical method for processing data from the 
survey. 
Results: Immunity is resistance of the organism against the physical, chemical and 
biological pathogenetic factors of the surrounding environment. Immune system in 
children is less developed and therefore often different forms of immunostimulation 
are used. It has been established that certain medicinal plants modulate various 
components of the immune system. Some of the most commonly used as 
immunostimulants medicinal plants are eldberry, echinacea, garlic, and others. 
Echinacea exhibits an immunomodulatory effect by increasing phagocytosis, total 
monocytes, neutrophils and NK cells. Elderberry shows antiviral activity against some 
viruses that increase morbidity during winter months, including common cold and flu, 
which is evident in both in-vitro and in-vivo models. 
A survey was conducted consisting of four modules - a passport section, 
pharmacists' awareness of immunostimulants, attitudes and barriers to 
pharmaceutical care. The study shows that pharmacists are well aware of the means 
of immunostimulation, the possibilities for their application in different age groups, 
and warn of difficulties in providing pharmaceutical care. 
Conclusion: The use of traditional medicinal plants and plants products provide 
great immunomodulation capabilities, and any recommended therapy must be age 
appropriate. In order to provide high-quality pharmaceutical care, due to increased 
consumer confidence in the pharmacist, it would be good practice in the pharmacy to 
have a separate place for consultation. 
Key words: Immunity, medicinal plants, pharmacist 
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MEDICINES UTILIZATION PATTERNS AMONG OLDER 
AMBULATORY PATIENTS IN BULGARIA – A PILOT STUDY 
Stoeva J.1, Tachkov K.1, Kamusheva M.1, Petrova G.1, Brkic J.2, Fialová D.2,3 
1Department of Organization and Economics of Pharmacy,  
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
2Department of Clinical and Social Pharmacy,  
Faculty of Pharmacy in Hradec Králové, Charles University, Czech Republic 
3Department of Geriatrics Gerontology, 1st Faculty of Medicine,  
Charles University, Czech Republic 
Corresponding author: Maria Kamusheva,  
e-mail: mkamusheva@pharmfac.mu-sofia.bg, Tel. Number: 0886428154 
 
The aim of the study: The aim is to analyze medicines utilization among elderly 
patients over the age of 65 years. 
Materials and methods: It is a prospective, questionnaire-based pilot survey 
conducted in a community pharmacy setting. The questionnaire was developed for 
the purposes of comprehensive assessment of older adults in a H2020 project 
EUROAGEISM, FIP7 program financed by the European Commission (2017-2021) 
and includes questions about demographic characteristics, social status, results of 
clinical geriatric scales, diagnostic diseases, medicines and laboratory parameters. 
The participants were enrolled on the basis of provided signed informed consent. 
Descriptive statistics was used to present the data. 
Results: 31 older patients 65+ (81% female and 17% male) were involved randomly 
in the study and those between 65 and 69 years prevailed – 39%. 25 out (81%) of 31 
interviewed patients were diagnosed with any cardiovascular disease. Logically, 
cardiovascular medicines (anatomical main group C of the Anatomical Therapeutic 
Chemical Classification System) consisted 51% of all consumed medicines, followed 
by group A (alimentary tract and metabolism) (17%) and group N (Nervous system) 
(17%). Adverse drug reactions (ADRs) (32%) were mainly associated with ACE 
inhibitors (dry cough), non-steroidal anti-inflammatory drugs (stomach problems) and 
anticoagulants (bleeding). 
Conclusions: The diseases prevalence was in accordance with the national 
statistical data as cardiovascular disorders are a leading cause for morbidity and 
mortality among Bulgarian population. Reported adverse drug reactions are probably 
as a result of polypharmacy and co-morbidity among older patients. The ADRs were 
classified as mild or moderate, but some of them might be a reason for potentially 
serious DRPs. Therefore, close monitoring of risky patients group should be provided 
by the community pharmacists. 
The EUROAGEISM H2020 project has received 
funding from the European Union‟s Horizon 2020 
research and innovation programme under the Marie 
Skłodowska-Curie grant agreement No 764632. 
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MOLECULAR DOCKING STUDY OF RUSCOGENIN, 
NEORUSCOGENIN AND DIOSGENIN ON ESTROGEN RECEPTORS 
Marinova V.*, Atanasova M., Simeonova R., Krasteva I., Doytchinova I. 
Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria 
*Corresponding author: vasilena.pm@gmail.com; phone: +359 2 9236 599 
 
Steroidal saponins with aglycones ruscogenin (RSG) and neoruscogenin (NSG) were 
found in the underground parts of Ruscus aculeatus L. The extract from rhizome of 
the species is used for treatment of chronic venous insufficiency, varicose veins, 
hemorrhoids, orthostatic hypotension, colitis, and diarrhea and locally - against 
inflammation and arthritis. It is known that saponins with steroidal structure mimic 
human sex steroidal hormones (estrogens and androgens) and might alleviate the 
risk of fracture in osteoporotic patients. RSG closely resembles diosgenin‟s structure 
and differs only in one additional hydroxyl group. The roots and rhizomes of 
Dioscorea spp. are a source of diosgenin (DSG), which has shown a vast range of 
pharmacological activities as anticancer, cardiovascular protective, anti-diabetes, 
neuroprotective, immunomodulatory, estrogenic and skin protective effects. 
Additionally, DSG inhibits osteoclastogenesis, stimulates osteogenic activity of 
osteoblasts in vitro and exerts antiosteoporotic effects in rats in vivo. The structural 
similarity of RSG and NSG to DSG makes them therapeutic candidate agents for 
bone protection. 
In the present study we used molecular docking to evaluate the ability of RSG and 
NSG to bind in alpha and beta estrogen receptors (ERs). The docking was performed 
by GOLD v.5.2.2 software tool. The docking protocol was optimized in terms of 
scoring functions, rigid or flexible protein and ligand, presence or absence of 
structural water. Estradiol (EST) and DSG were used as reference compounds. It 
was found that RSG and NSG form stable complexes with alpha and beta ERs with 
binding scores equal to these of EST and DSG. The intermolecular interactions of the 
complexes were analyzed. 
 
 
MOLECULAR DOCKING STUDY OF DIOSGENIN, RUSCOGENIN AND 
NEORUSCOGENIN ON VITAMIN D RECEPTOR 
Hyuseinova M.*, Atanasova M., Simeonova R., Krasteva I., Doytchinova I. 
Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
*Corresponding author: melis.u@abv.bg; phone: + 359 2 9236 599 
 
A lot of natural compounds present in dietary and medicinal plants could be useful in 
the prevention and treatment of osteoporosis. Diosgenin (DSG) is an aglycone of 
steroidal saponins isolated from the roots and rhizome of different Dioscorea spp. It 
is claimed to have osteogenic activity. In fact, this compound is known to possess 
anti-inflammatory and antioxidant properties. Ruscus aculeatus L. (Liliaceae) 
contains steroidal saponins with aglycones ruscogenin (RSG) and neoruscogenin 
(NSG). Typically, the rhizome extract of R. aculeatus is used to treat varicose veins 
and hemorrhoids due to its vasoconstrictive effects and anti-inflammatory capability. 
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The structures of RSG and NSG are similar to DSG which makes them candidates 
as anti-osteoporotic agents. 
In the present study the binding of DSG, RSG and NSG to vitamin D receptor (VDR) 
was studied by molecular docking. GOLD v.5.2.2 software was used for the docking 
calculations. The docking protocol was optimized in terms of scoring function, 
ridgid/flexible ligand and protein. 
The in silico prediction by molecular docking showed that DSG, RSG and NSG are 
able to bind to VDR and thus they are able to affect the intestinal Ca absorbtion 
and/or estradiol synthesis. These predictions are in a good agreement with the 
predictions made by the SwissADME tool. 
 
 
INFLUENCE OF MINERAL ADDITIVES ON SAPONARIN 
PRODUCTION BY IN VITRO CULTURES OF GYPSOPHILA 
TRICHOTOMA 
Shkondrov A., Popova P., Zdraveva P., Krasteva I., Ionkova I. 
Department of Pharmacognosy, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
 
Aim of the study: The aim was to investigate the influence of mineral additives to 
the culturing media on the accumulation of saponarin in vitro cultures of endangered 
Gypsophila trichotoma Wend. (Caryophyllaceae). 
Materials and methods: Shoots, callus and suspension cultures were established. 
They were cultivated on different media, supplemented or not with mineral additives 
such as Ca2+, Mg2+ and NaCl. Analysis of the quantity of saponarin in each culture 
was performed by high performance liquid chromatography. The results were 
compared to corresponding cultures, grown on non-modified media. 
Results: For the first time in vitro cultures of G. trichotoma were established on 
nutrition media containing mineral supplements. Significant differences in the quantity 
of saponarin were observed amongst individual cultures.  The results obtained from 
this study show that the problem is more complex and probably each of these 
ingredients contributes to the production of flavonoids in the cells. 
Conclusion: Although the suspension cultures grown on G48 medium without Mg2+ 
accumulated nearly twice as little saponarin compared to shoots on MS medium, we 
suggest them as a promising source of this rare flavonoid. The results will serve as a 
basis for detailed optimization of the growth media composition and could serve to 
establish high-productivity in vitro lines in respect of saponarin. 
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DAVID HOSACK (31.08.1769-22.12.1835) – PHYSICIAN, BOTANIST, 
EDUCATOR AND SCIENTIST, CREATOR OF THE FIRST BOTANICAL 
GARDEN IN NEW YORK IN 1801 
Dimitrova Z.1, Andreevska K.1, Burgasliev H.2, Madžarov V.3 
1Faculty of Chemistry and Pharmacy, 
 "Sveti Kliment Ohridski" Sofia University, Sofia, Bulgaria 
2Department of Pharmacy,  
“Prof. Dr. Assen Zlatarov” University, MK, Bourgas, Bulgaria 
3Department of Pharmaceutical Sciences, Faculty of Pharmacy,  
Medical University, Plovdiv, Bulgaria 
 
Purpose of the study: To acquaint the pharmaceutical society in Bulgaria with the 
ideas and activities of David Hosack, a brilliant American surgeon and a botanist of 
world renown and recognition. 
Materials and methods: The historical method is applied. The two biographical 
novels were analyzed for Dr. Huzack of Victoria Johnson and of Christine Roberts. 
Scientific publications were used by Dr. Huzack in the field of medicine and medicinal 
plants, letters from his conversations with the most famous botanists from around the 
world were explored. 
Results: Born and raised in New York City during the British occupation, determined 
to educate himself in medicine and botany in Europe also (London, Paris, 
Edinburgh), he returned to America to apply the knowledge and skills to the welfare 
of his beloved hometown and homeland. The young doctor and professor of 
medicine and botany set a goal above all others - to create the first botanical garden 
in New York, which manages to realize with its own resources in 1801. 
Conclusion: The еstablishment of Botanical Garden provides not only a good base 
for the training of students, but there will also be conducted scientific studies on 
growing species throughout the continent and throughout the world. 
 
 
TRENDS IN MARKETING AUTHORIZATION ON DRUGS IN 
EUROPEAN UNION AND TIME FOR MARKET ACCESS ON NEW 
DRUGS IN BULGARIA FOR THE PERIOD 2017-2019 
Panayotova D., Dimitrova M. 
“Organization and Economy of Pharmacy” Department, 
Faculty of Pharmacy, Medical University, Sofia 
 
The aim of the study: A retrospective analysis of the trends in the issued marketing 
authorizations (MAa) in the European Union and the market access in Bulgaria for 
the period 2017-2019. 
Materials and methods: A retrospective critical analysis of the European Medicines 
Agency (EMA) database for MAs and the National Council on Prices and 
Reimbursement of medicines (NCPR) for the period 2017 - 2019 was carried out. 
Data on the type of MA procedures issued by the European Commission (EC), type 
of medicine and therapeutic area were collected from EMA. Data from NCPR were 
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analyzed to evaluate which of the medicines were granted market access in Bulgaria 
and when. 
Results: About 45% all issued MAs (202) over the observed period are for innovative 
medicines. A steady trend in marketing authorization of biosimilars is observed – 16 
for both 2017 and 2018. However, a decline in MA by centralized procedure for 
generics (20 for 2017 and 12 for 2018), while orphan designation MA increases – 15 
for 2017 and 21 for 2018. Up to May 2019 there are 16 MAs issued. 6 conditional 
approvals and 4 under exceptional circumstances were issued for 2017-2018, all for 
orphan medicines. A higher percentage of market access in Bulgaria is observed for 
the biosimilar medicines – 40% of those that received marketing authorization have 
been included in PDL. 
Conclusion: Market access for new drugs in Bulgaria is a relatively fast, but further 
research is needed in order to identify the major underlying causes for delays. 
 
 
DETERMINATION OF THE NUMBER OF CHELATORS CONJUGATED 
TO TRASTUZUMAB, ANTIBODY BASED RADIOPHARMACEUTICAL, 
USING A MALDI-TOF MS 
Arev M.1, Džodić P.2, Dimovski A.3,4, Davalieva K.3, Kiprijanovska S.3, 
Apostolova P.1, Drakalska E.1, Janevik-Ivanovska E.1 
1Faculty of Medical Sciences, “Gotse Delchev” University Shtip,  
Republic of North Macedonia 
2Faculty of Medicine, Department of Pharmacy, University of Niš, Nis, Serbia 
3“Georgi D Efremov” Research Centre for Genetic Engineering and Biotechnology, 
Macedonian Academy of Sciences and Arts, Skopje, Republic of North Macedonia 
4Faculty of Pharmacy, “St. Cyril and Methodius” University, Skopje,  
Republic of North Macedonia 
 
The aim of the study: To show that successful conjugations of monoclonal antibody 
(mAb) trastuzumab (Tr) with different bifunctional chelators (BFCs) prepared for 
labeling with suitable radioactive isotope (Lutetium177 and Yttrium90), dependent of 
different molar ratio of BFCs and of an optimal number of chelating groups per 
molecule of antibody (4-5). 
In our study, p-SCN-Bn-DTPA (ratio 1:10, 1:20, 1:50), p-SCN-Bn-DOTA ( ratio 1:20), 
and  p-SCN-Bn-1B4M-DTPA ( ratio  1:10, 1:20, 1:50) were used as  bifunctional 
chelators to obtain the most appropriate stable formulation of radioimmuniconjugates. 
Material and methods: Matrix-Assisted Laser Desorption Ionization Time-of-Flight 
Mass Spectrometry (MALDI-TOF MS) was employed for determination of average 
number of BFCs. Resuspension solution (30% ACN/70% 0.1 TFA) was added to the 
samples. An aliquot of 1 μl of the final sample was applied to the well plate template 
and mixed with 1 μl of matrix (20 mg/ml Sinapinic acid in 50% ACN/50% 0.1 TFA). 
Acquisition mass range of the instrument is 100-300000 Da. 
Results: An optimal number of BFCs was calculated in all samples. There was no 
significant difference in the number of the attached chelating groups by higher 
excess of the chelators: p-SCN-Bn-DTPA-Tr [1:10 (5 groups); 1:20 (4.8 groups); 1:50 
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(5.3 groups)]; p-SCN-Bn-DOTA-Tr 1:20 (4.9 groups); p-SCN-Bn-1B4M-DTPA [1:10 
(4.9 groups); 1:20 (4.5 groups); 1:50 (4.3 groups)]. 
Conclusion: MALDI-TOF MS can be considered as important method for 
determination of successful antibody conjugations with and suitable chelator during 
the formulation of the ready to use radiopharmaceuticals. 
Key words: conjugation, chelators, trastuzumab, MALDI-TOF MS 
 
 
RISK COMMUNICATION IN COMMUNITY PHARMACIES THROUGH 
THE PRISM OF SELF-MEDICATION 
Lebanova H.1, Staynova R.2, Grigorov E.3 
1Department of Pharmaceutical Sciences and Social Pharmacy, Faculty of 
Pharmacy, Medical University, Pleven, Bulgaria 
2Department of Pharmaceutical Sciences, Faculty of Pharmacy,  
Medical University, Plovdiv, Bulgaria 
3Department of Organization and Economics of Pharmacy,  
Faculty of Pharmacy, Medical University, Varna, Bulgaria 
Corresponding author: Assoc. Prof. Hristina Lebanova 
+359 888 71 52 86; e-mail: hristina.lebanova@gmail.com 
 
Aim: The aim of the study was to assess community pharmacists‟ approach to risk 
communication on self-medication. 
Methods: An anonymous, questionnaire-based, descriptive study was performed. A 
pre-validated close-ended questionnaire was distributed among random sample of 
community pharmacists. Data was analyzed using SPSS v.19. 
Results: A total of 99 valid questionnaires were collected. 60.6% of the responders 
claim that patients very often consult them about their self-medication practices but 
rarely about possible adverse drug reactions and other drug-related problems such 
as drug interactions. 51.5% of pharmacists consider presenting information about 
risks as a mandatory part of the pharmaceutical consultation and the majority of them 
(87.9%) believe that it could affect patients‟ decisions. According to 18.2% of the 
responders up to 80% of self-medicating patients do not use their over-the-counter 
medicines as recommended in the patient leaflet. 63.6% of the responders believe 
that over-the-counter medical products have high potential for drug misuse and 
abuse and 12.1% consider them with a substantial potential for drug interactions. 
Conclusion: Data suggests that patients consider over-the-counter medicines safe 
and rarely seek information about possible risks. The conducted pilot study showed 
that pharmacists should be the primary and pro-active source of information about 
risks of self-medication products. 
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CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH TYPE 2 
DIABETES MELLITUS 
Mihaleva I.1, Yoncheva M.2,3, Andreeva–Gateva P.1 
1Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Medicine, Medical University, Sofia, Bulgaria 
2National Center of Public Health and Analyses, Bulgaria 
3Clinic of Endocrinology, Military Medical Academy Sofia, Bulgaria 
Address for Correspondence: Ivelina Mihaleva, MD, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Medical Faculty, Medical University of Sofia, 2 
“Zdrave” str., 1431 Sofia 
e-mail: ivelina_mbg@yahoo.com, telephone: + 359 88 3300 599 
 
Insulin resistance and cardiovascular diseases as well as the risk factors that 
contribute to their occurrence such as dyslipidemia, obesity, are main components of 
the metabolic syndrome. Different methods for insulin sensitivity estimation exist that 
are widely used in clinical practice. However most of them do not reflect the 
metabolic disturbances of an individual. That is why new indices emerge in the 
practice that estimate insulin resistance and cardiovascular risk using easily 
accessible anthropometric and functional parameters. These include TyG index, 
visceral adiposity index (VAI), lipid accumulation product (LAP), atherogenic index of 
plasma (AIP). Cardiovascular risk assessment in diabetic patients is of great 
importance and this can be seen in the clinical practice guidelines for type 2 diabetes 
treatment where the cardiovascular disease status of a patient to great extend 
determines the therapy. 
 
 
UHPLC/ORBITRAP MS METABOLOMICS PROFILE AND 
ANTIOXIDANT PROPERTIES OF ASPHODELUS ALBUS ROOTS 
GROWING IN BULGARIA 
Lazarova I.1*, Zengin G.2, Nedialkov P.3, Gevrenova R.3 
1Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia, 2 “Dunav” 
str., 1000 Sofia, Bulgaria 
2Department of Biology, Faculty of Science, 
Selcuk University, Campus, Konya, Turkey 
3Department of Pharmacognosy, Faculty of Pharmacy,  
Medical University of Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
Corresponding author: Tel.: +3592-9236-513; Fax: +359 2 987 98 74 
e-mail address: lazarova@pharmfac.mu-sofia.bg (Irina Lazarova) 
 
The aim of the Study: Asphodelus L. (Asphodelaceae) species are traditionally 
used as anti-microbial, anti-fungal, anti-parasitic, cytotoxic, anti-inflammatory or 
antioxidant agents. There is limited information on the chemical content of A. albus 
and there is no documented data related to biological activities of the plant. The 
phytochemistry of the Bulgarian herb wasn‟t investigated. The aim of the study is to 
back to 
contents 
 97 
 
analyze chemical composition and antioxidant potential of Asphodelus albus from 
Bulgarian origin. 
Materials and methods: The total phenolic and flavonoid content and flavonoids of 
Asphodelus albus crude dichloromethane, ethyl acetate, methanol and water extracts 
were determined using standard Folin-Ciocalteu method and  AlCl3 method 
respectively. Chromatographic analyses were performed by a Dionex UltiMate3000 
RSLC UHPLC (ThermoScientific Co, Waltham, MA, USA) and separations were 
achieved using a Waters ACQUITY UPLC BEH Shield RP18 column (2.1 x 100 mm, 
1.7 μm particle size). MS analyses were performed with an Orbitrap mass 
spectrometer (Q Exactive Plus, ThermoScientific Co, Waltham, MA, USA). 
Antioxidant capacity of the extracts were spectrophotometrically screened by 
different experiments as reduction potentials (by FRAP and CUPRAC assays) radical 
attenuation (using DPPH and ABTS radicals), metal chelating and 
phosphomolybdenum. 
Results: The antioxidant potential of Asphodelus albus was proved. The good 
correlation between phenolics content, radical-scavenging activity and  reducing 
power was observed. The main individual phenolic compounds, belonging to the 
groups of flavonoids, anthraquinones and phenolic acids, which are responsible for 
antioxidant activity were identified. 
Conclusion: This investigation highlights Asphodelus albus as a new source of 
bioactive compounds and its possible application as an antioxidant agent. 
 
 
MONITORING OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY 
AND NUTRITION HABITS IN PEOPLE LIVING WITH HIV – THE 
POSSIBLE ROLE OF THE CLINICAL PHARMACIST 
Kaneva A., Tashkov K., Dimitrova M., Yancheva N. 
Department of Organization and Economy of Pharmacy, Faculty of Pharmacy, 
Medical University, Sofia 
 
Research objectives: The objective of this research is to evaluate the possible role 
of clinical pharmacists in the process of highly active antiretroviral therapy (HAART) 
monitoring in people living with HIV (PLWH), nutrition habits (including dietary 
supplemens– DSs) and the possible interactions with the assigned pharmacotherapy. 
Materials and methods: In the period January 2019 – May 2019 a research was 
conducted on the prescribed HAART and nutrition habits through a direct anonymous 
questionnaire with PLWH, at “Prof. Ivan Kirov” University Hospital. Demographics 
(age, gender), data on pharmacotherapy and concomitant diseases, information on 
nutrition habits (diet and DSs) of PLWH and sources of information on possible 
undesired interactions were collected. Results were processed through descriptive 
statistics. 
Results: About 50% of the interviewees take dietary supplements, with some 
experiencing a potential risk of undesired HAART interactions. More than 70% of 
people living with HIV are aware that interactions between their assigned HAART 
and DSs taken are possible, but only 60% of the interviewees believe that this type of 
drug information should be obtained from the physician. None of the interviewees 
back to 
contents 
 98 
 
used the pharmacist as a reliable source of information. Approximately 50% of the 
people living with HIV use the Internet as a source of information. 
Conclusion: HAART monitoring in people living with HIV requires a multidisciplinary 
approach that should also include a clinical pharmacist with respect to optimizing 
drug information with regard to the prescribed pharmacotherapy and proper nutrition 
habits. 
 
 
STRATEGIES TO IMPROVE MEDICATION ADHERENCE IN 
CHILDREN - CHALLENGES FOR THE MODERN PHARMACIST 
Staynova R.1, Lebanova H.2, Georgieva Y.1 
1Department of Pharmaceutical Sciences, Faculty of Pharmacy,  
Medical University, Plovdiv 
2Department of Pharmaceutical Sciences and Social Pharmacy, Faculty of 
Pharmacy, Medical University, Pleven 
 
Aim: To analyze and assess the role of the pharmacist in improving pediatric 
medication adherence. 
Materials and methods: A systematic review of the scientific literature was carried 
out to identify studies that described interventions involving pharmacists aimed to 
improve medication adherence in patients under 18 years of age. The PubMed, 
Scopus, Embase, and Google Scholаr databases have been analyzed using the 
following keywords: "adherence", "children", "pharmacists", separate and in 
combination. 
Results: The results of 15 publications covering the 2008-2018 period are 
summarized. The results of the selected studies show that effective communication 
with pharmacists is considered a way to improve children's knowledge of medicines. 
Observations in pharmacies, however, show that a very small percentage of children 
receive direct consultation from the pharmacist, and mainly the parent is informed 
about drug therapy. Despite this trend, children have a positive interest in learning 
from the pharmacist how their medicines affect the human body and how they are 
manufactured. 
Conclusion: To ensure effective and safe use of medicines and to enhance 
children's health knowledge, pharmacists need to develop and implement interactive 
and training techniques. By creating a partnership with the child's parents and 
understanding their specific needs, pharmacists can help overcome barriers to 
adherence and offer ways to resolve them. 
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METFORMIN - THE NEW CONTENDER IN THE TREATMENT OF 
GESTATIONAL DIABETES MELLITUS 
Staynova R.1, Getova V.2, Yanachkova V.3 
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, 
 Medical University, Plovdiv 
2Bulgarian Drug Agency, Sofia 
3“Dr. Shterev” Hospital, Sofia 
 
Aim: The aim of the present study is to make a critical review of the safety and 
efficacy data for metformin with regard to its use in the treatment of gestational 
diabetes mellitus. 
Materials and methods: Data from observational and randomized controlled trials in 
women with gestational diabetes mellitus were summarized and analyzed. The long-
term effects of metformin on the offspring are also analyzed. For the purpose of the 
study, a systematic review of the scientific literature was carried out using the 
following databases: PubMed, Scopus and Google Scholar. 
Results: The reviewed publications show that there is adequate evidence of efficacy 
and short-term safety of metformin in the treatment of gestational diabetes mellitus in 
relation to maternal and neonatal outcomes. Some benefits have been observed with 
metformin associated with lower maternal weight gain and a lower risk of neonatal 
hypoglycaemia and macrosomia. In addition, metformin has a number of advantages 
such as: oral administration, lower cost and better compliance. There is insufficient 
data on the long-term effects of metformin on the offspring. It is necessary to further 
investigate the effect of metformin on the programming of the epigenome due to its 
significant transplacental transfer. 
Conclusion: Despite the undeniable benefits, there is need for more research before 
metformin can be considered as a standard for care in the treatment of gestational 
diabetes mellitus. 
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SELECTIVE CASPASE INHIBITORS FROM GYPSOPHILA 
GLOMERATA PALL Ex M.B. (CARYOPHILLACEAE) 
Sugareva P.1, Lozanova V.1, Dimitrova B.2,3*, Gevrenova R.3, Simeonova R.2, 
Lozanov V.1 
1Department of Medical Chemistry and Biochemistry,  
Medical University of Sofia, Sofia, Bulgaria 
2Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University of Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
3Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia,   
2 “Dunav” str., 1000 Sofia, Bulgaria 
*Corresponding Author: Bozhana Dimitrova, phone: +359883537717,  
e-mail: bojana_ruseva@yahoo.com 
 
The aim of the study: In the present study, we aimed at investigating the potential 
inhibitory activities of C- and C,O-glycosyl-flavons from the Gypsophila glomerata 
aerial parts against caspases, the main regulators of apoptosis. 
Materials and methods: G. glomerata aerial parts were extracted with aqueous 
methanol by sonication. The lyophilized extract was fractionated by flash 
chromatography. The fraction containing C- and C,O-glycosyl-flavons was 
additionally fractionated by semi-preparative reverse phase high-performance liquid 
chromatography (RP-HPLC). Eight main C- and C,O-glycosyl-flavons were obtained 
with >98 purity and their structures were elucidated by high resolution mass 
spectrometry and nuclear magnetic resonance spectroscopy. The isolated 
compounds were screened for potential caspase inhibition activity using the set of 10 
recombinant caspases by fluorometric kinetic assay. 
Results: Eight pure C- and C,O-glycosyl-flavons were isolated from methanol-
aqueous extract from G. glomerata aerial parts by combination of chromatographic 
techniques. The results of caspase inhibitory assays show that 3 of them are potent 
selective inhibitors of caspase-3 and 4 compounds possess selective inhibitor activity 
against caspase-7. No inhibition activity had been observed against inflammatory 
and activation caspases. 
Conclusion: The methanol-aqueous extract from G. glomerata aerial parts contains 
several selective inhibitors of caspase-3 and caspase-7 that possess inhibitory 
potential and could be used to control apoptotic events in mammals. 
Acknowledgements: The study was supported by the Project “Young Scientist 
2019”, №8231/20.11.2018, Contract D-140/2019 from the Medical Science Council at 
the Medical University of Sofia. 
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RENIN-ANGIOTENSIN SYSTEM INHIBITORS: A POTENTIAL ROLE 
IN SARCOPENIA 
Krasteva G., Lakova E.*, Krastev P., Stavreva G. 
Department of Pharmacology and Toxicology, Faculty of Pharmacy 
*Department of Physiology and Pathophysiology, Medical Faculty 
Medical University, Pleven 
Corresponding author: Genka Krasteva 
e-mail: krusteva_med@abv.bg; 064 884282 
 
Sarcopenia is age-related chronic condition characterized by progressive and 
generalized loss of skeletal muscle mass and function and may lead to higher risk of 
disability, morbidity and mortality. Current pharmacological strategies are 
unsatisfactory. Experimental and clinical studies have given interesting insight on role 
of the renin-angiotensin system (RAS) in the skeletal muscles, suggesting a potential 
benefit of angiotensin convertin enzyme (ACE) inhibitors and angiotensin receptor 
blockers (ARB) in sarcopenia. 
Objectives: We highlight current knowledge of the physiological role of RAS in 
skeletal muscle and discuss the possibility to treat sarcopenia with RAS inhibitors. 
Methods: Review of the literature. 
Results: Circulating RAS regulates blood pressure and electrolyte homeostasis. 
Local, tissue RASs are important in the regulation of the cell growth, regeneration, 
apoptosis, inflammation and angiogenesis. Regulation of local perfusion by AT-II is 
fundamental for metabolic activity and function of the musculature. Increase of AT-II 
levels induces skeletal muscle wasting through enhanced protein degradation and 
apoptosis and decreased protein synthesis. Recently, the attention was focused on 
muscle satellite cells (muscle progenitor cells) as main target of RAS activation or 
blockade. AT-II reduces satellite cell migration, differentiation and growth through 
AT1R. Observational and experimental studies have confirmed that blockade of the 
AT-II/AT1R axis may be useful in the treatment of sarcopenia.  In the future, the 
“good arm” of the RAS – AT-(1-7)/Mas receptor and AT2R may also be subject to 
positive modulation with the identification of effective receptor agonists. 
Conclusion: RAS is a reliable target for the prevention and treatment of sarcopenia. 
Key words: renin-angiotensin system, satellite cells, sarcopenia 
 
 
ANTIBIOTICS AND ANTIBIOTIC RESISTANCE – TIME FOR 
INTERVENTIONS IN THE STUDENTS’ EDUCATION? 
Keuleyan E.1,3, Nikolov R.2,3, Dimitrova D.3, Ivanova E.3 
2Medical Institute, Ministry of the Interior 
3Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Medicine, Medical University, Sofia 
4“Y. Philaretova“ Medical College, Medical University, Sofia 
 
Aim: Antibiotic resistance /АR/ today reaches enormous dimensions and is 
proclaimed by WHO as a global threat. On the occasion of 18 November 2018 – The 
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European Antibiotic Day - we elaborated an educational poster at The                      
“Y. Philaretova” Medical College on the basis of British Society of Antimicrobial 
Chemotherapy materials. After familiarizing the poster, we conducted an inquiry 
among students in “Medical technician” specialty. Task of the current work is to 
analyze the students‟ knowledge about antibiotics and AR. 
Materials and methods: Questionnaire forms consisted of 11 questions with 3 to 5 
multiple choice answers. They were distributed to be filled in voluntarily and 
anonymously. In analysis of the results SPSS and determining relative rate were 
applied. 
Results: From 85 questionnaires distributed 77 were returned (87.5 %). Excellent 
answers were obtained for the questions concerning the reasons and consequences 
of development of AR – relative rate between 71 % and 100 %. Lower success rate - 
43-95 % - was achieved for questions about mechanisms and epidemiology of AR. 
Unsatisfactory were the answers of questions concerning the importance of 
antibiotics for current achievements in medicine and for the perspective if AR will not 
be reduced – respectively 11 % and 56 %. 
Conclusion: The students demonstrated relatively good level of knowledge for AR 
/apparently supported by the elaborated poster/. Much more serious knowledge 
about antibiotics and antibiotic resistance are needed for the future medical 
specialists, incl. by improvement of the educational programs – more hours and 
multidisciplinary training are necessary. 
 
 
INVESTIGATION OF THE EFFECTS OF 1,2,3-THIADIAZOLE 
CONTAINING HYDRAZONE DERIVATIVE ON THE LIVER AND 
KIDNEY FUNCTIONS IN FEMALE MICE 
Angelova V.1, Simeonova R.2 
1Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, Bulgaria 
2Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University of Sofia, Bulgaria 
 
The aim of the study: It is well documented that isoniazid (INH), a first line drug to 
treat tuberculosis (TB), is associated with hematological disturbances and 
hepatocellular-type liver injury, with a marked elevation of hepatic transaminases. In 
our previous investigations, 1,2,3-thiadiazole containing hydrazone derivative 
showed excellent antimycobacterial activity against a referent strain M. tuberculosis 
H37Rv (MIC 0.39 μM), low cytotoxicity and selectivity index SI>2000. Additionally, 
the compound does not have toxic effects when administered by oral or 
intraperitoneal routes to experimental animals, LD50>2000 mg/kg b.w. 
The aim of the present study was to determine the effects of 1,2,3-thiadiazole 
derivative on the liver and kidney functions in female mice and to compare with INH.  
Materials and methods: The compound was administered orally for 14 days at three 
doses (100, 200, and 400 mg/kg b.w.). The quantity of malondialdehyde (MDA), the 
level of reduced glutathione (GSH), blood hematological and biochemical parameters 
were assessed, and urine analysis was carried out. As a positive control INH was 
used, orally treated at a dose of 50 mg/kg b.w. 
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Results: The investigated compound did not affect the urine and serum 
hematological and biochemical parameters as INH did. The new antimycobacterial 
agent did not affect significantly the MDA quantity and maintained its level near to the 
control values, though lower by 36% (p<0.05), compared to the control. At the higher 
doses, 200 and 400 mg/kg, it depleted the GSH content by 25% (p<0.05), compared 
to the control. However, its level remained 47% (p<0.05) higher than in the INH 
treated animals. 
Conclusion: These findings revealed the suitability of the test compound for further 
investigation as a safe and non-toxic antimycobacterial agent. 
Funding: This work was partly supported by the National Science Fund of Bulgaria 
(research grant contract № DN 13/16 21.12.2017). 
Correspondence: Violina T. Angelova 
Tel: +359 029236586; e-mail: violina_stoyanova@abv.bg 
 
 
DEVELOPMENTS AND APPLICATIONS OF CHEMICAL 
CHARACTERIZATION OF BIOPHARMACEUTICALS 
Gjorgieva Ackova D., Smilkov K. 
Department of Pharmacy, Faculty of Medical Sciences, “Gotse Delčev” University, 
Štip, R. North Macedonia 
 
The aim of the study: Understanding the behaviour and function of biomolecules at 
the molecular level is the key to the discovery and development of new drugs, as well 
as diagnostic techniques. The characterization of biological drugs, where therapeutic 
monoclonal antibodies (mAbs) are placed, poses many challenges compared to 
those of low-molecular mass drugs because of their inherent complexity due to their 
protein nature. Achievements in this field of science have changed the way that 
drugs are being designed and developed nowadays. 
Materials and methods: Vibrational spectroscopy techniques, like Fourier Transform 
Infrared (FTIR) Spectroscopy and Raman Spectroscopy (RS) have been applied and 
helped to determine the secondary structure and possible interactions and 
modifications of complex protein molecules, as well as protein-ligand complexes. 
Results: Our investigation has demonstrated the use of these tools to understand 
protein-ligand interactions in important immune-complexes with previously no 
available structural information. 
Conclusion: The approach presented here has significant potential for analyzing the 
structure, stability and possible toxicity of biotherapeutics as well as any other 
biological molecules which are used as therapeutic/diagnostic agents. 
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EFFECTS OF PIOGLITAZONE ON SERUM LEVELS OF 
PROINFLAMMATORY CYTOKINES IN EXPERIMENTAL MODEL OF 
AUTISM 
Stefanova Z., Bogdanov G., Kamenova K., Varadinova M. 
Department of Pharmacology and Toxicology, Medical Faculty,  
Medical University, Sofia 
 
Recent studies have demonstrated the involvement of neuroinflammation and 
increased central and peripheral levels of proinflammatory cytokines in the 
development of neurological and neuropsychiatric disorders. The combined 
pharmacotherapy of autism spectrum disorder (ASD) includes atypical 
antipsychotics, antidepressants, antiepileptics, probiotics, and diet. The effects of 
PPARɣ agonists on behavioral symptoms in children with ASD, as well as their 
potential anti-neuroinflammatory properties are intriguing. 
Aim: To investigate the effects of pioglitazone on serum levels of IL-1β and IL-6 in an 
experimental model of autism. 
Materials and methods: The male offspring of pregnant Wistar rats treated or not 
with valproic acid were separated from their mothers on the 23rd postnatal day and 
were divided into 4 groups: 1. Control; 2. With experimental autism; 3. Control, 
treated with pioglitazone; 4. With experimental autism, treated with pioglitazone. After 
21 day-treatment the rats were decapitated, blood was collected and the sera were 
used to determine proinflammatory cytokine levels. 
Results: In the present study there were not observed significant changes in the 
serum levels of IL-1β between the control and the experimental groups. There was 
demonstrated a significant increase in the IL-6 levels in the experimental group 
compared to the control group. The experimental autism group treated with 
pioglitazone had a considerably lower IL-6 levels were compared to the untreated 
group. 
Conclusion: Beneficial effects of pioglitazone on proinflammatory parameters are 
demonstrated, suggesting its role in neuroinflammatory and in neurotrophic 
regulation, respectively. 
 
 
PRODUCTS CONTAINING EXTRACTS FROM MEDICINAL PLANTS 
FOR PREVENTION OF OSTEOPOROSIS 
Tsvetkova D., Ivanova S. 
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, 
Medical University, Sofia, Bulgaria 
 
Osteoporosis is characterized by low bone mass and microarchitectural deterioration 
with increase in bone fragility. In postmenopausal women the reduction of estrogen 
leads to elevation of oxidative stress and lipid accumulation, which promote 
osteoblasts apoptosis. 
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Aim of the study: The aim of the study is the collection, analysis and comparison of 
content and distribition in different dosages and formulations of the most common 
manufactured products containing extracts from medicinal plants for osteoporosis. 
Materials and methods: The investigation has been made through the electronical 
database of medical sourses. 
Results: The most promising plants for potential prevention of osteoporosis are: 
Alchemilla vulgaris, Angelica sinensis, Avena sativa, Camellia sinensis, Coriandrum 
sativum, Dioscorea macrostachya, Dioscorea villosa, Equisetum arvense (silicic 
acids), Ganoderma lucidum, Fucus vesiculosus (minerals), Flax seed, Glycine max 
(isoflavones), Glycyrrhiza glabra, Macafem, Matricaria chamomilla, Medicago sativa, 
Oenothera biennis, Panax ginseng, Persea americana (vitamin D), Petroselinum 
crispum, Piper methysticum, Populus friemontii, Pueraria lobata, Salvia officinalis, 
Trifolium pratense (isoflavones), Vitex agnus castus, Withania somnifera. Isoflavones 
significantly increase bone mineral density and inhibit the bone resorption due to 
reduce the number of osteoclasts. 
The most used products containing extracts from medicinal plants are: Cimicifuga 
racemosa Bionorica Menopret tabl., Trifolium pratense caps.; Ayrvedic: Arjuna 
(Terminalija arjuna) caps., Ashwagandha (Withania somnifera) caps., Emblica 
officinalis caps., Lakshadi Guggul caps. and multicomponent: Vitabiotics Menopace 
Plus tabl. USANA Phyto Estrin; True Health – Osteopenia Bone Health System. 
Conclusion: An observational study shows different trade form preparations: tablets, 
capsules, powders, solutions of monocomponent and multicomponent products 
containing extracts from medicinal plants for osteoporosis. 
Corresponding author: Assist. prof. Dobrina Tsvetkova, PhD 
tel.: 0877757118, e-mail: dobrinka30@mail.bg 
 
 
COMPARISON OF DIFFERENT EXTEMPORANEOUSLY 
COMPOUNDED VEHICLES FOR ORAL LIQUID DOSAGE FORM FOR 
PEDIATRIC PATIENTS 
Pehlivanov I., Andonova V. 
Department of Pharmaceutical Technologies, Faculty of Pharmacy,  
 “Prof. dr. P. Stoyanov” Medical University, Varna 
 
Objectives: To evaluate the stability of Nitrofurantoin suspended in different 
extemporaneously compounded vehicles after storage at 4ºC and at 25ºC. To 
formulate an effective, readily available vehicle that can guarantee extended stability 
and precise dosing. 
Methods: Nitrofurantoin was suspended at concentration 10 mg/mL in seven 
different vehicles compounded of different blends of: Syrupus Simplex; Sorbitol 70%; 
Methylcellulose 1%; Gummi Arabici 1%; Gummi Xanthani 1%; NaCMC 1%. Samples 
of 100 mL of every compounded suspension was stored in graded glass bottles at 
4ºC and at 25ºC and in dark. Samples were analyzed at the beginning and every 10 
days up to the 30th day and every 30 days after. Variations of physical properties 
such as sedimentation, viscosity, ease of resuspension, color, odor and taste were 
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evaluated visually and organoleptically. Variations in Nitrofurantoin concentration and 
pH were evaluated with suitable analytical procedure (UV-Vis, HPLC). 
Results: To the 30th day, only three of the compounded suspensions exhibit 
significant physical stability and slight change in taste and odor stored at both 
temperatures. Two samples stored at 25ºC exhibited Nitrofurantoin concentration 
greater than 95% and 4 samples stored at 4ºC – concentration greater than 95%. To 
the 120th day only three of the compounded suspensions, stored at 4ºC, exhibit 
relatively high Nitrofurantoin concentrations: 88.2%, 92% and 81.1%, respectively. 
Conclusions: The suspensions compounded with vehicles of blends of syrups, 
Xanthan, Croscarmellose and Sorbitol exhibit low to none sedimentation, good 
uniformity of content and organoleptically are suitable for pediatric administration. 
Further studies are to be concluded in order to be defined the most stable vehicle 
and final shelf life. 
 
 
PLANT SOURCES OF MAURITIANIN AND EVALUATION OF ITS 
PROTECTIVE POTENTIAL 
Shkondrov A., Krasteva I., Kondeva-Burdina M. 
1Department of Pharmacognosy, Faculty of Pharmacy, 
Medical University, Sofia, Bulgaria 
2Laboratory of Drug metabolism and Drug toxicity, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Faculty of Pharmacy, 
Medical University, Sofia, Bulgaria 
 
Aim of the study: Recent phytochemical research of A. monspessulanus subsp. 
monspessulanus (Fabaceae) afforded a kaempferol triglycoside (mauritianin). Only 
few studies of its pharmacological action have been conducted. The aim of the 
present study was to investigate extracts from overground parts of several Astragalus 
species in order to reveal the quantity of mauritianin and to isolate it in sufficient 
quantity for pharmacological research. 
Materials and methods: A highly accurate liquid chromatography-mass 
spectrometry screening method was used for the analysis of the samples. Isolation of 
the compound from the appropriate plant was achieved by chromatographic means. 
In addition, a pharmacological study of the possible protective effects of the flavonol 
in an in vivo model of intoxication was conducted. 
Results: The flavonoid was found in relatively small number of the species 
investigated. Its quantity was varied, but a source was established. The isolated 
compound proved its in vivo protective effects, comparable to silymarin. 
Conclusion: These findings will serve as a perspective for further investigations of 
the pharmacological effects of mauritianin. 
Acknowledgement: Financial support from Council of Medicinal Science at Medical 
University of Sofia, contract №D-76/23.04.2019 is gratefully acknowledged. 
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SECONDARY METABOLITES IN ASTRAGALUS CORNICULATUS 
Stambolov I., Shkondrov A., Krasteva I. 
Department of Pharmacognosy, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
 
Aim of the study: The aim of this study was to investigate the novel for Bulgarian 
flora Astragalus corniculatus Bieb. (Fabaceae) for the presence of notable secondary 
metabolites. 
Materials and methods: A highly sensitive ultrahigh performance liquid 
chromatography-mass spectrometry method was applied to reveal the phytochemical 
content of a methanol extract, obtained from the aerial parts of the species. 
Results: Results showed that the species contained hydroxymethyl glutaric acid 
derivatives of kaempferol and quercetin glycosides as well as the flavonol 
triglycosides alcesefoliside and mauritianin. 
Conclusion: These findings serve as an addition to the information of the 
phytochemical content of A. corniculatus and could be a basis for further studies of 
this valuable plant. 
Acknowledgement: This work was supported by the Bulgarian Ministry of Education 
and Science under the National Program for “Young Scientists and Postdoctoral 
Students” Research. 
 
 
ANTIBIOTIC TREATMENT – OPPORTUNITIES FOR OVERCOMING 
RESISTANCE 
Mihaylova S.1, Tsvetkova A.1, Todorova A.2 
1Medical College, Medical University, Varna, Bulgaria 
2Faculty of Pharmacy, Medical University, Varna, Bulgaria 
 
Introduction of antibiotics into the clinical practice and their frequent and 
unreasonable use has led to the occurrence of a large number of antibiotic-resistant 
pathogens. By 2050 antimicrobial resistance can become a more frequent cause of 
mortality than neoplastic diseases. Globally, on an annual basis, it causes the death 
of 700 thousand people, 25 000 of whom are patients in Europe. 
Objective: To research and analyse modern tendencies for overcoming resistance of 
pathogenic microorganisms. 
Methodology: Review of literature and analysis of the information from different 
electronic data bases, Pub Med, Scopus, Medline and others, using key words: 
ESKAPE pathogens, resistance, CDAs and antibiotic activity. 
Results: In 2017 the World Health Organisation published a list of pathogenic 
microorganisms, for which new antibiotics had to be developed urgently.  The priority 
ones are Carbapenem-resistant, Acinetobacter baumannii, Pseudomonas 
aeruginosa and Enterobacteriaceae, from the group of so called ESKAPE pathogens, 
multidrug resistant gram-positive and gram-negative bacteria. Calcium-dependent 
acidic lipopeptide antibiotics (CDAs) are a potential source of new antimicrobial 
agents. FDA and EMA allow the use of the cyclic lipodepsipeptide Daptomycin for 
treatment of complicated skin and soft tissue infections caused by multi -resistant 
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Gram-positive bacteria. Malacidines are a new group of CDAs, made by soil 
microorganism found in 2018. In 2019 scientists from the Rockefeller University 
described a new group of CDAs - Cadasides, active against multi-resistant Gram-
positive bacteria. In vitro research on the effect of these antibiotics continues. 
Conclusion: Discovery of new antimicrobial medicines against ESKAPE pathogens 
is one of the greatest challenges in fighting life-threatening infections and protecting 
global health. 
 
 
EVALUATION OF THE ANTICONVULSANT, ANTIDEPRESSANT AND 
ANTIOXIDANT EFFECTS OF NOVEL MELATONIN DERIVATIVES IN 
MICE 
Tchekalarova J., Ivanova N., Nenchovska Z., Stoynova T., Angelova V., 
Andreeva-Gateva P., Tzoneva R. 
Institute of Neurobiology 
 
Aim: The aim of the present study was to explore the effects of newly synthesized 
melatonin derivatives, containing aroylhydrazone moieties, for anticonvulsant activity, 
antidepressant in in-vivo tests in mice as well as in-vitro for their activity against 
oxidative stress. 
Materials and methods: The series of synthetized indole C-3 substituted 
aroylhydrazones 3a-i and a positive control melatonin, administered at doses of 10, 
30, 60 and 100 mg/kg, were explored 30 min on seizure threshold, measured by the 
timed intravenous pentylenetetrazole (iv PTZ) infusion; motor activity and anxiety in 
the open field (OF) and depressive-like behavior in tail suspension test (TST) in ICR 
mice. Immediately after TST, the mice were decapitated and frontal cortex (FC) and 
the hippocampus was isolated. The level of oxidative stress was examined by Elisa 
test. 
Results: Three out of six compounds, 3c, 3f and 3e, respectively, dose-dependently 
increased the PTZ-induced seizure thresholds for myoclonic twitch, clonic and tonic 
seizures comparable to the effect of carbamazepine and melatonin. Their 
anticonvulsant effect was blocked by the non-selective melatonin receptor antagonist 
luzindol. These three active compounds as well melatonin showed decreased motor 
activity and anxiety in the highest doses compared to controls as well as dose-
dependent antidepressant activity. The compounds 3e and and 3f decreased stress-
induced lipid peroxidation and increased superoxide dismutase activity specifically in 
the FC.  
Conclusion: Our previous and present results suggest that 3c, 3f and 3e can be 
considered promising agents with pharmacological activity on melatonin receptors in 
brain. 
Acknowledgement: This research was supported by the National Science Fund, 
Bulgaria (grants No. DN DH13/16, 21.12.2017; DH13/16, 21.12.2017). 
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TWO NEW PHENOLIC GLYSOSIDES FROM AERIAL PARTS FROM 
HYPERICUM CERASTIOIDES 
Nedialkov P., Ilieva Y., Kokanova-Nedialkova Z. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia 
 
Aim: The aim of current study is to isolate and identify the unknown phenolic 
metabolites from methanol extract of aerial parts from Hypericum cerastoides 
(Spach) N. Robson. 
Materials and methods: The plant material of H. cerastioides was collected July 
2018 in Treshtenik locality, near Yakoruda town (south slopes of Rila Mountain), 
dried, powdered and subsequently extracted with dichloromethane and methanol. 
The methanol extract was partitioned between water and ethylacetate. The 
ethylacetate layers was combined, evaporated and subjected to series of 
chromatographic procedures included column chromatography on MCI gel and 
Sephadex LH-20. Final purification on semiprep.-HPLC led to isolation of two new 
phenolic glycosides. 
Results: The structures of the isolated compounds were established by means of 
mass spectrometry and 1D and 2D nuclear magnetic resonance experiments as 4-O-
{6-[(2E)-p-hydoxycinnamoyl]-β-D-glucopyranosyl}-6-isopropyl-tetrahydro-2H-pyran-2-
on and 3-O-{6-[(2E)-p-hydoxycinnamoyl]-β-D-glucopyranosyl}-6‐methyl-
5‐hydroxyheptanoate that were given the trivial names hypercerstosides B and C, 
respectively. 
Conclusion: An extensive chromatographic procedure of ethylacetate extract of 
aerial parts from Hypericum cerastoides led to the isolation of two new phenolic 
glucosides that were given the trivial names hypercerstosides B and C. 
Acknowledgements: This work was supported by the Council of Medical Science of 
Medical University of Sofia (Grand № D-75/03.05.2018). 
 
 
ANALGESIC ACTIVITY OF MELATONIN AND MELATONIN 
DERIVATIVES BEARING AROYLHYDRAZONE FRAGMENT 
Gateva P.1, Tzinev A.1, Mancheva I.1, Koleva V.1, Marchev S.1, Angelova V.2, 
Tchekalarova J.3, Surcheva S.1, Vlaskovska M.1 
1Department of Pharmacology, Pharmacotherapy and Toxicology,  
Medical Faculty, Medical University, Sofia 
2Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia 
3Institute of Neurobiology, Bulgarian Academy of Sciences 
Corresponding author: P. Gateva +359 889 428 105,  
e-mail: pandreeva_gateva@outlook.com 
 
Melatonin is an endogenous indoleamine with chronobiological, antioxidant and 
neuroprotective properties. Preclinical and clinical data indicate that melatonin has 
also dose-depending analgesic effect. The aim of this study was to compare the 
potential analgesic effects of newly synthesized melatonin derivatives with anti -
seizure activity demonstrated in our previous experiments. 
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Materials and methods: After synthesis of series of melatonin-containing 
aroylhydrazones, four of the substances demonstrated anti-seizure activity when 
testing with the test for maximal electroshock (MES), penthylene tetrazole (PTZ) and 
6Hz. Those four substances and melatonin were screened for analgesic activity with 
the hot plate test and formalin test after intraperitoneal injection of 50, 100, 200 and 
300 mg/kg in saline solution in male mice 20-25 g. N=6 for each of groups including 
controls. 
Results: Melatonin demonstrated dose-depending analgesic activity in the formalin 
test. The dose of 200 mg/kg demonstrated the higher effect, the antinociceptive 
behavior of the animals was reduced by 80% for both phases of the test. Melatonin 
did not demonstrated antinociceptive activity in the hot plate test. Two of the tested 
melatonin-aroylhydrazone derivatives, namely the thiophen substituted and the 
second indol substituted, demonstrated activity both in the hot plate test - 20% 
reduction of the antinociceptive activity in doses of 200 and 300 mg/kg, as well as a 
reduction of the antinociceptive behavior in phase 2 of the formalin test similarly to 
melatonin. 
Conclusion: The two newly synthesized substances with demonstrated 
antinociceptive activity deserves to be further tested for potential applicability in 
different pain-related pathological process. 
Acknowledgement: Supported by the National Science Fund of Bulgaria DN 13/16, 
21.12.2017. 
 
 
POLYMERIC MICROSPHERES WITH ENALAPRIL MALEATE FOR 
TASTE MASKING 
Georgieva Y., Pilicheva B., Kassarova M. 
Department of Pharmaceutical Sciences, Faculty of Pharmacy,  
Medical University, Plovdiv, Bulgaria 
High-technological Center of Emergency Medicine, Plovdiv, Bulgaria 
For correspondence: Yana Georgieva, 0879189804,  
e-mail: iana_georgieva9@abv.bg 
 
Aim of the study: Development of polymeric microspheres with enalapril maleate 
(ENA) for taste masking in order to incorporate them into orodispersible tablets. 
Materials and methods: Polymeric microspheres were prepared by emulsion 
solvent evaporation technique. For the preparation of the O/W emulsion, the oil 
phase (dichloromethane, acetone and the dissolved ENA, Eudragit Epo® and 
ethylcellulose) was emulsified in the aqueous phase containing Tween 20®. The 
emulsion was stirred for 6 hours until complete evaporation of the organic solvents. 
The resulting particles were isolated after filtration and dried at room temperature. 
For the characterization of the obtained microspheres, UV-spectrophotometric 
quantitative analysis, IR spectroscopy, optical and scanning electron microscopy, 
powder X-ray diffraction and thermogravimetric analysis were applied. 
Results: Five models of polymeric microspheres were developed by varying the 
amount of the drug and the polymers.  The yield of the microspheres was between 
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39% and 53%. The drug loading ranged from 17% to 40% and the encapsulation 
efficiency varied from 0.89% to 2%. The average size ranged from 140 μm to 339 μm 
and the moisture content was below 9%. Scanning electron microscopy showed the 
spherical shape and the uneven surface of the microparticles. The release of ENA 
from the obtained models in artificial saliva without enzymes (pH 6.8) showed 
minimal values by model EMS 3 (ENA: Eudragit Epo®: ethylcellulose 0.2: 0.27: 0.53), 
an evidence for masking the bitter taste of ENA. 
Conclusion: The obtained microspheres with Eudragit Epo® and ethylcellulose are a 
suitable carrier of enalapril maleate and provide optimal taste masking. 
 
 
MOST COMMON TOXIC METALS IN CHILDREN WITH 
DEVELOPMENTAL PROBLEMS IN BULGARIA 
Ciurinskiene S., Savcheva M., Kadiyska T. 
 
Autism is a neuro-developmental syndrome, perceived as a multigene disorder with 
epigenetic influences. There is no single diagnostic marker found. 
A number of researchers (Yasko, Amy, 2009; Walsh, William, 2011) have discovered 
the connection between autism spectrum disorders and the incapability of an 
organism to excrete metals, due to genetic disturbances in the methylation cycle. 
Variations of certain enzyme coding genes, which take part in the methylation and 
urea cycle, as well as sulfation, has been identified. Depending on the gene 
variations, these enzymes are increased or decreased. As a result, detoxification is 
disturbed. 
Objective of the study: 
1. To identify the predominant, most common metals in Bulgarian children with 
developmental disorders (ASD) 
2. To identify whether there is a correlation to variations of increased toxic metals 
and various genes: GPX1, GPST1, CBS, NOS, NAT2, CBS. 
Materials and methods: The study spans over 53 children, at the age of 1 – 13. 47 
boys and 6 girls, were tested for toxic metals overload, from January 1st 2017 to 
March 30th 2018. The level of toxicity was identified, using a hair metal elements test. 
The genetic analysis included genetic variants, known to be important and involved in 
the metabolism (synthesis, transport and degradation) of the neurotransmitters 
dopamine and serotonine, vitamin deficiencies including vitamin D, B6, B9 and B12, 
energetic balance of the cell, methylation cycles, detoxification capacity of the cell 
and histamine intolerance. 
The autistic symptoms were tested with the test battery CARS2. 
Results: 53 out of 53 children with developmental disorders turned out positive for 
increased level of one or more toxic metals. The severity of the autistic symptoms, 
however, correlated not with the extent of increase, but with the numbers of the 
detected metals – the more the number of the different metals were, the heavier the 
symptoms. 
Conclusions: Our study supports the metabolic deficiency theory, which occurs as 
result of disturbed detoxification, caused by variations of several genes like GPX1, 
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GPST1, CBS, NOS, NAT2, CBS. etc., which in turn leads to intoxication with metal 
and bad metabolites, accompanied by gut and brain inflammation. 
Key words: autism, toxic metals, detoxification 
 
 
SYNTHESIS AND PREDICTION OF ADME PARAMETERS OF SOME 
NEW DERIVATIVES OF BEXAROTENE 
Mitkov J.1, Agova N.2, Georgieva S.2, Zlatkov A.1 
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy,  
Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy,  
Medical University, Varna, 55 “Prof. Marin Drinov” str., 9002 Varna, Bulgaria 
 
Aim: The aim of the present work is to obtain and structurally characterize novel 
hydrazide-hydrazone derivatives of Bexarotene. They will be subjected to an in silico 
study to predict ADME parameters and substrate / metabolic specificity. 
Materials and methods: Structural characterization of newly obtained compounds 
was performed using instrumental methods. 
The prediction of the substrate/metabolic specificity is performed using the SMP web-
service. The prediction is based on PASS technology and MNA descriptors 
(http://www.way2drug.com/SMP/). 
Calculation of physicochemical descriptors as well as prognosis of ADME 
parameters, pharmacokinetic properties and drug nature of the tested compounds 
were performed using the Swiss-based web application SwissADME 
(http://www.swissadme.ch/). 
Results: The present study describes the synthesis of series new Bexarotene 
hydrazid-hydrazone derivatives which are subjected to in silico prediction of ADME 
parameters and substrate / metabolic specificity. All compounds show minimal 
deviations of Log P, while the other parameters are fully satisfying the Lipinski‟s rule. 
All compounds showed minimum aberration in Log P, while other parameters are 
fully in agreement with Lipinski‟s rule. All test compounds fall into the group of 
moderately soluble compounds. These calculations represent the compounds as 
lipophilic. Higher values of the parameter Pa (probability "to be active") are obtained 
with respect to the enzymes CYP2C19 and CYP3A4. 
Conclusion: It was found to be probable that the molecules are lipophilic and slightly 
water soluble, so they are predicted as poor bioavailable. 
Based on the obtained data we consider the tested compounds to perform most 
probably as CYP2C19 and CYP3A4 substrates. This can be a cause of drug 
interaction with certain inhibitors or inducers of those enzymes, such as 
ketoconazole, grapefruit juice, pioglitazone etc. 
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LAVENDER OIL MICROENCAPSULATION USING BOSWELLIA 
SERRATA RESIN AS A WALL MATERIAL 
Katsarov P.*, Penkov D., Pilicheva B., Georgieva Y., Peneva P., Kassarova M. 
Department of Pharmaceutical Sciences, Faculty of Pharmacy, 
Medical University, Plovdiv 
Technological Center for Emergency Medicine, Plovdiv 
*Corresponding author: tel. 0899040776, e-mail: plamen.katsarov@yahoo.com 
 
Aim of the Study: Formulation of lavender oil microcapsules with optimal structural 
and morphological characteristics and high stability of the encapsulated essential oil, 
using Boswellia serrata resin as a wall material. 
Materials and methods: Microcapsules were obtained by a spray drying method 
using Buchi B-290 Mini Spray-dryer at 140˚C temperature, 95% aspiration and 10% 
pump rate. Aqueous dispersions of Boswellia serrata resin with different 
concentrations were used, with essential oil: resin ratio of 1:4. Microcapsules shape 
was observed through scanning electron microscopy. Median diameter and particle 
size distribution of the models were determined by laser diffraction. Gas 
chromatography was used to analyze the phytochemical composition of the 
encapsulated oil. The total amount of lavender oil in the microcapsules after 
preparation and after 12 months of storage was determined by distillation in a 
Clevenger apparatus. 
Results: Three models of lavender oil microcapsules (M12, M15, M17) were 
formulated, using aqueous dispersions of Boswellia resin with concentration of 12, 15 
and 17%, respectively. The microcapsules were spherical in shape, with median 
diameter 5.4μm - 8.9μm and production yield - 28.11% - 51.25%. Model M15 was 
outlined as the most promising one, showing the highest yield (51.25%), a total oil 
content of 8.85% and a satisfactory stability - 19% loss of essential oil after 12 
months of storage. 
Conclusion: Boswellia resin can be successfully used as a wall material for 
formulation of lavender oil microcapsules. The obtained results may serve as a basis 
for preparation of solid dosage forms with essential oils. 
The study was financed by MU-Plovdiv through university project № НО – 12/2015. 
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IN VIVO DETERMINATION OF THE ANTIOXIDANT ACTIVITY OF DRY 
LEAF EXTRACT FROM SILVER BIRCH 
Penkov D.1,2, Delev D.3, Katsarov P.1,2, Kassarova M.1,2 
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, 
Medical University, Plovdiv, Bulgaria 
2High-Technological Center of Emergency Medicine, Plovdiv, Bulgaria 
3Department of Pharmacology and Clinical Pharmacology, Faculty of Medicine, 
Medical University, Plovdiv, Bulgaria 
Corresponding author – Dimitar Penkov, tel. 0883348490,  
e-mail: dimitar_penkov@abv.bg 
 
Aim: The aim of this work was to investigate in vivo the antioxidant activity of a dry 
leaf extract from Betula pendula, Roth. 
Materials and methods: 36 white male Wistar rats were used (weight 200 – 250 g). 
They were divided into 4 groups of 9 animals each, as follows: 
Group I - Saline (0.9% NaCl); 
Group II - Trolox 160 mg/kg bw; 
Group III - extract 100 mg/kg bw; 
Group IV - extract 500 mg/kg bw. 
The assay was performed in acute and chronic manner. Test solutions were 
administered once (in the acute) and daily (in the chronic experiment) for 14 
consecutive days. Blood collection was performed. The samples were centrifuged 
and blood plasma was collected to test the antioxidant activity. The FRAP reagent 
was prepared as a mixture in a ratio 10:1:1 (acetate buffer pH 3.6:10 mM TPTZ 
solution:20 mM FeCl3.6H2O solution). 
Results: Animals treated with the extract, at doses of 100 and 500 mg/kg, showed a 
significant increase in serum antioxidant activity compared to the control group 
(p<0.001 and p<0.0001 respectively). An interesting trend was observed - higher 
values in the acutely treated groups compared to the chronically treated. This can be 
probably explained by the biotransformation and elimination processes, which leads 
to a rapid decrease in the concentration of biologically active substances, responsible 
for the antioxidant effect. The reference group treated with the synthetic antioxidant 
Trolox showed the highest results. 
Conclusion: Dry birch leaf extract exhibits a relatively strong antioxidant activity, 
therefore it can be used as a natural source of antioxidants. 
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SYNTHESIS, DRUG LIKENESS AND TOXICITY PREDICTION OF 
SOME NEW IMIDAZOLE-THIOALKANIC ACIDS 
Mitkov J.1, Stamova S.2, Georgieva S.2, Georgieva M.1 
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, 
Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, 
Medical University, Varna, 55 “Prof. Marin Drinov” str., 9002 Varna, Bulgaria 
 
Aim: The aim of the present work is to synthesize and structurally characterize series 
new imidazole-thioalkanic acids. The obtained structures will be subjected to an in 
silico evaluation for prediction of their Drug likeness and toxicity ptoperties. 
Materials and methods: The structural characterization of newly obtained 
compounds was performed using instrumental methods. 
The Drug likeness prediction was based on the methodology used in the web 
program OSIRIS Property Explorer Data Warrior, and for toxicity prediction was 
applied the web based server ProTox II (http://charite.de/protox_II). 
Results: The calculated values for the molecular descriptors agree with Lipinski‟s 
Rule and MDDR quidelines. In relation to Drug likeness and Drug score parameters 
were obtained positive values for Drug score, close to 1 and positive values for Drug 
likeness.  
The tested compounds were classified as Predicted Toxicity Class 4 – low toxic, with 
toxicity probability above 60%. Concidering the predicted hepatotoxicity properties, 
the evaluated structures are expected to be non-toxic. 
Conclusion: The structures of the newly synthesized compounds was confirmed by 
instrumental methods. From the obtained results of Drug likeness and Drug score 
predition may be concluded that the tested thioalkane acids may be concidered as 
Drug like molecules. 
The performed in silico prediction of the Drug Induced Liver Injury (DILI) indicated the 
targed molecules as non-hepatotoxic.  Their classification as Predicted Toxicity Class 
4 presents them as low toxic compounds. 
 
 
DEVELOPMENT OF TECHNOLOGICAL METHOD TO PRODUCE 
NANOSTRUCTURED LIPID CARRIERS BASED ON NATURAL LIPID 
Dobreva M., Stefanov S., Andonova V. 
Department of Pharmaceutical Technology, Faculty of Pharmacy,  
Medical University, Varna 
 
The aim of the study: Development of technological method and investigation of 
crucial technological parameters, during preparation of nanostructured lipid carriers 
(NLC) based on natural oils, as novel drug delivery systems. 
Materials and methods: Solid and liquid lipids including Compritol 888 ATO, Cera 
alba and borage oil were used as components of the lipid matrix. Combination of 
nonionic emulsifiers (Polysorbate 80, Span 80, Poloxamer 407) were selected for 
stabilization of the particles surface. NLC were prepared using high-shear 
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homogenization method with Ultra- turrax T25 equipment, followed by 
ultrasonication. 
The obtained NLC have been characterized in terms of particle size, polydispersity 
index and zeta potential (Zetasizer Ultra), also stability study of dispersions was 
conducted. 
Results: The composition of dispersions selected for characterization were 10% lipid 
phase with 5% surfactant. Solid lipid: liquid lipid ratio forming the lipid matrix wаs 
established at 3:1. Different combinations of lipids were melt at temperatures, above 
their melting points. For Compritol-borage oil (CB) blend that was 85°С and for Cera 
alba- borage oil (CAB) blend – 75°С. High-shear homogenization at 10 000 rpm for 5 
minutes was applied for mixing the dispersion. Depending on surfactants used, NLC 
prepared with CB lipid matrix have size from 215 nm to 328 nm. Their average zeta 
potential was around zero (1.18 till -2.65). The NLC comprised of CAB blend show 
similar size (278 nm -314 nm), but much higher zeta potential (-24.5 to -34.2). 
Conclusion: The described technological method is suitable for preparation of NLC 
offering beneficial characteristics of prospective drug delivery systems. 
 
 
FOOD SUPPLEMENTS FOR THE MAINTENANCE OF NORMAL 
LIVER FUNCTION ON THE BULGARIAN PHARMACEUTICAL 
MARKET – IN COMPLIANCE WITH THE EUROPEAN 
RECOMMENDATIONS FOR HEALTH CLAIMS AND POSSIBLE 
INTERACTIONS WITH MEDICINES FOR LIVER DISEASES 
Balkanska A., Kondeva M., Dimitrova M. 
Faculty of Pharmacy, Medical University, Sofia 
 
Research objective: То evaluate the clinical and laboratory indicators of the second 
most common active substances in food supplements (FS), used for maintenance of 
normal liver function (MNLF), for possible interactions with medicines for variety of 
liver diseases. 
Materials and methods: A critical analysis of the European regulation (EO) No 
1942/2006 was conducted to evaluate the requirements for health claims for the FS 
for MNLF and their inclusion in international recommendations and 
pharmacotherapeutic guidances. The most delivered FS for liver function from 
wholesalers to pharmacies for MNLF were analysed for the dosage of the active 
substance. Subsequent evaluation of potential interactions with medicines for 
treatment of liver diseases published in the literature was performed. 
Results: Hepatoprotectors are included in the international guidelines and 
pharmacotherapeutic guidances as an option to maintain normal liver function. The 
second most frequent active substance in the liver FS, after sylimarin, is choline 
(citrate/bitartanat). Health claim for MNLF may be used only for foods/food 
supplements which contain at least 82,5 mg of choline per 100 g /100 ml. To present 
no significant interactions were found in the literature between choline and medicines 
for the treatment of variety of liver diseases. 
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Conclusion: The hepatoprotectors are part of the pharmacotherapeutic guidances 
as a recommendation to maintain the health of the liver while curing liver diseases. 
More detailed quality analysis and evaluation of the FS use for liver health, are about 
to be done with evaluation of eventual interactions in patients with liver diseases. 
 
 
А NEW SYNTHETIC ROUTE OF OBTAINING OF 5-METHYL-5-
BENZYL HYDANTOIN. X-RAY ANALYSIS AND THEORETICAL 
CALCULATIONS 
Buyukliev R.1, Nikolova R.2, Shivachev B.2, Cherneva E.1, Bakalova A.1 
1Department of Chemistry, Faculty of Pharmacy, 
Medical University of Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Institute of Mineralogy and Crystallography, 
Bulgarian Academy of Science, 107 “Acad. G. Bonchev” str., 1113 Sofia, Bulgaria 
 
The aim of the study: It is known from the literature that the 5,5-disubstituted 
hydantoins have anti-convulsive, antipyretic, antibacterial properties. The compound 
5-methyl-5-benzyl hydantoin was obtained as early as 1932. The goal of the study is 
to describe various synthetic route of the obtaining of 5-Methyl-5-benzyl hydantoin 
and to investigate its structure by X ray analysis. 
Materials and methods: 5-Methyl-5-benzyl hydantoin has been synthesized and 
characterized by single crystal X-ray diffraction, IR and NMR spectrometry. Quantum-
chemical computations were used to investigate the structure of the compound 
based on DFT at the B3LYP/6-311++G** level of theory. 
Results: The X-ray diffraction analysis revealed that the compound is crystallized in 
the monoclinic space group of the Pn (N°7) system. In addition, theoretical 
calculations based on the DFT/B3LYP/LANL2DZ method were performed. A good 
consistency was found with the experimental results. 
Conclusion:  A different synthetic pathway of the compound was realized. The 
crystal structure of 5-methyl-5-benzyl hydantoin has been determined by X-ray 
diffraction analysis and also by elemental analyses, IR, 1H and 13C NMR spectra. A 
good agreement has been found between calculated and experimental structural 
parameters. The theoretical wavenumbers showed very good agreement with the 
experimental values. 
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THE EMPLOYMENT OF STUDENTS FROM PHARMACEUTICAL 
SPECIALTIES IN BULGARIA – A PILOT STUDY 
Gergov K.1, Georgiev J.1, Burgazliev H.2, Hristov E.1, Ognianov S.1 
1Faculty of Chemistry and Pharmacy, 
“Sveti Kliment Ohridski” Sofia University, Bulgaria 
2Department of Pharmacy, Medical College, 
"Prof. Dr. Assen Zlatarov” University, Bourgas, Bulgaria 
 
Aim: The primary objective is to analyze employment, job-seeking, work habits and 
preferences of students in pharmaceutical specialty in higher education institutions in 
Bulgaria. The secondary objectives: To analyze employment opportunities, legal 
assessment, analyze available practices, identify the main problems in reconciling 
learning with work. 
Materials and methods: We conducted a pilot study in two centers in Bulgaria. The 
data collection was done using the "direct individual poll" method. The questionnaire 
containing 28 questions - open and closed type. Target group is 130 students - 
pharmacy students from “Sveti Kliment Ohridski” Sofia University, Faculty of 
Chemistry and Pharmacy and bachelor-pharmacists from the Medical College, "Prof. 
Dr. Assen Zlatarov” University, Bourgas. The data are processed with the SPSS 
software. 
Results and discussion: The pilot study proves that the majority of pharmacy 
students work during their studies - 86.4%. The main incentive to start work is 
financial. 56.8% are employed on a labor contract and nearly one third are employed 
without any contract. In group of assistant pharmacists - 45.3% of respondents work, 
financial reasons 66.7% are leading again. 86.2% have an employment contract but 
67.9% are insured on a minimum wage basis. Mostly, students work in their 
specialty, in particular to the retailing of medicinal products - as trainees in 
pharmacies. Students express difficulties in the process of reconciliation of work and 
training, negative attitude towards the legal framework and a distinctive negative 
attitude towards the main field of realization for the master pharmacists - the work in 
the pharmacy. 
Key words: Student employment, pharmacy students, assistant pharmacists, 
pharmacy. 
Corresponding author: Konstantin Gergov, Faculty of Chemistry and Pharmacy, 
“Sveti Kliment Ohridski Sofia University, 1 “James Boucher” blvd., 1164 Sofia, 
Bulgaria; e-mail: konstantingergov@gmail.com 
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DESIGN, SYNTHESIS, THEORETICAL AND CYTOTOXIC 
INVESTIGATION OF NEW Pt(II) COMPLEXES WITH 3-METHYL-8-
THIA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE 
Bakalova A.1, Buyukliev R.1, Michailova R.2, Momekov G.2, Cherneva E.1 
1Department of Chemistry, Faculty of Pharmacy, Medical University, Sofia, Bulgaria 
2Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University, Sofia, Bulgaria 
Corresponding author: Adriana Bakalova, tel. +359 897086067,  
e-mail: adrigebk@abv.bg 
 
The aim of the study: Platinum complexes are still the leading drugs in 
chemotherapy of cancer. More than thirty Pt(II) and Pt(IV) complexes are in clinical 
investigation in different stages. The mixed ammine/amine platinum complexes with 
chlorido ions as leaving groups have demonstrated better antiproliferative activity 
against cisplatin-resistant cells in vitro and are less toxic than cisplatin. The synthesis 
of other types of platinum complexes containing different leaving groups, such as 
iodido ions also showed higher activity than their chlorido analogues and they 
exceeded the activity of the platinum-based drugs. 
Materials and methods: The new compounds have been studied by elemental 
analyses, IR, 1H and 13C NMR spectral analyses and DFT calculations, using the 
B3LYP/ LAN2DZ level of theory. The most probable conformations were constructed 
and optimized. The geometry of the complexes is square-planar. The cytotoxic 
effects of the compounds were studied vs. the referent antineoplastic agent cisplatin 
against two human tumour cell lines using the standard MTT-dye reduction assay for 
cell viability.  
Results: The platinum complexes with chemical formulas cis-[PtL(NH3)Cl2] and cis-
[PtL2I2], where L is 3-methyl-8-thia-1,3-diazaspiro[4.5]decane-2,4-dione were 
synthesized and studied. The physico-chemical analyses show that the coordination 
of the ligand with platinum ion is realized through the sulfur atom in the both of 
complexes. 
Conclusion: The platinum complexes showed higher cytotoxic activity on chronic 
myeloid leukemia K562 and acute lymphoblastic leukemia REH than the ligand but 
they have lower cytotoxic activity than the reference drug cisplatin. 
Acknowledgment: Thanks are due to Medical Science Fund at the Medical 
University – Sofia (Grant №84/23.04.2019) for the financial support. 
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MATERIOVIGILANCE IN THE NORTH MACEDONIA-REGULATION 
AND HARMONIZATION 
Angelovska B., Drakalska Sersemova E., Stefanovska K. 
Faculty of Medical Sciences, , 
“Gotse Delchev” University, Shtip, 
Republic of North Macedonia 
corresponding author: e-mail: elena.drakalska@ugd.edu.mk 
 
Aim of the study: The purpose of this study is: to analyze the recommendations of 
the WHO, EU, FDA, PGEU and their implementation in developed countries and RM, 
to realize the aim of harmonizing the vigilance system, to define the specifics on the 
classification, the quality standards of materiovigilance that guarantee safety for 
using the medical devices and legal support that it provides, the opportunities and the 
degree of harmonization of the vigilance system in Macedonia compared to other 
countries. 
Materials and methods: In order to achieve the set goals, we reviewed relevant 
literature sources of primary and secondary literature, documents and 
recommendations of the WHO, EU, FDA, PGEU and specific regulatory authorities 
for nomenclature, classification, standardization and quality assurance. We made a 
comparison of the regulation systems of materiovigilance in America, Australia, 
England, India and Macedonia. 
Results and discussion: The obtained results show that there is a high degree of 
harmonization of regulatory systems of the Republic of Macedonia with other 
members of GHTF which guarantees a high level of efficiency, security and 
accuracy, partly limited by the possibility of parallel imports. 
Conclusion: Medical devices equally as medicines, are an important segment for 
normal functioning of the health system and an integral part of pharmacy practice. 
We conclude that implementation of the system of materiovigilance is in accordance 
with the recommendations of the WHO, EU and specific bodies established for that 
purpose. 
 
 
WHETHER AMORPHA FRUTICOSA FRUIT EXTRACT POSSESS 
GENOTOXIC AND MUTAGENIC EFFECT ON SACCHAROMYCES 
CEREVISIAE OR NOT? 
Todorova T.1, Parvanova P.1, Dimitrova M.1, Ionkova I.2, Krasteva I.2,  
Shkondrov A.2, Mitrovska Z.1, Kozuharova E.1, Chankova S.1 
1Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences 
2Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia 
 
Aim of the study: To reveal the potential genotoxic and mutagenic effect of 
Amorpha fruticosa fruit extract. 
Materials and methods: Mature fruits of this invasive plant were collected in 
October 2018 and botanically identified by Ekaterina Kozuharova. Aqueous extract 
was prepared following a standard procedure. The dried material (300g) was 
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pulverized, sieved (3mm) and percolated exhaustively with dichloromethane (4.5l). 
The defatted plant substance was further extracted with 80% methanol (12l), then 
resulting extract filtered, evaporated on a rotary evaporator and lastly lyophilized. 
Cell suspensions (1x107cells/ml) of Saccharomyces cerevisiae strain D7ts1 in the 
end of exponential growth phase were treated with Amorpha fruticosa extract for 30 
min and Zeocin as a positive control. Seven extract concentrations in the range of 
1µg/ml - 1000µg/ml were applied for preliminary evaluation of the potential 
genotoxicity. Further, 10, 100 and 1000µg/ml were tested by Zimmermman‟s test 
using the following endpoints: cell survival for genotoxic and mitotic gene conversion, 
reverse mutations and mitotic crossingover - for mutagenic effects. 
Results: The intensity of the spots was similar among all the samples treated with 
Amorpha and the untreated ones suggesting lack of genotoxicity. Data obtained by 
Zimmermman‟s test revealed that the survival after the treatments was comparable 
to the negative control - untreated cells. No effect was obtained regarding the genetic 
events - convertant and revertant frequencies as well as total aberrants. 
Conclusion: Based on the results presented here, Amorpha fruticosa fruit extract at 
the studied concentrations does not possess genotoxic and mutagenic effect on 
Saccharomyces cerevisiae. 
Acknowledgements: This work has been carried out in the framework of the 
National Science Program "Environmental Protection and Reduction of Risks of 
Adverse Events and Natural Disasters", approved by the Resolution of the Council of 
Ministers № 577/17.08.2018 and supported by the Ministry of Education and Science 
(MES) of Bulgaria (Agreement № D01-230/06.12.2018). 
 
 
ANXIOLYTIC EFFECT OF THE NEW ANTICONVULSANT 
LACOSAMIDE COMPARED TO TOPIRAMATE IN THE PILOCARPINE-
MODEL OF TEMPORAL LOBE EPILEPSY IN RATS 
Shishmanova-Doseva M.1, Peychev L.1, Mincheva M.2, Boyuklieva R.2 
1Department of Pharmacology and Drug Toxicology, Faculty of Pharmacy,  
Medical University, Plovdiv 
2Pharmacy Student, Faculty of Pharmacy, Medical University, Plovdiv 
 
The aim of the study: was to investigate the effect of Lacosamide (LCM) and 
Topiramate (TPM) on anxiety in naïve rats and in animals subjected to Pilocarpine 
(Pilo)-induced status epilepticus (SE). 
Material and methods: Male Wistar rats were randomly divided into 6 groups (n=8) 
and SE was evoked by a single administration of Pilo (320 mg/kg) i.p. in half of them. 
During the next one month all animals were daily treated per os as follows: 1st group 
(C-veh)–with saline, 2nd Pilo-veh, 3rd (LCM) – LCM 30 mg/kg, 4th (Pilo-LCM) – LCM 
30 mg/kg, 5th (TPM) – TPM 80 mg/kg and 6th (Pilo-TPM) – TPM 80 mg/kg. The test 
was performed in the Elevated-plus maze which consisted of two open and two 
enclosed arms and a central platform. It was measured (1) number of entries in the 
open arms; (2) time spent in the open arms; and (3) anxiety index. 
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Results: Both groups Pilo-LCM and Pilo-TPM had higher numbers of entries in the 
open arms (p < 0.01, p < 0.05) and spent longer time in them compared to the Pilo-
veh group (p < 0.001). LCM animals had also higher numbers of entries in the open 
arms in comparison with C-veh animals (p < 0.05). A lower anxiety index was 
demonstrated for the groups treated with different anticonvulsants and subjected to 
status epilepticus comepared to Pilo-veh animals (p < 0.001). 
Conclusion: Both antivonvulsants LCM and TPM produce anxiolytic effects in a 
model of temporal lobe epilepsy while LCM decreaces anxiety in naïve rats as well. 
 
 
A SURVEY OF OPINION AND READINESS TO APPLY SEASONAL 
FLU SHOT VACCINATION 
Hristova H.1, Getov I.2 
1Sofia university “St. Kliment Ohridski”, Faculty of chemistry and pharmacy, Bulgaria 
2Medical university, Faculty of pharmacy, Sofia, Bulgaria 
 
The aim of the study: The aim of the study is to examine the attitudes of visitors in 
the pharmacies in regards to the seasonal flu shot vaccination in Bulgaria in relation 
with the introduction of a national immunization program for people over and above 
the age of 65. 
Materials and methods: For the purposes of the survey we used two methods - a 
direct individual survey with a questionnaire and a statistical overview. The 
questionnaire with 10 multiple option-answers was filled by a random selection of 
respondents - visitors of pharmacies in the period between January to February 
2019. 
Results: The study found that 81% of the respondents (108 individuals) were not 
vaccinated during the current season and they don‟t do it on annual basis.  
When presented with the option to vaccinate at the expense of the NHIF, 50% of the 
interviewed share that they are more likely to be immunized. 
The majority of the interviewed say that they place their trust in their GPs about the 
vaccine, and that if they would need more information they would ask them. 
For 61% of the interviewed, the flu shot vaccines are safe, but the main reason that 
prevents them from being vaccinated is unwanted reactions - 83%. 
Conclusion: Individuals in the group of the age of 65 and above are not used to, nor 
they are positively predisposed towards flu vaccination. 
Conclusions on flu vaccine coverage should not be made based on a sales basis. 
The opinion of the respondents is equally distributed between the intention to 
vaccinate at the expense of the NHIF, however the majority agrees to the assumption 
that this cost should be covered from public funds. 
The main reason preventing the respondents of getting a flu shot vaccination is post-
vaccination undesired reactions, and the primary and preferred source of information 
is their GP and then the Magister Pharmacist. 
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ANALYTICAL STUDY OF ACTIVE INGREDIENTS IN MODEL 
MIXTURES CONTAINING EXTRACTS FROM MEDICINAL PLANTS 
CRATAEGUS SP., TRIBULUS TERRESTRIS L. AND SIDERITIS 
SCARDICA GRIZEB 
Mitkov S.1*, Yordanov D.2, Najdenov V.3, Petrova Z.4, Pencheva I.5 
1”INOLAB” Ltd, ”Mladost”1, Sofia 1797, Bulgaria 
2Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of 
Science, 9 ”Acad. G. Bonchev” Blvd., Sofia 1113, Bulgaria 
3,4“ Medical Point” Ltd, “Biala Buka” str., Sofia 1220, Bulgaria 
5Faculty of Pharmacy, Medical University, Sofia, 2 “Dunav” str.,Sofia 1000, Bulgaria 
 
The aim of the study: The medicinal plants Hawthorn (Crataegus sp.), Tribulus 
(Tribulus terrestris L.) and Mountain tea (Sideritis scardica Grizeb.) are well-known 
and have long been used in medicine. They have a beneficial effect on 
cardiovascular function, antioxidant protection, sexual activity, tone and muscle 
strength. The subject of the present work is the development of a HPLC procedure 
for the identification and quantification of pharmacologically active flavonoids and 
procyanidins in model mixtures of medicinal plants. 
Materials and methods: HPLC method with UV detector, model mixtures of 
medicinal plants. 
Results: Tests for identification and assay of the active ingredients contained in 
mixtures of extracts of Crataegus sp.,Tribulus terrestris L. and Sideritis scardica 
Grizeb. have been developed. Selectivity, reproducibility, accuracy, linearity, LOD 
and LOQ were determined. 
Conclusion: Validated methods for the identification and assay of biologically active 
flavonoids and procyanidins in model mixtures of plant extracts are intended to serve 
in the process of quality control as required by the European Pharmacopoeia. 
 
 
METHODOLOGICAL AND TECHNOLOGICAL APPROACH TO 
IMPROVING THE STATISTICAL ACCURACY OF DIAGNOSTIC TEST 
AND METHODS 
Mitov K., Doneva M., Tachkov K. 
Faculty of Pharmacy, Medical University, Sofia, Department of Organisation and 
Economics of Pharmacy 
 
Goal: To present a local version of an automated system for generating, validating, 
evaluating and archiving exams, for the purposes of educating, professional analysis 
and socio-cultural education, as well as emphasize the benefits of improving, and 
objectifying the evaluation process, which would overall lessen the burden. 
Materials and methods: A local version of the system was developed with Visual 
Basic for Excel. Its development was based on the professional experience of the 
authors, as well as world-wide experience, and the benefits offered by technological 
advances. To minimize the probability of exam passes to be due to random chance, 
a function was developed on the basis of the properties of the normal distribution. A 
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web-version on a local server would allow the integration of a separate module of a 
validated system in an educational facility to help objectify the exam process. 
Results: The local version of the system is an excel file, allowing any computer with 
MS office to access it. It has a user-friendly interface, whereby the grading scale can 
be set by the examiner or generated automatically. The function is based on the 
properties of the normal distribution. This minimizes the possibilities of a successful 
test to be due to random guessing of answers. Upon completion of the exam, the 
system offers the possibility of statistical analysis and archiving of results and grades. 
The system presented here has already been implemented in several departments at 
the Faculties of Pharmacy and Medicine. 
Conclusion: Utilization of a local version of this automated system allows 
generating, evaluating, grading and archiving grades for the purposes of education, 
professional analysis and accumulation of knowledge in real-world practice. Its 
implementation greatly eases the burden of assessing, experienced by educators, 
and adds objectivity to the process. 
 
 
CHALLENGES IN THE DIAGNOSIS OF DISEASES THROUGH 
REFERENCE INTERVALS AND THEIR CHANGES 
Tachkov K., Savova A., Mitov K. 
Faculty of Pharmacy, Medical University of Sofia, Department of Organisation and 
Economics of Pharmacy 
 
Goal: To present a local version of an automated system for generating, validating, 
evaluating and archiving exams, for the purposes of educating, professional analysis 
and socio-cultural education, as well as emphasize the benefits of improving, and 
objectifying the evaluation process, which would overall lessen the burden. 
Materials and methods: A local version of the system was developed with Visual 
Basic for Excel. Its development was based on the professional experience of the 
authors, as well as world-wide experience, and the benefits offered by technological 
advances. To minimize the probability of exam passes due to random chance, a 
function was developed on the basis of the properties of the normal distribution. A 
web-version on a local server would allow the integration of a separate module of a 
validated system in an educational facility to help objectify the exam process. 
Results: The local version of the system is an excel file, allowing any computer with 
MS office to access it. It has a user-friendly interface, whereby the grading scale can 
be set by the examiner or generated automatically. The function is based on the 
properties of the normal distribution. This minimizes the possibilities of a successful 
test to be due to random guessing of answers. Upon exam completion, the system 
offers the possibility of statistical analysis and archiving of results and grades. It has 
already been implemented in several departments at the Faculties of Pharmacy and 
Medicine. 
Conclusion: Utilization of a local version of this automated system allows 
generating, evaluating, grading and archiving grades for the purposes of education, 
professional analysis and accumulation of knowledge in practice. Its implementation 
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eases the burden of assessing, experienced by educators, and adds objectivity to the 
process. 
 
 
COMPARISON BETWEEN PEDIATRIC AND ADULT SUSPECTED 
NEUROLOGICAL AND PSYCHIATRIC ADVERSE DRUG 
REACTIONS(ADRs) OF MELATONIN REPORTED TO THE 
EUROPEAN MEDICINES AGENCY (EMA) AND US FOOD AND DRUG 
ADMINISTRATION (FDA) 
Bakalov D.1, Andreeva-Gateva P.2, Hadjiolova R.1 
1Pathophysiology department, Medical University, Sofia, Bulgaria 
2Pharmacology and toxicology, Medical University, Sofia, Bulgaria 
 
Aim: We are using the ADR databases of EMA and FDA to compare the distribution 
of melatonin‟s neurological and psychiatric ADRs between pediatric and adult 
population. The results will serve as basis for future research involving melatonin use 
in specific populations. 
Methods: All ADR reports received in EMA and FDA up to 14 may 2019 were 
analyzed for overall numbers, age and gender. The nature of the ADRs and the most 
frequently reported drug events were evaluated using Medical Dictionary for 
Regulatory Activities (MedDRA). 
Results: Adult reports of ADRs in were more common than those in children under 
the MedDRA classification 'nervous system disorders', „psychiatric disorders'. In 
pediatric population most common ADRs reported were somnolence, agitation, 
headache, insomnia and anxiety, and in people over 18 years old – headache, 
dizziness, somnolence and insomnia. For children, in most of the cases melatonin 
was reported as used off-label, and even though most of the cases were resolved 
without sequel, there were few cases reported of un-resolved effects. 
Conclusions: The present study focused on the neurological and psychiatric ADR 
reports of melatonin in some of the largest databases. It confirmed that reports of 
reactions in children were different to those in adults, not only in terms of reactions 
but also more concentrated around limited sets of reaction types and drugs. It 
showed that future research of melatonin in pediatric population is needed, because 
the current SmPCs lack such information, and in the last few years the cases of 
melatonin use in children is increasing. 
Keywords: melatonin, ADR, children, pharmacovigilance. 
This work is supported by the Bulgarian Ministry of Education and Science under the 
National Program for “Young Scientists and Postdoctoral Students” Research. 
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OLMESARTAN TABLETS – DRUG RELEASE OPTIMAZITION BY 
GRANULATION IN FLUIDIZED BED APPARATUS 
Tzankov S.1, Ivanova I.2 
1Faculty of Pharmacy, Medical University, Pleven 
2“Tchaikapharma” High Quality Medicines Inc. 
 
Olmesartan medoxomil (angiotensin-II-antagonist) is practically insoluble in water 
drug. This makes a problem with drug`s release from tablets. The micronization of 
the substance is a widely used method for drug release optimization. A special 
equipment is needed for the micronization process. The aim of this study is to 
enhance dissolution rate of olmesartan by a simple method without using special 
equipment. The literature search suggested the method of dissolved active 
substance spraying in fluid-bed apparatus as an appropriate tool for this purpose. 
Most often, during the process, the drug substance is in an amorphous form with high 
dissolution rate.    
The dissolution media phosphate buffer (pH 6,8) was established as discriminative 
during the studies of drug release in medias with different pH values. It was defined 
for studding of olmesartan release. 
The technological process was developed for granulation in fluid-bed apparatus. The 
suitable co-solvent, which completely dissolve olmesartan (such as methanol and 
acetone), and binding polymer (hydroxypropyl cellulose) were chosen. At the same 
time, granules without dissolving of active substance were produced using 
conventional technology. 
The comparison of drug release from tablets, produced by the both technological 
methods, demonstrates significant and rapid dissolution rate from tablets produced 
by dissolving of olmesartan in granulated solution. This dissolution profile is similar to 
those of the originator Olmetec. The final assessment can be done after the 
completely evaluation of finished product stability. 
In conclusion, the performed experiments prove the possibility for optimization of 
drug release from Olmesartan tablets by using a simple granulation method in fluid-
bed apparatus, without need of other special equipment. 
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DEVELOPMENT AND OPTIMISATION OF THE PROCESS OF 
DECARBOXYLATION OF TETRAHYDROCANNABINOIC ACID, 
FOLLOWED BY FTIR DETECTION OF TETRAHYDROCANNABINOL 
IN MEDICINAL CANNABIS 
Cocovska I.1,2, Demirovski Kockova K.1, Trajanovska Faizova V.1,      
Maksimova V2. 
1Oaza Alakaloidi, Shtip, Gladno pole, bb, Tarinci, POB 2000, Shtip,  
Republic of North Macedonia, 
2”Gotse Delchev” University, Krste Misirkov, bb, POB 2000, Shtip,  
Republic of North Macedonia 
 
Aim of the study: Conversion of tetrahydrocanabinoic acid (THCA) to 
tetrahydrocannabinol (THC), is the main reaction essential for the use of cannabis, 
Cannabis indica L. buds in medicinal purposes. Therefore, the aim of this study was 
to develop and optimize the thermal treatment of Cannabis buds, required for the 
reaction of decarboxylation of THCA to THC followed by FTIR technique. 
Materials and methods: Cannabis buds were heated on aluminum shelves, 
programmed by heating oven POL EKO SL 400. Temperature program was strictly 
monitored and changes were recorded on every 5 minutes. Mid Infrared spectra were 
collected for each sample and temperature, respectively, using Perkin Elmer 
Spectrum Two™ coupled to an UATR accessory in spectral range of 400-4000 cm-1. 
Results: Changes in the infrared spectra indicated that the required elimination of 
water and appropriate conversion of THCA to THC were established, as the reaction 
progressed. Reaction of decarboxylation has occurred in temperature range from 85-
120° C. Conversion of THCA to THC contributed for obtaining of high concentrations 
of THC which ranged 38-80% w/w. The progress of the decarboxylation enhanced 
the obtaining of THC. 
Conclusion: Monitoring of the process of decarboxylation with FTIR technique 
presents a fast and plausible method for controlling the conversion of acidic forms of 
cannabinoids to their neutral forms. The thermal treatment has shown a high yield of 
THC up to 80% w/w. It should be stressed out that these two methods could be 
ideally suited to everyday analysis because of their high performances. 
Key words: cannabinoids, Cannabis indica, decarboxylation, FTIR 
 
 
TECHNOLOGICAL APPROACHES FOR EXTEMPORANEOUS 
PREPARATION OF ORAL PEDIATRIC FORMULATIONS WITH 
SILDENAFIL CITRATE 
Dimitrov M., Borinarova M. 
Faculty of Pharmacy, Medical University, Sofia 
e-mail: mdimitrov@pharmfac.mu-sofia.bg, tel. +35929236526 
 
The aim of the study: The aim of the study is to analyze and critically evaluate 
potential technological approaches for extemporaneous preparation of pediatric oral 
formulations containing sildenafil citrate for pediatric personalized therapy. 
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Materials and methods API: Oral pediatric formulations with sildenafil citrate based 
on active substance-raw material (API) and by dispensing of pre-formulated model 
tablets were prepared with utilization of suitable carriers. 
Results: Literature search on the possibilities and limitations for preparation of oral 
sildenafil citrate formulations for pediatric practice have been collected and analyzed. 
Various approaches to the extemporaneous preparation of oral formulations with 
sildenafil citrate have been applied and evaluated. The main factors influencing the 
stability of the prepared formulations have been investigated and evaluated. 
Conclusion: All oral formulations tested remained unchanged with respect to the 
appearance at selected storage conditions: at room temperature of 25° C ± 5° C and 
5° C ± 2° C in the refrigerator within the design of the experiment. The quantitating 
content of sildenafil citrate in all prepared oral formulations remains above 95% w / v. 
The microbiological quality of the formulated preparations as well as the stability after 
the first opening of the package within 10 consecutive days for the water-carrier 
formulations and 14 days for the formulations with sugar or fructose syrup were 
confirmed. 
 
 
DEVELOPMENT OF MESOPOROUS SILICA PARTICLES AS A DRUG 
DELIVERY SYSTEM FOR QUERCETIN 
Voycheva C., Tsankov B., Popova T., Spassova I., Kovacheva D., Yoncheva K., 
Lambov N. 
Faculty of Pharmacy, Medical University, Sofia 
 
Purpose: The flavonoid quercetin is widely studied for its antioxidant and anti -
inflammatory properties. However, poor water solubility, low stability and short half-
life may limit its use in therapy and skin care products. The purpose of this work is 
exploring the possibility of influencing the process of dissolving quercetin, through its 
inclusion in two types of mesoporous silica nanoparticles, in particular MCM-41 and 
HMS. 
Materials and methods: The loading of both particle types with quercetin was 
determined by thermogravimetry. The basic physico-chemical characteristics of the 
particles, such as size, polydispersity index and zeta-potential, were determined. 
Their specific structure was examined using transmission electron microscopy. In 
vitro dissolution tests was performed in buffer with pH 5.5 (Apparatus 5 Paddle, USP 
37), in view of the subsequent incorporation of the systems into a dosage form for 
topical administration. 
Results: The results of the dissolution tests showed differences in the quercetin 
release profiles of the two particle types. HMS particles release quercetin significantly 
slower than MCM-41 particles, in particular the dissolution rate is twice as low as that 
seen with MCM-41. However, in both cases, a higher dissolution rate was 
established when quercetin was included in the mesoporous particles, compared with 
dissolution of unencapsulated quercetin. 
Conclusion: The inclusion of quercetin in mesoporous silica nanoparticles could be 
an alternative approach to solving problems with its dissolution. 
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EFFECTS OF ANTHOCYANINS
R
 ON FRUCTOSYLTRANSFERASE 
Lm17 ACTIVITY 
Bodlev S., Vasileva T., Iliev I.*, Nikolova M. 
Department of Biochemistry and Microbiology, Faculty of Biology, “Paisii Hilendarski” 
Plovdiv University, 24 “Tzar Assen” str., 4000 Plovdiv, Bulgaria 
*Correspondence author: e-mail: ilievini@abv.bg, +35932261479 
 
The aim of the study: The aim of the present study was to investigate the effect of 
different anthocyaninsR on the enzyme activity of fructosyltransferase Lm17. 
Material and methods: A spectrophotometric method for detecting enzyme activity 
was used as well as a HPLC assay to determine the type and concentration of 
anthhocyaninsR. 
Results: When using the anthocyanins delphinin-3-galactoside, delphinine-3-
glucoside and cyaniding-3-glucoside, as well as anthocyaninsR as acceptor of 
glycosidic molecules and sucrose as a donor, the rate of the transferase reaction of 
fructosyltransferase Lm17 is monitored. Ratios between the acceptor 
(anthocyaninsR) and the substrate are used, varying very widely from 1:80 to 1:1. 
More than 85% inhibition of fructosyltransferase Lm17activity is achieved by using an 
A / S ratio of 1: 2.5, the acceptor being a mixture of the delphinidin-3-galactoside, 
delphinidin-3-glucoside and cyanidin-3-glucoside =1.3:1.3:1 and 5% sucrose. Fifty 
percent inhibition of enzyme activity is reached at a ratio of 1:4 and a 2% substrate 
output concentration and an acceptor combination of delphinin-3-galactoside, 
delphinine-3-glucoside and cyanide-3-glucoside. 
Conclusion: The study found that the enzyme fructosyltransferase Lm17 can 
successfully be used to modify the structure of anthocyaninsR (a mixture of delphinin-
3-galactoside, delphinine-3-glucoside and cyaniding-3-glucoside) that could show 
new biological activities. This could be critical to improve their pharmacokinetic 
parameters. 
Acknowledgements: The authors express their gratitude to the National Science 
Fund, Bulgarian Ministry of Education and Science for the financial support in this 
study made in connection with the project DM16/2. 
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PHENOLIC COMPOUNDS WITH RADICAL-SCAVENGING, ANTI-α-
GLUCOSIDASE AND PROLIPASE ACTIVITIES FROM THE AERIAL 
PARTS OF HYPERICUM CERASTOIDES (SPACH) N. ROBSON 
Kokanova-Nedialkova Z., Nedialkov P., Ilieva Y. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia, 2 
“Dunav” str., 1000 Sofia, Bulgaria 
 
The aim of the study: Seven phenolic compounds (coumaroylquinic acid 1, 
myricetin-3-O-glycoside 2, myricetin-3-O-galactoside 3, hypercerastoside A 4, methyl 
ester of chlorogenic acid 5, hypercerastoside B 6 and hypercerastoside C 7) isolated 
from the aerial parts of Hypericum cerastoides (Spach) N. Robson. were tested for 
radical-scavenging, anti-α-glucosidase  and prolipase activities. 
Materials and methods: DPPH and ABTS methods were used for the determination 
of radical-scavenging activity. Anti-α-glucosidase and prolipase activities were 
established by LC-MS. 
Results: The highest DPPH activity possessed compounds 2 (84.32%), 3 (82.70%) 
and 5 (84.57%), compared to the radical-scavenging activity of Vit C (59.44%) and 
Trolox (88.33%). All compounds displayed ABTS activity. The highest activity 
possessed the glycosides of myricetin respectively compounds 2 (97.23%) and 3 
(96.04%). Their radical-scavenging activity were higher than that of Vit C (66.21%) 
and Trolox (94.16%). The results from the in vitro investigations showed that 
compounds 1 (IC50 = 44 µM), 3 (IC50 = 206 µM) and 6 (IC50 = 371 µM) possessed 
similar activity to acarbose (Glucobay)(IC50 = 206 µM), a known anti-diabetic drug 
used to treat diabetes mellitus type 2. Five of the seven isolated compounds, 
respectively substances 1-3, 5 and 6, exhibited prolipase activity. The highest activity 
was expressed by the myricetin glycosides, compounds 2 and 3, which stimulated 
the activity of the enzyme lipase extensively five times when were applied at a 
concentration of 200 μM. 
Conclusion: The research of the aerial part of Hypericum cerastoides confirmed the 
scientific hypothesis that the title plant contains phenolic compounds with radical-
scavenging, anti-α-glucosidase and prolipase activities. 
Acknowledgements: This work was supported by the Council of Medical Science of 
Medical University of Sofia. 
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BASIC STUDY OF PHARMACEUTICAL BIOECONOPHYSICAL 
ASPECTS OF DRUG ADMINISTRATION 
Petrov M., Petrova V. 
“Galantus” Pharmacy, Bourgas 
0892230778, e-mail: galantusgratus@abv.bg 
 
Aim of the research: The modern stage of the development of pharmacy and 
medicine in general involves a massive integration of different scientific directions 
into a new scientific integrative system such as pharmaceutical bioeconophysics [1], 
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[2] which is an integrative scientific system of pharmacy, biophysics, human 
physiology and the economical sciences. In accordance with this new concept, the 
aim is the study of the obtaining of a quantitative law of the cost of one mole of drug 
substance in interaction with different types of organ receptors and this law contains 
such parameters as molar mass, half-life time, the mass of drug‟s form (tablets, 
capsule, solution, etc.), with the application of the microeconomical econophysical 
model of the "ideal gas" [3] and that could serve as an estimation of the cost of one 
mole of new synthesized molecules. 
Means and methods: The drugs that enter the human stimulate certain receptors, 
ion channels, act on enzymes or transporters proteins. As a result, they cause the 
human body to react in a specific way by creations of complexes formed of receptors 
and drugs molecules or other products of chemical reactions. The human being is a 
complex biological system that can be studied by biophysical methods and 
interacting with social and economical systems of societies by bioeconophysical 
methods respectively [1], [2]. 
Generalizing what has been said above, we can conclude that pharmaceutical 
bioeconophysics can be defined as a new multidisciplinary philosophical 
scientific orientation that studies the general laws of the evolution of the 
economical processes of pharmaceutical supply for the maintaining of social 
and physiological healthy equilibrium state of Human being by the application 
of physics - mathematical and statistical methods of the integrative system of 
philosophical, biophysical and pharmaceutical sciences. 
The econophysical studies that include the principle of Pareto were reflected in [3] 
which shows that each stock article of pharmaceutical products is characterized by 
so-named econophysical temperature that represents the capacity of the generating 
power of average turnovers (average revenues) during one day of one stock article 
and respectively for each rating marketing groups A, B, C, X, Z of the stocks these 
values of temperatures are KA=21; KB=13; KC=8; KX=5; KZ=3 that coincide with the 
numbers of Fibonacci which stay on the basement of so-named “Golden ratio” of 
Nature‟s structures, biological structures and economical systems. [3], [4], [5]. The 
studies of [3] apply the physical model of the “ideal gas” of the pharmaceutical stocks 
and this model is related to the marketing state in the conditions of hyper 
competition. The sold and reserve inventory of stocks is described by the equation of 
marketing state [3]: 
                                                     KNNP arttotp                                                     
(1)     
here pP  is the average price of one pharmaceutical product; totN - total amount of 
products of the inventory; 
artN - total amount of the names of articles; K - the value of 
econophysical temperature and for the full big ensemble of stocks this value is 
65,5K which is calculated on the base of KA=21; KB=13; KC=8; KX=5; KZ=3 by the 
consideration of the peculiarities of ABC analysis and this value 65,5K  is a 
worldwide constant that is independent on national currencies [3]. The value 65.5K  
is such a constant that describes the equilibrium of the system, stability and harmony 
by statistical point of view of big ensemble of constituent components of the system. 
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This equation of the marketing state (2) has a best analogy with the equation of 
Mendeleev – Clapeyron of the state of ideal gas and this equation has a profound 
deep meaning and could stay to the basis of analyzes of the administered doses of 
the drugs. 
Econophysics operates with economical and social structures that carry out activity 
and this activity is described specifically by this equation of state of “ideal gas” [3]. 
Referring to biological structures such as the human being and the drug 
administration, then this equation can be prescribed as:                         
 NPNK mart                                          (2)  
where N is the total amount of administrated drug‟s molecules; 
mP  is the average 
price of one molecule; 
artN is the amount of various types of drug‟s articles 
approximately administrated at the same moment of time; 65.5K .  The case when 
one article is administrated then 1artN . This equation (2) could be stated as the 
equation of pharmaceutical bioeconophysical state of Human being. 
As a result of administration of doses a series of biochemical processes between 
molecules of the drug and receptors take place. According to the thermodynamical 
laws of the conservation of energy a work is performed. This work is the emitted 
energy as the result of chemical reactions between receptors and drug‟s molecules. 
The first law of thermodynamics is known as such formulation: It is impossible to 
have a thermal machine in the first kind, the unique result of which is the production 
of work without the consumption of energy from external environment [3]. 
Transposed to bioeconophysics this formulation has such explanation: The human 
being will not resist statistically for a long time basing only on the proper internal 
energy. Finally the internal energy will be consumed and new energy as the form of 
food or drugs (if it is necessary drugs) is necessary to maintain the equilibrium. The 
first law of thermodynamics quantitatively is written as: 
                                                             AQU                                                     (3) 
The variation of the internal energy of the system U is the result of the heat 
Q transmitted to the system and the work A done by the system. The drug and 
receptor interaction occurs at approximately constant temperature and the process 
can be considered isothermal process. The respective work A/ that is within the limits 
of activation energies of receptors by the creation of complexes of ligands with 
receptors is considered as the performed work upon the system at isothermal 
process is calculated as: 
2ln
2/1
2/1
/   art
N
N
art
N
N
NK
N
dN
NKdNPAA                            (4) 
here 
2/1N is the amount of molecules corresponding to the moment of half-life time. A 
biological half-life or elimination half-life is the time it takes for a substance (drug, 
radioactive nuclide, or other) to lose one-half from initial amount of molecules of its 
pharmacologic, physiologic, or radiological activity. In a medical context, the half-life 
may also describe the time that it takes for the concentration of a substance in blood 
plasma to reach one-half of its steady-state value (the "plasma half-life").[6] 
The formula of half-life time of elimination [7] is:           

2ln
2/1 T                             (5) 
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Here  is drug‟s elimination rate constant. 
Substituting (5) into (4), then:    2/1
/ TNKA art                                                       
(6) 
On the other hand the value /A represents the total energy of all receptors. The total 
amount of all receptors on cell‟s surface is 
rectot
N  and the energy of one receptor is 
recE  , then the total energy is rectotrec NEA 
/
and substituting in (6) will give: 
                             2/1TNKNE arttotrec rec                                           (7) 
Substituting (2) into (7) will give:  2/1TNPNE mtotrec rec                           (8) 
Finally, the price of one molecule is: 
2ln


N
NE
P rec
totrec
m                                        
(9) 
The total amount N of administrated molecules can be expressed by the amount of 
moles   
                         
M
m
N
N form
A
                                              (10) 
here formm  is the mass of one tablet, or one capsule, etc.; M – the molar mass; NA – 
number of Avogadro. Then:                                   A
form
N
M
m
N                                                 
(11) 
Substituting (11) into (9) will give: 
2ln


Aform
totrec
m
Nm
MNE
P rec                                (12) 
The respective expression for the price of one mole 
Ammole NPP   
                                  
2ln


form
totrec
mole
m
MNE
P rec                                      (13) 
The expression (13) shows that if the molar mass is increased then the price of one 
mole is increased at the constant value of constm form  and respectively for M=const 
the price of one mole is decreased if the mass formm is increased. The aim is how to 
know or to find the values of 
recE  and rectotN . Exact values for each parameter 
recE  and rectotN will not be found, but the factor rectotrec NE   is found by the 
dependence of  

















)2ln(
lnln
form
mole
m
M
fP  that is a linear dependence. So: 
 









)2ln(
lnlnln
form
mole
m
M
BP                                   (14) 
here 
rectotrec
NEB  . 
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Results: 
The following table it is necessary to fill in the data as follows: 
 
The graphic of the price of one molecule as a function of amount of molecules in one 
drug‟s form is represented in Fig. 1, a . The same similar dependence is for the price 
of one mole as a function of amount of moles (Fig. 1, b). 
These dependences of Fig. 1 as if imitating the microeconomic dependencies of 
demand, the lower prices the demand is bigger and vice versa. 
 
 
 
Fig. 1 The dependence of the price of one molecule as a function of amount of 
molecules in one drug‟s form (a) and similar for moles (b) 
 
The main aim is to check the expression (14). The respective graphic of the 
expression (14) is presented on Fig. 2. The value of 
078.05452.2ln 5452.2  eBB  
So: 078.0
rectotrec
NEB  
If the total amount of receptors is of order 2520 1010  then the energy of activation of 
one receptor is of such order: )(1082.121082.12
2520 jouleE rec
  . 
The respective value of energy for one mole of receptors is: 
)(77)(1092.761002.61082.121002.6 3232023 kJJouleEE recmole 

that is of 
order of data presented in [8]. 
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Fig. 2 The dependence of  



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

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So, the expression (13) will be written simply as:    
formformform
totrec
mole
m
M
m
M
m
MNE
P rec







1132.0
2ln
078.0
2ln
                                   (15) 
The expression (15) could be written also by the coefficient B0(t) that in general 
depends in time because of the evolution of prices each five-seven years. 
       
form
mole
m
MtB
P


)(0 ;   1132.0)2019( oB                       (16) 
For example, metamizole natrium with molar mass 333.34 gr/mole and the tablets 
with 500 mg, then: 
 
If the aim is to estimate the cost of one gram, then the expression (16) will be divided 
by the molar mass M, and: 
form
gr
m
tB
P
)(0 . 
For this example of metamizol natrium the calculation of the price of one gram gives: 
)(22.0
5.0
1132.0)(0 BGN
m
tB
P
form
gr  . 
Another example, cetirizine dihydrochloride of the tablets Zyrtec 10 mg with the molar 
mass 388 gr/mole and the tablets with 10 mg, then:
 )(16.4392
01.0
3881132.01132.0
BGN
m
M
P
form
mole 



  
The respective cost of one gram of cetirizine dihydrochloride 
)(46.75
5.0
34.3331132.01132.0
BGN
m
M
P
form
mole 




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)(32.11
01.0
1132.01132.0
BGN
m
P
form
gr   
Conclusions: This young bioeconophysical science puts forward cardinal tasks of 
in-depth study with the integration of different separate scientific fields. It seeks ways 
to explain the role of man in the complex social and economic system as well as not 
only internal but also external factors that influence the state of human health. The 
pharmacokinetics and pharmacodynamics of the administered doses have an 
integration initiation in this new scientific system, which gives an appreciation not 
only for drug interaction with the respective receptors, but also for a way of 
estimating the cost and what is the possible duration of time of prophylaxis and 
treatment could be. It is a possibility to operate with the energy, energy of activation 
of the receptors of cell‟s membranes and to include into the quantitative laws of 
description. Money also is the form of energy in econophysics and somehow i t is 
related to the processes with production of pure physical energy. The alive systems 
step by step are described not only by biophysical methods but also by 
bioeconophysical ones operating with the first law of thermodynamics that in this  
paper the quantitative expression of first law of thermodynamics for human being 
somehow includes parameters as half – life time, energy  of activation of receptors, 
prices of molecules, etc. Usually, the modern tendency of econophysics is to 
incorporate in one quantitative expression a lot of parameters from various parts of 
researched methods that have some logical interconnection. 
Like any other science that always undergoes transformation during history, 
bioeconophysics remains as an open way of discussion and performance of 
suggested models. 
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INFLUENCE OF PHARMACEUTICAL CARE AND PROFESSIONAL 
PHARMACISTS’ CONSULTATION OF THE PATIENT  
Kachulev K.1, Simova T.2, Enchev D.3 
1Faculty of Public Health at Sofia Medical University 
2TSC Directorate, Bulgarian Drug Agency 
3Faculty of Public Health, Medical University, Sofia 
 
Aim of the study: To investigate and evaluate the influence of the pharmaceutical 
care and the professional pharmacist‟s consultation on the patient. Patients‟ and 
pharmacists‟ interviews with subsequent comparison of the results. 
Materials and methods: 
Patient poll: 
From 10.2016 until 01.2017 a cross-sectional study of patients was conducted 
through a survey (609 questionnaires). 
A qualitative criterion for selecting respondents in the study is to meet the definition 
of a patient or to use prescription or OTCs purchased in the pharmacy. 
Pharmacists‟ Survey: 
A cross-sectional study was conducted using a rapid data collection method - 15 
days across the country through one of the drug distributors in Bulgaria. 
Results: The largest percentage of patients (42%) reported that their pharmacists 
spent between 3 and 6 minutes for counseling. 75% of patients said they had access 
to pharmacist‟s care. 72.41% (441 out of 609) from the respondents have access to a 
pharmacy and access to pharmaceutical care. 
The pharmacists can spend an average of 8.32 minutes for the patient's 
pharmaceutical care. More than half of the pharmacists say that doctors send their 
patients to their pharmacies for pharmaceutical advice and care, which is a good 
trend. 
Conclusion: There is a difference between the concept of pharmaceutical care and 
the routine work of the pharmacists, but the time and the attention that pharmacists 
spend on the patients' problems is a good start for the introduction of the concept into 
practice. However, the time that the pharmacists can spend, at this stage, is 
extremely inadequate. 
For correspondence: Konstantin Kachulev, +359 878 287 705,  
e-mail: kkachulev@gmail.com 
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PILOT STUDY OF THE ATTITUDES OF MASTER PHARMACISTS 
AND PATIENTS TO THE APPLICATION OF PHARMACEUTICAL 
CARE IN REAL PHARMACEUTICAL PRACTICE 
Georgiev S., Asipova N., Lazarova G., Kadiev A., Andreevska K., Hristov E. 
Faculty of Chemistry and Pharmacy, 
 "Sveti Kliment Ohridski" Sofia University, Bulgaria 
 
Purpose: In Bulgaria, pharmaceutical care is not regulated by legislation as part of 
the pharmaceutical profession, but it is included in pharmacy curricula. The primary 
objective is to evaluate patients 'and pharmacists' attitudes about the need for 
pharmaceutical care. Secondary aims are to assess the level of knowledge of 
pharmaceutical care and their practical relevance. 
Materials and methods: Pilot survey conducted among master pharmacists and 
patients in Bulgaria. We developed a questionnaire containing 16 questions in 
different directions - defining the term pharmaceutical care, target patient groups, 
disease groups, specific pharmaceutical activities. We processed the results with 
descriptive statistical methods. 
Results: discussion and conclusion. The study included more than 300 respondents 
(pharmacists and patients) between 18 and 75 years old. Respondents are stratified 
by demographic indicators and availability of medical education. A share of 2/3 of the 
patient group considers that there is a need for pharmaceutical care, most often for 
patients with chronic illness, cardiovascular disease, endocrine disorder (diabetes), 
respiratory disease, patients in elderly and others. There is a predominant view that 
patients should not pay for the care they receive from pharmacists, although about 
60% of respondents say that receiving pharmaceutical care determines which 
pharmacy they visit. Approximately 30% of the surveyed leading factor remains the 
price of medicines. Some of the pharmacists surveyed are restrictive to the provision 
of additional services if there is no adequate funding from the state or the NHIF. 
 
 
THE HIGH TECH IN STRESS MONITORING AND MANAGEMENT 
Manasiev E., Grigorov E., Kochev S. 
NCPHA, Medical University, Varna 
 
This study aims to find the possibility to include the high tech in the measurement of 
the stress level. The general assumption is that the stress is more like negative 
issue, which blocked, lead to discomfort and the various pathological diseases. It 
may be concluded that more of activities are related with the programs for stress 
reduction and in general it avoidance. On the other hand some new studies show 
that the stress is the single solution for the enhancement. In this topic the studies are 
mainly related with the subject which is visible easy to be measured like music, 
sports, some form of arts. There was just few or nothing related with the working 
daily routine. 
In our study we made research in the current practice in stress measurement and 
was looking for different solutions where the high tech was included. Along with the 
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standardized tests for stress measurement we researched some more high tech 
method including biofeedback sensors for body temperature, heart rate, heart rate 
variability, electromagnetism of the different body parts, blood and monitoring of 
hormones like cortisol and adrenalin. 
We also tested with biofeedback wrist bands a team of professional athletes where 
we were able to provide feedback when the optimal stress level is achieved and to 
able to manage it. 
Regarding the research and the experiments we came  to conclusion that there is a 
way for the broad study to be made with the topic how we can managed and control 
the level of stress with the new high technology and machine learning for some 
activities. 
 
 
PREPARATION OF COMPLEX CHITOSAN-ALGINATE 
NANOPARTICLES LOADED WITH EXTRACT FROM ASTRAGALUS 
GLYCYPHYLLOS AND INVESTIGATION OF ANTITUMOR EFFECT 
ON GRAFFI TUMOR-BEARING HAMSTERS 
Georgieva D.1, Kostova B.1, Krasteva I.2, Shkondrov A.2, Georgieva A.3, 
Toshkova R.3 
11Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of 
Pharmacy, Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Department of Pharmacognosy, Faculty of Pharmacy, 
 Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
3Bulgaria Institute of Experimental Morphology, Pathology and Anthropology with 
Museum, Bulgarian Academy of Sciences, 25 “Acad. G. Bonchev” Str., 1113 Sofia, 
Bulgaria 
*Dilyana Georgieva: diljana1977@abv.bg, phone number 02 9236 571 
 
Aim of study: The aim of the present study was to obtain complex chitosan-alginate 
nanoparticles (NP) loaded with defatted extract from Astragalus glycyphylos L. and to 
assess their antitumor effect on Graffi tumor-bearing hamsters. 
Materials and methods: NP were prepared by adding the extract into a chitosan 
solution in 1% acetic acid under mechanical stirring for 24 hours, after that adding 
dropwise Tripolyphosphate pentasodium (TPP) solution. A solution of sodium 
alginate was used to coat the chitosan NP with alginate. The samples were left at 
room temperature for 24 h until complete formation of the NP. In order to 
demonstrate the antitumor effect several biometric markers were studied, such as 
transplantability (%), survival rates (%), mean survival time, mortality (%), and tumor 
size (mm). 
Results: Extract-loaded NP were obtained by a previously developed method. 
Conducted in vivo experiments showed antitumor activity. Lower mortality and 
prolonged mean survival time were observed. Reduction of the rate of growth as well 
as the size of the tumors was established. 
Conclusions: NP with A. glycyphylos were prepared and their antitumor potential 
tested. The applied experimental therapy with the complex chitosan-alginate NP 
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showed protective effect expressed in delayed tumor growth and prolonged mean 
survival time. This is a basis for further research on improving the obtained systems. 
 
 
ESTIMATION OF MOLECULAR PROPERTIES OF 
DIHYDROXYBENZALDEHYDE BASED HYDRAZONES 
Nikolova-Mladenova B.1*, Ivanov D.1 
1Department of Chemistry, Faculty of Pharmacy, Medical University, 2 “Dunav” str., 
1000 Sofia, Bulgaria 
*e-mail: boriananik@abv.bg 
 
Hydrazones of the type R'-CH=N-NH-CO-R obtained by the condensation of aromatic 
aldehydes and various hydrazides display a broad range of pharmacological 
properties  
The aim of the study: The current study reports in silico evaluation of molecular 
parameters and biological activity of 2,3-dihydroxy-, 2,4-dihydroxy- and 2,5-
dihydroxybenzlaldehyde based hydrazones. The important molecular properties were 
calculated to reveal how the presence and positions of two OH-groups affect the 
lipophilicity of the compounds. 
Materials and methods: The hydrazones were designed by inserting of two OH-
groups at different positions in aldehyde moiety and various hydrazide moieties. The 
molecular properties of the compounds, important for drug pharmacokinetics in the 
human body, were assessed by method based on group contribution. The 
appropriate molecular parameters include molecular weight, lipophilicity, hydrogen 
bond donors/acceptors, solubility and other related properties. 
Results: All dihydroxy-substituted hydrazones are small flexible molecules with 
balanced lipophilicity which suppose good permeability of the compounds over the 
cellular plasma membranes. 
Conclusion: The obtained results revealed that all compounds are potential 
candidates for future drug discovery study. 
Acknowledgements: Thanks are due to Medical Science National Fund at the 
Medical University – Sofia (Grant D-83/23.04.2019) for the financial support. 
 
 
SYNTHESIS AND CYTOTOXIC ACTIVITY OF DIHYDROXY-
SUBSTITUTED HYDRAZONES 
Nikolova-Mladenova B.1*, Momekov G. 2 
1Department of Chemistry, Faculty of Pharmacy,  
Medical University, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University, 2 “Dunav” str., 1000 Sofia, Bulgaria 
*e-mail: boriananik@abv.bg 
 
Aroylhydrazones obtained by condensation of aromatic aldehydes and hydrazides 
show diverse biological activities including a high anticancer activity. Numerous 
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hydrazones with different substituents have been synthesized in order to discover 
new active compounds. 
The aim of the study: The study reports synthesis, spectral characterization and 
pharmacological investigations of 2,3-dihydroxy-, 2,4-dihydroxy- and 2,5-dihydroxy-
benzlaldehyde based hydrazones. 
Materials and methods: The hydrazones were prepared by the condensation 
between 2,3-dihydroxy-, 2,4-dihydroxy- and 2,5-dihydroxybenzlaldehyde and 
different hydrazides in ethanol. The compounds were characterized by elemental and 
thermo-gravimetric analysis, IR, NMR and mass spectroscopy. The cytotoxic activity 
was assessed using the MTT-dye reduction assay on leukemic and cancer human 
cell lines. 
Results: The molecular formulas of the hydrazones were determined on the basis of 
the elemental, thermo-gravimetric and mass analyses. The IR, 1H-NMR and 13C-
NMR spectral data confirmed the structures and proved the formation of hydrazone 
bond. The bioassay results demonstrated that the compounds exhibit concentration-
dependent cytotoxic effects at low micro molar concentrations. The obtained IC50 
values were lower than these of the referent cytotoxic drug melphalan. 
Conclusion: The results revealed that compounds are potential candidates for future 
drug discovery study. 
Acknowledgements: Thanks are due to Medical Science National Fund at the 
Medical University – Sofia (Grant D-83/23.04.2019) for the financial support. 
 
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC 
DETERMINATION OF TINIDAZOLE AND SOME PROTON PUMP 
INHIBITOR 
Smerikarova M.1, Bozhanov S.1, Maslarska V.1 
1Faculty of Pharmacy, Department of Chemistry, Medical University, Sofia 
 
Aim of the study: A reversed phase high performance liquid chromatographic 
method was developed and validated for the determination of Tinidazole, 
Esomeprazole and Lansoprasole in synthetic mixture. 
Materials and methods: Separation was achieved on a C18 column (LiChrospher® 
(250 x 4 mm, 5 μm)). Isocratic elution is carried out at a flow rate of 1.0 ml/min at 
ambient temperature. Mobile phase containing Acetonitrile: Phosphate buffer 
(pH=7.6±0.1) (40:60 v/v) was used. Ultraviolet detection was performed at 280 nm. 
Results: The retention times of Tinidazole, Esomeprazole and Lansoprasole were 
found to be 5.36, 11.73 and 17.69 min, respectively. The method was validated for 
analytical parameters specificity, linearity, precision, and accuracy, limit of detection 
and limit of quantitation. The response was linear and R2 was 0.9995 for both 
Tinidazole and Esomeprazole and 0.9994 for Lansoprazole. The concentration 
ranges were selected according to the prescribed doses of each drug and were 12.5 
- 100 μg/ml, 5.0 – 40.0 μg/ml and 7.5 – 60.0 μg/ml for Tinidazole, Esomeprazole and 
Lansoprazole respectively. The relative standard deviation was found to be not 
greater than 2 %. 
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Conclusion: The results of the studies showed that the proposed chromatographic 
method is simple, rapid, precise and accurate, which can be applied for the routine 
analysis of Tinidazole and proton pump inhibitors - Esomeprazole and Lansoprazole 
in quality control practice. 
 
 
MULTYFUNCTIONAL POLYMER NANOCARRIERS FOR EFFICIENT 
MITOCHONDRIA-TARGETING 
Momekova D.1, Babikova D.2, Ugrinova I.3, Momekov G.4, Dimitrov I.2 
1Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of 
Pharmacy, Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Institute of Polymers, Bulgarian Academy of Sciences, 103A  
“Akad. G. Bonchev” str., 1113 Sofia, Bulgaria 
3Institute of Molecular Biology, “Acad. Roumen Tsanev”,  
Bulgarian Academy of Sciences, 21 “Akad. G. Bonchev” str., 1113 Sofia, Bulgaria 
4Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University, Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
 
Aim: Over the past decade, subcellular drug targeting of biologically active 
molecules to and into cell organelles, has gained significant interest and is referred to 
as a “new frontier” or “third level” of drug targeting. The aim of the present study is 
the design and preparation of a novel mitochondria targeted multyfunctional polymer 
nanocarriers with a biodegradable hydrophobic core, a polycationic middle layer 
possessing the buffering capacity needed for the nanovehicle‟s endosomal escape, 
modified with pendant subcellular targeting ligands, and PEG outer shell, detachable 
in slightly acidic conditions, bearing cell targeting ligands. 
Material and methods: Amphiphilic poly(D,L-lactide)-b-poly(N,N-dimethylaminoethyl 
methacrylate)-b-poly(Ethylene oxyde)(PLA-b-PDMAEMA-b-PEO-TPP+) block 
copolymers ; curcumin;  acute myeloid leukemia HL-60,  multidrug-resistant subline 
HL-60/DOX and  human urinary bladder EJ carcinoma cells; NMR; GPC; DLS; TEM; 
MTT assay;  apoptosys assay, NF-κB (p65) inhibition assay, Fluorescent microscopy. 
Results: The block copolymer self-associated into multifunctional nanosized 
particles with an average diameter of 46 nm, which were successfully loaded with the 
hydrophobic natural anticancer drug curcumin. The multifunctional nanocarrier 
exhibited superior ability to trigger programmed cell death and more pronounced NF-
κBinhibitory effects on the chemosensitive cell line HL-60 and its drug-resistant 
variants as compared to the free drug, and more importantly as compared to a non-
functionalized nanocarrier of similar composition. Furthermore, the cellular 
internalization and targeted subcellular delivery to mitochondriaof multi - and non-
functionalized nanocarriers were visualized, revealing the clear advantage of the 
former. 
Conclusion: The results obtained are promising for further investigation of the 
multifunctional micelles as nanocarriers for enhanced subcellular targeted drug 
delivery. 
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ANTINEOPLASTIC ACTIVITY OF SAPONINS FROM TWO 
BULGARIAN ASTRAGALUS SPECIES 
Krasteva I.1, Shkondrov A.1, Mihaylova R.2, Konstantinov S.2 
1Department of Pharmacognosy, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
2Laboratory of Experimental Chemotherapy, Department of Pharmacology, 
Pharmacotherapy and Toxicology, Faculty of Pharmacy,  
Medical University, Sofia, Bulgaria 
 
Aim of the study: Astragalus glycyphyllos L. (Liquorice Milk-Vetch) is used in 
Bulgarian folk medicine as an antihypertensive, diuretic, anti-inflammatory, etc. 
Phytochemical investigation of the plant led to the isolation of six partially identified 
saponins, askenoside C and F, epoxycycloartane saponin lactone. A. glycyphylloides 
DC. (Pseudo Liquorice Milk-vetch) is morphologically similar to A. glycyphyllos. One 
oleanane-based saponin was isolated from the aerial parts recently were reported as 
well. The aim was to estimate the antineoplastic effects of purified saponins‟ 
mixtures, obtained from the two species on a panel of malignant cells of human origin 
(cutaneous T-cell lymphoma, myeloid and lymphoid leukaemia and urinary bladder 
cancer). 
Materials and methods: Saponins mixtures were obtained from n-butanolic extracts 
of A. glycyphyllos and A. glycyphylloides by chromatographic techniques and the 
content of the main saponins was evaluated by LC-MS. Various human malignant 
cell lines were used and their viability was assessed using MTT test. 
Results: Results showed that saponin fractions from both species possessed 
concentration dependent antitumor efficacy and could be regarded as sources of 
pharmacologically active compounds according to the estimated IC50 values 
(between 15.5 and 440 µg/ml). Interestingly some saponins‟ mixtures showed higher 
activity in MDR1 and BCR-ABL expressing tumour cells, which are expected to be 
less sensitive and are even resistant towards classical cytostatics. 
Conclusion: Taken together our experimental data indicate that Astragalus plants 
are valuable sources of antineoplastic saponins which need further detailed 
pharmacological evaluation. 
Acknowledgement Financial support from Ministry of Education and Science, 
program № DO1-217/30.11.2018 is gratefully acknowledged. 
 
 
STABILIZATION OF DOXORUBICIN BY ENCAPSULATION IN 
CHITOSAN-ALGINATE NANOPARTICLES 
Yoncheva K.1, Tzankov B.1, Spassova I.2, Kovacheva D.2 
1Department of Pharmaceutical Technology and Biopharmaceutics,  
Faculty of Pharmacy, Medical University, 1000 Sofia, Bulgaria 
2Institute of General and Inorganic Chemistry, Bulgarian Academy of Sciences 
 
Aim of the study: Doxorubicin is an anthracycline antibiotic, possessing a broad-
spectrum of anticancer activity, including breast, ovarian, lung, bladder cancer etc. 
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However, its photodegradation is a challenge for pharmaceutical technology. 
Encapsulation of doxorubicin in nanoparticles could represent a useful approach for 
preventing its photodegradation. The present study is dedicated on the encapsulation 
of doxorubicin in chitosan-alginate nanoparticles and its impact on the stability of the 
drug. 
Materials and methods: Doxorubicin was loaded in chitosan-alginate nanoparticles 
by ionic gelation method. The size, dispersity and zeta-potential of the resulted drug 
loaded nanoparticles were examined by photon correlation spectroscopy and 
electrophoretic laser doppler velocimetry. Scanning electron microscopy, 
thermogravimetric and X-ray analyses were also applied for the characterization of 
doxorubicin loaded nanoparticles. 
Results: The drug loaded chitosan-alginate nanoparticles possessed mean diameter 
around 300 nm and negative zeta-potential. The scanning electron microscopy 
revealed a spherical shape of the nanoparticles. The encapsulation of doxorubicin 
prevented the degradation of the drug under light exposure. 
Conclusion: Chitosan-alginate nanoparticles are considered to be an appropriate 
carrier for doxorubicin delivery providing efficient protection and stability of the drug 
against photodegradation. 
 
 
3'-METHYL-4-THIO-1H-TETRAHYDROPYRANSPIRO-5'-HYDANTOIN 
AND ITS Pt(IV) AND Pd(IV) COMPLEXES AS NOVEL POTENT 
XANTHINE OXIDASE INHIBITORS 
Cherneva E.1, Tomović K.2, Šmelcerović Ž.3, Šmelcerović A.4, Buykliev R.1, 
Bakalova A.1 
1Department of Chemistry, Faculty of Pharmacy,  
Medical University of Sofia, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Department of Pharmacy, Faculty of Medicine,  
University of Niš, 81 “Dr. Zorana Đinđića” blv., 18000 Niš, Serbia 
3Center for Biomedicinal Science, Faculty of Medicine,  
University of Niš, 81 “Dr. Zorana Đinđića” blv., 18000 Niš, Serbia 
4Department of Chemistry, Faculty of Medicine,  
University of Niš, 81 “Dr. Zorana Đinđića” blv., 18000 Niš, Serbia 
 
The aim of the study: Xanthine oxidase (XO) is a versatile molybdoflavoprotein, 
involved in the metabolism of purines, catalyzing the oxidative hydroxylation of 
hypoxanthine to xanthine, and xanthine to uric acid, with generation of reactive 
oxygen species. Not only uric acid produced by XO catalysis, but also free radicals 
are responsible for pathological consequences of XO overactivity. Allopurinol, potent 
competitive XO inhibitor, has widely been used in the therapy of gout, with latter 
approved febuxostat and topiroxostat. There are efforts towards the discovery of new 
XO inhibitors. 
In this study, 3'-methyl-4-thio-1H-tetrahydropyranspiro-5'-hydantoin (1) and its Pt(IV) 
and Pd(IV) complexes (Fig. 1) were evaluated for inhibitory activity against XO in 
vitro. 
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Figure 1. Structures of the assayed compounds 
 
Materials and methods: The synthesis of 3'-methyl-4-thio-1H-tetrahydropyranspiro-
5'-hydantoin and its Pd(IV) complex was performed as described in the previous 
study. In vitro evaluation of the inhibitory potential of 3'-methyl-4-thio-1H-
tetrahydropyranspiro-5'-hydantoin and its Pt(IV) and Pd(IV) complexes (1-3) on 
bovine milk XO was based on spectrophotometric measurement of uric acid 
formation at 293 nm, using allopurinol as positive control. 
Results: 3'-methyl-4-thio-1H-tetrahydropyranspiro-5'-hydantoin (1) and its Pd(IV) 
complex (3) did not show significant inhibitory activity on XO in vitro at concentrations 
below 150 μM, while its Pt(IV) complex (2) inhibited the enzyme with IC50 value 19.33 
± 5.80 μM. IC50 value of allopurinol was 1.70 ± 0.51 μM. 
Conclusion: 3'-methyl-4-thio-1H-tetrahydropyranspiro-5'-hydantoin Pt(IV) complex 
was shown as potent inhibitor of XO in vitro. This complex with some structural 
freshness in comparison to standard and reported XO inhibitors represents a 
candidate for further evaluation. 
Acknowledgments: The financial support of this work by Medical Science Fund at 
the Medical University, Sofia (Grant №84/23.04.2019), Science Fund/Chemical 
Technology and Metallurgy University (Grant 11523), Ministry of Education, Science 
and Technological Development of the Republic of Serbia (Grants No. OI 172044) 
and Faculty of Medicine of the University of Niš (Internal project No. 4) is gratefully 
acknowledged. 
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XANTHINE OXIDASE INHIBITORY ACTIVITY OF 
THIOCYCLOHEXANESPIRO-5'-HYDANTOIN AND 3'-
AMINOTHIOCYCLOHEXANESPIRO-5'-HYDANTOIN AND THEIR Pt(II) 
COMPLEXES 
Cherneva E.1, Šmelcerović Ž.2, Tomović K.3, Šmelcerović A.4, Buykliev R.1, 
Bakalova A.1 
1Department of Chemistry, Faculty of Pharmacy,  
Medical University, 2 “Dunav” str., 1000 Sofia, Bulgaria 
2Center for Biomedicinal Science,  
Faculty of Medicine, University of Niš, 81 “Dr. Zorana Đinđića” blv., 18000 Niš, Serbia 
3Department of Pharmacy, Faculty of Medicine,  
University of Niš, 81 “Dr Zorana Đinđića” blv., 18000 Niš, Serbia 
4Department of Chemistry, Faculty of Medicine,  
University of Niš, 81 “Dr Zorana Đinđića” blv., 18000 Niš, Serbia 
 
The aim of the study: Xanthine oxidase (XO), a metalloflavoprotein enzyme, 
catalyzes hydroxylation of hypoxanthine and xanthine to uric acid in purine 
catabolism producing reactive oxygen species, what leads to hyperuricemia and 
oxidative damage of the tissues where overactivity of XO is present. Allopurinol, 
purine-based XO inhibitor, has widely been used in gout treatment. Additionally, 
representatives of non-purine inhibitors, febuxostat and topiroxostat, have been 
approved. There is a need for new non-purine XO inhibitors. In this study, 
thiocyclohexanespiro-5'-hydantoin (1), 3'-aminothiocyclohexanespiro-5'-hydantoin (2) 
and their Pt(II) complexes(3 and 4) (Figure 1) were evaluated for inhibitory activity 
against XO in vitro. 
 
Figure 1. Chemical formulas of the studied compounds 
 
Materials and methods: The synthesis of compounds 1-3 was performed as 
described in the previous studies. Bovine milk XO was used for in vitro inhibition test 
based on the spectrophotometric determination of uric acid formation at 293 nm. 
Allopurinol was used as a positive control. 
Results: In comparison to ligands (1 and 2) which did not show significant inhibitory 
activity at concentrations below 150 μM, their Pt(II) complexes (3 and 4) inhibited XO 
acitivity in vitro with IC50 values 110.33 ± 26.38 μM and 115.45 ± 42.43 μM, 
respectively. IC50 value of allopurinol was 1.70 ± 0.51 μM. 
Conclusion: Thiocyclohexanespiro-5'-hydantoin and 3'-aminothiocyclohexanespiro-
5'-hydantoin Pt(II) complexes might offer a starting point for optimization of new XO 
inhibitors structurally different from reported inhibitors so far. 
Acknowledgments: 
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PREPARATION OF 5-METHYL-5-(4-PYRIDYLMETHYL) HYDANTOIN 
Buyukliev R.1, Burdjiev N.2 
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Pharmacy, Sofia University, 1 „James Bourchier“ blv., 1164 Sofia, Bulgaria 
 
Aim: The aim of the study. It is known from literature that the 5,5-disubstituted 
hydantoins have anti-convulsive, antipyretic, antibacterial properties. The metal 
complexes of these hydantoins with platinum and palladium have anti-tumor 
properties, with some activity being close to that of the cisplatin drug. In previous 
studies, we have investigated platinum and palladium complexes with various 
substituted 5-methyl-5- (4-pyridyl) hydantoin derivatives. To complete the series with 
pyridine hydantoins, we also wanted to synthesize 5-methyl-5- (4-pyridylmethyl) 
hydantoin. 
Materials and methods: It has been found, however, that the synthesis of the 
necessary ketone-methyl-4-pyridylmethyl ketone does not proceed as described in 
the literature, therefore we have applied new approaches to the synthesis of this 
compound. They proved to be successful. 
Results: Based on the newly synthesized ketone, the desired product 5-methyl-5- (4-
pyridylmethyl) hydantoin was successfully obtained. The reaction time for optimal 
yields of the products was determined. Structures of newly synthesized compounds 
were confirmed by elemental analysis, IR, 1H and 13C NMR spectra. 
Conclusion: The study of newly synthesized compounds for antitumor activity is 
forthcoming. New platinum and palladium complexes are also underway, with DFT 
calculations for their stability as well as their pharmacological test for anti -tumor 
activity. 
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POSITIVE IMPACT OF THE NOVEL MELATONINERGIC DRUG 
PIROMELATINE ON ANXIETY IN EXPERIMENTAL MODEL OF 
PRENATAL STRESS 
Ivanova N., Nenchovska Z., Kortenska L., Mitreva R., Stoyanova T., 
Tchekalarova J. 
Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria 
 
Aim of the study: The unstable emotional status of a pregnant mother is a risk 
factor for the developing psychiatric disorders in the offspring later in life. The aim of 
the current investigation is to explore the therapeutic effects of the melatoninergic 
compound Piromelatine on anxiety disturbances in offspring with a history of prenatal 
stress (PNS). 
Materials and methods: Different types of stressors were applied on pregnant 
mothers of Sprague Dawley rats, starting from the 7 th gestation day until the 21st day 
/birth/. Treatment and experimental studies were carried out on offspring male 
sexually mature rats of the prenatally stressed mothers. Chronic treatment with 
Piromelatine at a dose of 20 mg/kg, or vehicle for the matched controls, were applied 
intraperitoneally, for a period of 21 days. During the treatment period several 
behavioral tests were conducted to assess the anxiety-like behavior: Elevated plus 
maze (EPM), Open field (OF) and Light/Dark Test (LDT). 
Results: The prenatally stressed offspring showed decreased motor activity, less 
time spent in the aversive central zone and higher anxiety index compared to the 
controls in the OF and the EPM tests, which were corrected by Piromelatine 
treatment. The melatoninergic drug abolished the PNS decrease of the number of 
crossings and time spent into the light area, shown in the LDT. 
Conclusion: Current data support the fact that Piromelatine might affect positively 
the anxiety-like behavior in offspring caused by PNS. 
Acknowledgement: This research was supported by the National Science Fund, 
Bulgaria (grant No. DN KP- 06-Н21/10). 
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THE INVASIVE ALIEN SPECIES AMORPHA FRUTICOSA – A CHEAP 
SOURCE OF VALUABLE ESSENTIAL OILS 
Kozuharova E.1*, Benbassat N.1, Ionkova I. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University, Sofia 
 
The high tolerance of various habitat conditions and potent propagation ability of 
Amorpha fruticosa L. (Fabaceae) promote its aggressive invasive behaviour. The aim 
of this study is to evaluate 1) several populations of this plant by the potential yield of 
the fruit, 2) the approximate yield of the essential oils, and 3) composition of the 
essential oil. The potential yield of fruit is evaluated based on extrapolations of weight 
and number of fruits per infrutescence, number of infrutescences per plant and 
number of individuals per population. Steam extraction of the essential oil was 
performed and GS/MS analysis of the composition of the essential oil. 
Key words: essential oils, composition, yield 
Acknowledgements: This work has been carried out in the framework of the  Grant 
Д-79/23.04.2019, Project  8276/20.11.2019 CMS, MU-Sofia. 
 
 
CLINICAL PHARMACY- OCCURRENCE AND DEVELOPMENT 
Grekova D. 
Department of Pharmaceutical sciences, Faculty of Pharmacy, 
 Mesical University, Plovdiv 
 
Aim: To present and analyze historically the occurrence and development of clinical 
pharmacy. 
Materials and methods: It has been used documentary analysis and review of 
existing scientific literature. 
Results: Clinical pharmacy is defined as a service provide by pharmacists to ensure 
that patient's rational drug therapy is safe, appropriate and cost-effective. 
The main issues that stimulate the need for the introduction of clinical pharmacies 
are: 
- reduce the number of extemporal prescription prepared in the pharmacy; 
- a rapid and continuous increase in the number of pharmaceutical products 
produced by the pharmaceutical industry; 
- increasing the need for professional, competent and drug-independent 
pharmacovigilance, dosing, pharmacodynamics, pharmacoeconomic and 
pharmacoepidemiology, improving the patients` adherence with therapy and 
agreement the instructions given by the physician and pharmacist; 
- growth in drug-induced disease and mortality. 
The term "clinical pharmacy" has its roots in US-practiced hospital pharmacy in the 
early 1960s. In the United Kingdom, clinical pharmacy is developing similarly to 
practice in the United States and Australia. In many Asian countries like Japan, India, 
Singapore, Thailand and Malaysia, there is a great interest in clinical pharmacy for 
more active inclusion of pharmacists in the health care system. 
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Conclusion: Clinical pharmacy has its long history. The key to its future 
development will be patient demand for safe and effective drug therapy. There are 
opportunities for expanding the clinical services provided by pharmacists. Patient 
consultation is a major component of the practice of clinical pharmacists. 
 
 
STUDY ON THE ACUTE TOXICITY OF NEWLY SYNTHESIZED 
ISOQUINOLINE PRECURSOR 
Saracheva K.1, Dimitrova D.2, Nikolova S.3, Gledacheva V.4, Stefanova S.4, 
Krastev A.4 
1Department of Pharmacology and Drug Toxicology, Faculty of Pharmacy,  
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Aim of the study: The aim of this study is to determine the acute toxicity of a newly 
synthesized isoquinoline precursor 2-chloro-N-(1-(3,4-dimethoxyphenyl)propan-2-yl)-
2-phenylacetamide (NIQP) in mice. 
Materials and methods: Seven experimental groups of male ICR white mice were 
used.  All of the mice were treated per orally as following: first group (control) with 0.1 
mL/10g body weight dimethyl sulfoxide (DMSO), used as a solvent; second group 
with 500 mg/kg NIQP; third group with 1000 mg/kg NIQP; fourth group with 1500 
mg/kg NIQP; fifth group with 2000 mg/kg NIQP; the sixth one with 3000 mg/kg NIQP 
and the seventh group with 4000 mg/kg. The Lethal Dose, 50% (LD50) were defined 
by Chiendu et al., (2013) method. 
Results: No behavioral signs of acute toxicity and mortality were identified for the 
control group or the first four experimental groups (500, 1000, 1500, and 2000 mg/kg 
NIQP). Mice treated with a dose of 3000 mg/kg did not have any disturbances but 
after 24 hours, mortality was reported in two of them. Mortality wasn‟t observed in 
animal tests even in the highest dose used of 4000 mg/kg. Based on the results 
obtained by the method of Chiendu et al. (2013) we found that the LD50 of 2-chloro-
N-(1-(3,4-dimethoxyphenyl)propan-2-yl)-2-phenylacetamide was 3500 mg/kg. 
Conclusion: Compounds with LD50 of over 5000 mg/kg are with a high level of 
safety. The newly synthesized compound has higher LD50 and lower acute toxicity 
than the well-known in the practice isoquinoline Papaverine hydrochloride with LD50 
750 mg/kg. 
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MODERN TRENDS IN REFORMING THE PHARMACEUTICAL 
INDUSTRY 
Nedelcheva Y. 
Bulgarian Drug Agency 
 
The aim of the study: to present the new reality in which the pharmaceutical 
industry operates. The effects of the global financial crisis are shaping new 
challenges for reforming the pharmaceutical industry. 
Materials and Methods: The research covers the external environment factors and 
pharmaceutical industry reforms for the period 2008-2019. Modern methodologies 
have been used, endorsed in the international practice for analysis of the 
pharmaceutical industry. 
Results: Reforms in Bulgaria are similar to those in the international pharmaceutical 
industry. Leading factor for reforms are the effects of the global financial crisis and 
increased state involvement through regulatory policy in the pharmaceutical industry. 
Conclusion: The external environment is leading in reforming the pharmaceutical 
industry in Bulgaria. The wave of globalization and the effects of the global financial 
crisis have increased the role of regulatory policy. Finding a balance between 
effective and affordable medicines is giving way to growing social expectations from 
the pharmaceutical industry. Reforming is about adapting regulatory policy to the new 
reality. 
Keywords: Bulgaria, regulatory policy, new reality 
 
 
ACTIVITY-GUIDED IDENTIFICATION OF ANTICANCER LIGNANS IN 
JUNIPER EXTRACTS 
Nedialkov P.1, Ivanova D.2*, Tashev A.3, Kokanova-Nedialkova Z.1, Ilieva, Y.1, 
Angelov G.2, Richardson K.4, Dosmann M.4, Atanassova T.1 
1Department of Pharmacognosy, Faculty of Pharmacy, 
Medical University, Sofia 1000, Bulgaria 
2Institute of Chemical Engineering, 
Bulgarian Academy of Sciences, Sofia 1113, Bulgaria 
3Department of Dendrology, University of Forestry, Sofia 1756, Bulgaria 
4Arnold Arboretum, Harvard University, Boston 02130-3500, MA, USA 
*Corresponding author e-mail: dianadoc@abv.bg, mobile phone: +359 884 43 13 52 
 
Aim of the study: Podophyllotoxin (PPT) is a precursor for the synthesis of the 
drugs etoposide, etopophos, teniposide, used in the therapy of lung, breast, ovarian, 
testicular, stomach, bladder, pancreatic, brain cancer, leukemias etc. 
Sinopodophyllum hexandrum (Royle) T. S. Ying (Himalayan mayapple) and 
Podophyllum peltatum L. (American mayapple) are sources of PPT, however they 
are already endangered species because of their intensive exploitation. Thus, 
alternative sources of PPT are necessary. We aimed this study at a comprehensive 
identification of lignans in the extracts of more than 20 juniper representatives, 
back to 
contents 
 152 
 
originating from different continents of the world, as potential sources of anticancer 
compounds. 
Materials and methods: Junipers were delivered from the Arnold Arboretum, 
Harvard University, USA, and Bulgaria. MTT tests were performed on NB4, K-562, 
BV-173, T-24, HT-29 cells. Lignans were identified by ultra-high performance liquid 
chromatography, coupled to high-resolution mass spectrometry (UPLC-HRMS). 
Results: A plenty of lignans, such as podophyllotoxin, deoxypodophyllotoxin, beta-
peltatin, anhydropodorhizol, yatein, matairesinol etc. were found in various 
concentrations in the most efficient anticancer extracts of J. sabina var. balkanensis, 
J. virginiana, J. × media, J. scopulorum, J. communis and their cultivars, as it was 
determined by UPLC-HRMS. 
Conclusion: The identified anticancer junipers produce a plenty of lignans that set 
the pattern for their future exploitation as potential sources of compounds for the 
combination therapy of cancer. 
Acknowledgements: This research is financially supported under contract №37-
2016 with the Arnold Arboretum, Harvard University, and contract №DN 07/25 (2016) 
of the Bulgarian Fund for Scientific Research. 
 
 
BIOCOMPATIBILITY AND CYTOTOXICITY OF SILICA-BASED BONE 
SUBSTITUTE MATERIALS 
Dimova T. 
Departament of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University, 
Varna, 55 „Prof. Marin Drinov“ str., 9002 Varna, Bulgaria 
e-mail: biotan@abv.bg 
 
Objectives: The aim of the study is to evaluate the biocompatibility and cytotoxicity 
of bioactive glasses (BG) using the osteosarcoma cell line MG63. In this study,  was 
used BG in the system 70SiO2-25CaO-5P2O5 (BG0) with and without Ag2O for bone 
tissue regeneration. BGs have been created as fillers for the treatment of bone 
defects in dental practice. 
Materials and methods: BG in the SiO2-CaO-P2O5 and SiO2-CaO-P2O5-xAg2O 
system (x=1,2 and 4wt%) were synthesized from TEOS, CaO, H3PO4, AgNO3. Cell 
viability was measured by means of a 3-(4,5-dimethylthiazol-2yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. Absorption is measured at 590 and 630 
nm reference to ELISA-Reader. The statistical analysis of the results was carried out 
with an ANOVA test and Bonferoni procedure (p<0.05). The morphological 
alterations of the MG63 were observed directly by a phase contrast microscope. 
Results: The synthesized silicate-based materials contain carbonate bound 
hydroxyapatite type B, silver and wollastonite (BG3). The relatively high content of 4 
wt% Ag2O incorporated in the BG3 has an important effect in the improvement of the 
proteins for this type of materials. The results of this study indicate that BG0 has no 
toxic effects, whereas BG1, BG2 and BG3 cause minimal toxic effects. BG stimulate 
MG63 cells to differentiate into osteogenic media. 
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Conclusion: BG0 and BG containing silver have toxic effects on the cell line MG63. 
They cannot be used as biocompatible materials at concentrations higher than 
1μg/cm2. BG containing up to 1 μg/cm2 of Ag2O stimulate cellular mineralization and 
osteogenic differentiation of MG63 cells. 
 
 
IN VITRO TOXICITY EVALUATION OF H2S-DOX IN HUMAN 
HEPATOCARCINOMA HEPG2 CELLS 
Tzankova V.1, Yordanov Y.1, Aluani D., Saponara S.2 
1Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of 
Pharmacy, Medical University, 1000 Sofia, Bulgaria 
2Department of Life Sciences, University of Siena, Siena, Italy 
 
Aim: Doxorubicin (DOX) is a potent broad-spectrum antineoplastic antibiotic, isolated 
from Streptomyces species. It is widely used as a single agent or in combination with 
other anticancer drugs in treating of hematological cancers and solid tumors, 
lymphomas, and sarcomas. In attempt to overcome the frequent drug-related toxicity 
and multiple drug resistance (MDR), H2S-releasing doxorubicin derivative (H2S-
DOX) was obtained by combining DOX with appropriate H2S donor substructures1,2.  
Our special attention was focused on in vitro toxicity evaluation of  H2S-releasing 
doxorubicin derivative (H2S-DOX)  as potentially safe and target specific drug carrier. 
Methods:  The initial toxicological evaluation of the resulting compound was 
performed on human hepatocarcinoma HepG2 cells by incubating H2S-DOX (0.01-
50 μM) for 48 and 72 h. In vitro cytotoxicity evaluation was performed by LDH-
release and MTT-test assay; IC50 was also calculated. 
Results: Differently from DOX, most of the products were less toxic on HepG2 cells. 
Thus, the IC 50 of H2S-DOX calculated at 48 and 72 h incubation were 4.3 and 2.9 
μM, compared to 0.2 and 0.1 μM for DOX. 
Conclusion: The initiam in vitro hepatotoxicity screening of H2S-DOX on human 
hepatoma cells HepG2 shows better safety profile of newly synthetized   H2S-
releasing anthracycline compared to DOX, and opens the possibility for future 
detailed in vitro and in vivo pre-clinical assessments of this perspective compound. 
Acknowledgements: This publication is based upon work from Cost Action 
CA17104 (STRATAGEM), supported by COST (European Cooperation in Science 
and Technology). 
References: 
1Chegaev, Konstantin, et al. "H2S-donating doxorubicins may overcome 
cardiotoxicity and multidrug resistance." Journal of medicinal chemistry 59.10 (2016): 
4881-4889. 
2Buondonno, Ilaria, et al. "Endoplasmic reticulum-targeting doxorubicin: a new tool 
effective against doxorubicin-resistant osteosarcoma." Cellular and Molecular Life 
Sciences 76.3 (2019): 609-625. 
Corresponding author: Virginia Tzankova 
e-mail: virginia_tzankova@yahoo.com; tel: +359887930982 
 
back to 
contents 
 154 
 
MARKET LANDSCAPE AND SOME ASPECTS OF REAL WORLD 
EVIDENCE OF THE NON-PSYCHOACTIVE PHYTOCANNABINOIDS 
Kirilov B.1, Zhelyazkova M.1, Petkova-Georgieva Е.2 
1Bulgarian Drug Agency, Sofia, Bulgaria 
2Medical University, Plovdiv, Bulgaria 
 
Aim: Real world evidence has demonstrated the potential to validate the therapeutic 
value of pharmaceutical products and help customize product development in a more 
patient-centric manner. In our study we conducted a survey with experts in the area 
(academia, industry and other associations) to solicit their opinions on trends in the 
cannabinoid market of products received from industrial hemp of the Cannabis plant. 
Methods: We used the European Pharmacovigilance Issues Tracking Tool (EPITT) 
functionalities to communicate on the regulatory matters and government policies of 
the non-psychoactive cannabinoids. To add on, we closely monitored the databases 
of suspected adverse reactions, including national databases, EudraVigilance, the 
database of the WHO Programme for International Drug Monitoring (VigiBase), for 
such products. Our secondary sources include a detailed analysis of marketing 
strategies for cannabidiol as a dietary supplement and a poll assessing the current 
situation of the legal market of such products in Bulgaria. 
Results: We provide an analysis of the current status of the market of the medicinal 
products Sativex® (Nabiximols, containing THC and CBD1:1) and Epidiolex® 
(Cannabidiol) in relation to their approved and unapproved indications. A detailed 
publication analysis of close to 500 articles that have been published in the last five 
years, highlighted the key focus areas of ongoing real world evidence-based 
research activity in the pharmaceutical and life sciences industries. 
Conclusion: Our poll and analysis help to explore the potential of real world 
evidence in the different stages of product development of the non-psychoactive 
cannabinoid market. 
Key words: phytocannabinoids, medicinal drugs, dietary supplements, Cannabidiol, 
marketing strategies 
 
 
THE COMBINATION TREATMENT OF TUMOR-CELL LINES WITH 
EPIRUBICIN AND ARTEMISININ, AND MECHANISMS OF THEIR 
SYNERGISTIC EFFECTS 
Zhelyazkova M.1, Momekov G.2, Hristova-Avakumova N.2, Hadjimitova V. 2 
1Bulgarian Drug Agency, Sofia, Bulgaria 
2Medical University, Sofia, Bulgaria 
 
Aim: Clinical studies involve cotreatment of  Epirubicin (EPI) with taxanes, platinum 
drugs, nitrogen mustard analogs, fluoropyrimidines, and Vinca alkaloids. Well known 
are the drug–drug interactions with trastuzumab or taxanes that result in 
cardiotoxicity. However, in this study we demonstrate for the first time the ability of 
artemisinin (ART) to modulate the response of EPI. 
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Materials and Methods: In our experiments with sensitive and resistant to 
doxorubicin HL-60 cell lines synergistic effects of the combination of ART and EPI 
were obtained using MTT assay and the method of Chou Talalay. We assessed the 
scavenging potential of EPI in stable free radicals (ABTS and DPPH) systems and 
we tested its protection effect under conditions of Fe(II) induced peroxidation in 
sample, containing lecithin and deoxyribose as oxidisable substrate. 
Results: ART significantly enhances the damage induced by EPI, thereby achieving 
greater efficacy in the resistant cell line. EPI possess the capability to decrease the 
concentration of both used radicals – ABTS and DPPH. Having in mind the fact than 
in both systems containing biologically important molecules we used the same 
mechanism of oxidative damage we observed different effects that could be 
attributed to dissimilarity in the interaction between the tested substance and the 
oxidisable substrate. 
Conclusion: Тhese data gives us a reason to conclude that the free radicals induced 
by EPI and ART participate in the genomic damage of DNA, but the mechanism of 
cardiotoxicity is associated predominantly to the lipid peroxidation and depends on 
the applied concentration. 
Key words: Epirubicin, Artemisinin, combination indices, synergism, lecithin-
obtained and deoxyribose damages 
 
 
A STUDY OF PARTICIPATION OF PHARMACISTS AND THEIR ROLE 
IN THE PROCESS OF PHARMACEUTICAL MANUFACTURING IN 
BULGARIA 
Stefanova T.1, Petrova G.2, Grigorov E.2,3 
1Student, Faculty of Pharmacy, Medical University, Varna, Bulgaria 
2Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, 
Medical University, Varna, Bulgaria 
3National Center of Public Health and Analyses, Sofia 
 
Introduction: Over the last decades, the pharmaceutical industry has become one of 
the vast growing high-tech industries in the world. Main global policies influence on 
the pharma-market forming a new concept of drug policy. 
Aim: The aim of the current study is to investigate and analyze registered 
manufacturers/importers of medical products who have received a marketing 
authorization in Bulgaria from the Bulgarian Drug Agency and to define the share of 
pharmacists on leading positions in the field as production managers or qualified 
persons. 
Methods and materials: This study is based on the analysis of Bulgarian and 
foreign literature sources and on the results of analysis of official data from BDA 
published on its internet page. For segmentation of the different 
manufacturers/importers of medical products, we use the six economic regions in 
Bulgaria. The relevant data were assessed with SPSS analysis for defining of 
relations and consequences. 
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Results: The registered manufacturers/importers who have received marketing 
authorization licenses from the national authority are 48. In this study, 
manufacturers/importers are considered from the point of view of the economic 
zones in Bulgaria. In South-East Bulgaria, 35 MAH or 72.9% of the respondents are 
located. The remaining areas are represented by one or more 
manufacturers/importers. An exceptionally strong impression is attributed to the 
number of persons qualified(MAH) – 6 pharmacists for the South-West economic 
region and only 1 for Central-North economic region. 
Conclusion: The results on this study show meager appurtenance of pharmacists in 
the process of supply and manufacturing of the medicines. This number is extremely 
insufficient and the pharmaceutical industry should consider attracting and 
stimulating more of the qualified pharmacist. 
Key words: MAH, pharmacist, import, manufacturing 
 
 
PHARMACOVIGILANCE OF MEDICINES FOR OVARIAN 
HYPERSTIMULATION. ANALYSIS FROM PATIENT PERSPECTIVE 
Stoev S., Lebanova Hr., Dimitrova J., Getov I. 
 
Aim: Current study aims to evaluate the type, incidence and severity of suspected 
adverse drug reactions (ADR) during controlled ovarian hyperstimulation (COH).  
Patients awareness of System for spontaneous reporting of ADRs has been 
evaluated.  
Materials and Methods: Statistical analysis of data, generated by completion of 
validated questionnaire during direct interview with 659 patients for a study period of 
14 months, has been performed. 
Results: Almost 40 % of participants reported a suspected ADR as a consequence 
of stimulation hormone application. Mean number of reported ADRs per patient is 
1.27. In 90% of cases of an experienced ADR, participants would evaluate the 
adverse effect as mild. Suspected ADRs have led to therapy termination in 3.8 % of 
investigated cases of adverse reaction. More than 2/3 of experienced ADRs are 
associated with local injection site reaction(63.1%), followed by reports of headache 
(9.8%), gastro-intestinal discomfort (5.8%) and nausea (4,7%). Women, underwent 
therapy for assisted reproduction are not well aware of functional principles of 
System for spontaneous ADR reporting and are not motivated enough to directly 
report a suspected ADR. 
Conclusion: According to women underwent assisted reproduction treatment, 
therapy for COH is associated with low incidence of mild ADRs, that are not 
significant enough for cycle cancellation. Levels of direct reporting of ADRs remains 
extremely low. 
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WHEN EFFECTIVENESS MEANS SAFETY. ANALYSIS OF CLINCIAL 
EXPERIENCE WITH DIFFERENT APPROACHES FOR CONTROLLED 
OVARIAN HYPERSTIMULATION. 
Stoev S., Lebanova Hr., Naseva E., Getov I. 
 
Aim: Current retrospective cohort study analyzes 4726 clinical database records of 
controlled ovarian hyerstimulation (COH) cycles to assess the significance of target 
effectiveness endpoints from a safety perspective. 
Materials and Methods: Following statistical methods were applied: descriptive 
statistics, Mann-Whitney U test, Kruskal-Wallis test, Pearson chi-square test, binary 
logistic regression. Comparative analysis of urinary and recombinant stimulations has 
been performed according to both primary and secondary endpoints as following: 
incidence of cycle cancelation, clinical regnancy rate, ovarian hyperstimulation 
syndrome (OHSS), induced plasma values of estradiol, progesterone, luteinizing 
hormone, oocyte yield, exogenous gonadotrophin exposure, eggs with normal 
maturation. 
Results: Safety surveillance of COH cycles exaggerates adverse drug reactions 
reporting and OHSS incidence. Induced follicle count, oocyte yield, mean values of 
estradiol, luteinizing hormone and progesterone, and cancellation rate are valid 
indicator for stimulation cycle safety as well as COH effectiveness. Discussed 
endpoint measures are within the “safe window” for all the investigated groups of 
medicinal products. Urinary group is characterized with higher cycle cancellation rate, 
luteinisng hormone levels and mean dose of FSH applied. 
Conclusion: Suboptimal effectiveness of COH may jeopardize wellbeing of treated 
couples. Due to the specific therapeutic characteristics of COH, well-established 
effectiveness endpoints are valid markers for safety of stimulation medicinal 
products. 
 
 
EVALUATION OF THE NEUROPROTECTIVE AND ANTIOXIDANT 
PROPERTIES OF NEW N-ALKYLATED BENZIMIDAZOLE 
HYDRAZONES WITH POTENTIAL APPLICATION FOR 
NEURODEGENERATIVE DISORDERS 
Anastassova N.1*, Aluani D.2, Hristova-Avakumova N.3, Kostadinov A.1, 
Tzankova V.2, Kondeva-Burdina M.2, Hajimitova V.3,Yancheva D.1 
1Institute of Organic Chemistry with Center of Phytochemistry, 
Bulgarian Academy of Sciences, Sofia, Bulgaria 
2Department of Pharmacology, Pharmacotherapy and Toxicology, 
Faculty of Pharmacy, Medical University of Sofia, Bulgaria 
3Department of Medical Physics and Biophysics, Faculty of Medicine, 
Medical University of Sofia, Bulgaria 
 
The aim of the study: Safety evaluation and neuroprotective activity of newly 
synthesized  N-akylated benzimidazole hydrazones, as well as estimation their ability 
to act as radical scavengers. 
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Materials and methods: In vitro toxicity screening of the newly compounds on 
human neuroblastoma SH-SY5Y cell line. The viability of the cells was assessed by 
MTT assay. The anti-radical properties of the hydrazones were determined by 
assessing their ability to decrease the concentration of the stable free radicals ABTS 
and DPPH. The neuroprotective properties of the compounds were determined in a 
model of H2O2-induced oxidative damage in SH-SY5Y cells. For comparison, effects 
of rasagiline and melatonin were determined. 
Results: Most of the compounds have IC50 values over 200 µM and possess 
statistically significant protective effects. It should be noted that the neuroprotective 
effects were more pronounced than those of melatonin and rasagiline. The 
determined from the concentration-radical scavenging effect C50 values for the 
hydrazones in the ABTS containing system were similar or lower to the one of 
melatonin. Variable capability to decrease the absorbance of the DPPH containing 
samples depending of the structural differences between the compounds is being 
observed. 
Conclusion: The new series of N-alkylated benzimidazoles containing methoxy and 
hydroxyl substituents exhibits low toxicity and a good in vitro safety profile. The 
improved neuroprotective and antioxidant properties compared to melatonin and 
rasagilin, makes them were synthesized as promising radical scavengers for 
neuroprotective application and showed improved neuroprotective and antioxidant 
properties. 
Acknowledgments: The financial support by the National Science Fund of Bulgaria 
(contract KП-06-М29/4) is gratefully acknowledged. 
Corresponding author: Denitsa Aluani 
e-mail: denitsa.aluani@gmail.com tel: 359888869426 
 
 
POLYVINYL ALCOHOL-BASED FILAMENTS AS A FEEDSTOCK 
MATERIAL FOR THREE DIMENSIONAL PRINTING OF SOLID 
DOSAGE FORMS 
Ilieva S., Dimitrov M. 
Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of 
Pharmacy, Medical University, Sofia 
 
The aim of the study: Hot melt extrusion (HME) coupled with fused deposition 
modeling (FDM) three dimensional (3D) printing is a modern approach of producing 
patient-specific dosage forms. The purpose of this study is to test the feasibility of 
three grades of polyvinyl alcohol (PVA) for the production of filaments for FDM. 
Materials and Methods: Mixtures containing three grades of partially hydrolyzed 
polyvinyl alcohol (PVA 1 - 13 000-23 000 MW, PVA 2 – 31 000-50 000 MW and PVA 
3 - 72 000 MW) and polyethylene glycol PEG 6000 or sorbitol as a plasticizer were 
extruded as filaments in a single screw extruder (Wellzoom, PRC). The suitable 
filaments were printed with a 3D printer (Delta Rostock mini G2S pro, PRC). 
Additionally, the polymers‟ viscosity was measured with a HAAKE Viscotester iQ 
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Rheometer (Thermo scientific, USA) and compared with a commercial PVA filament 
(Shenzhen Lankeda Technology, PRC). 
Results: The viscosity of PVA 1 and PVA 2 was comparable to the reference 
filament. However, the extrudates produced with PVA 1 were brittle, with uneven 
diameter and could not be fed into the printer. The extrudates containing PVA 2 and 
PVA 3 had smooth surface and uniform diameter, which allowed to be loaded into the 
printer. Only PVA 2 proved to be printable, while PVA 3 caused nozzle blockage due 
to its higher molecular mass. 
Conclusion: Filaments containing PVA with 31 000-50 000 MW and a hydrophilic 
plasticizer were found suitable for the production of 3D printed solid dosage forms. 
 
 
CARDIOVASCULAR MEDICINES UTILIZATION IN BULGARIA FROM 
THE NATIONAL HEALTH INSURANCE FUND PERSPECTIVE 
Kovachka G., Mitkova Z., Kamusheva M., Petrova G. 
Faculty of Pharmacy, Medical University, Sofia 
Corresponding author: Gabriela Kovachka, 
e-mail: gabriela.kovachka@gmail.com, tel.: 0892096929 
 
Purpose: The goal is to evaluate the reimbursed cardiovascular medicines utilization 
pattern in Bulgarian ambulatory patients for a 1-year period (2018). 
Methods: It is a retrospective, quantitative utilization study analyzing 67 mono-
component products acting on CV system paid by the National Health Insurance 
Fund (NHIF).Medicines utilization is measured in terms of defined daily dose (DDD) 
using the following formula: DDD/1000/inhabitants/day = ((Sales in mg/ 
DDD)/(number ofinhabitans×365)×1000). Reimbursable costs have also been 
compared. Data was gathered from the NHIF official register. 
Results: We have found a very high total consumption of CV medicines, measured 
in DDD/1000/inhabitants/day. The highest utilization is revealed for Ca-channel 
blockers (49.71) followed by β-blockers (47.59), ACE- inhibitors (46.69), sartans 
(34.65) and statins (32.40). The lowest consumption is measured for fibrates (0.51), 
endothelin receptor antagonist (0.01), selective aldosterone receptor antagonist 
(0.30) and adrenergic alpha2-agonist (0.34). The NHIF pays the highest 
reimbursement values for Lercanidipine 4 009 363 BGN, Nebivolol 3 971 512 BGN, 
Bisoprolol 2 642 796 BGN, Torasemide 2 433 471 BGN and Ivabradine 2 286 518 
BGN. 
Conclusion: The CV medicines utilization is the highest mainly in the groups where 
new generics and international non-proprietary names (INNs) were registered. The 
medicinal products, established in the practice, continue to be utilized. Their 
consumption is relatively low as a result of generic and therapeutic competition in 
cardiovascular medicines market. Further quantitative and qualitative studies are 
needed to predict the trends in CV medicines utilization from the NHIF perspective as 
well as to assess the rationality of their use. 
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ONCOPHARMACOLOGICAL CHARACTERIZATION OF THE 
ARYLTETRALIN LIGNAN ANTHRICIN 
Petrova E., Mihailova R., Atanasova T., Ionkova I., Momekov G. 
 
The antiproliferative activity of aryltetralin lignan anthricin has been studied in a 
spectrum of human tumor cell lines, wherein the compound exhibits pronounced 
cytotoxic activity at low concentrations. Pharmacodynamic studies indicate that 
cytotoxic activity is mediated by induction of apoptosis through caspase-dependent 
mechanisms. An in silico study of the physicochemical and pharmacokinetic 
properties of lignan shows that it is characterized by optimal properties as a potential 
antineoplastic agent. 
 
 
PHARMACOANALYTICAL INVESTIGATION OF PRODUCTS 
FOR ALZHEMER TREATMENT  
Obreshkova D. 
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, MU-Sofia 
Sofia, Bulgaria  
 
The current and growing importance of development of new effective products for 
prevention and slowing of Alzheimer's disease progression is expanded by including 
substances with antioxidant and antiinflammatory effects after precise 
characterization. 
Aim of the study: Aim of the study was the pharmacoanalytical characterization of 
products with a beneficial effect on Alzheimer's disease using modern analytical 
techniques and approaches. 
Materials and methods 
Materials: Galantamine hydrobromide/Pymadine, Docosahexaenoic acid, Aminoacid 
Standard, Curcumine, Ol. Ocimum basilicum L., Extr. Clinopodium vulgare L., Extr. 
Echium vulgare L. 
Methods: High Performance Liquid Chromatography (HPLC), Gas Chromatography 
(GC), Densitometry, UV-Vis-Spectrophotometry, Chemiluminescence, DPPH. 
Results:mRepeatability of densitometric and HPLC-methods was confirmed by the 
absence of statistically significant differences:
___
X Rf=0.663;
___
X tR=3.179 min. 
(Galantamine hydrobromide), 
___
X Rf=0.433; tR=5.272 min. (Pymadine). In HPLC 
accuracy is: 97.71% (Galantamine hydrobromide); 101.72% (Pymadine). Radical-
scavenging effect of the combination (20.19%) is stronger than activity of 
Galantamine hydrobromide (15.44%). For densitometric analysis of 
Docosahexaenoic acid: y=1.108+9370.7. For HPLC: L-Glutamic acid: y=2.109.x–
458796; L-Arginine: y=2.108.x–98532. For TLC: L-Leucine: y=1.106.x+2949.7; L-
Valine: y=916928.x+404.72. Stability of aminoacids in gamma-irradiation was 
demonstrated by HPLC. Curcumine antioxidant activity was determined by UV-Vis-
spectrophotometry and chemiluminescence. Antibacterial activity of Ol. Ocimum 
basilicum L. has been confirmed. Linalol, Linolen, Methylchavikol, Methylcinnamat in 
Ol. Ocimum basilicum L. and phenolcarboxylic acids (Cinnamic, p-Coumaric, 
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Ferrulic) in Extr. Clinopodium vulgare L. and Extr. Echium vulgare L. have been 
analyzed with GC. 
Conclusion: Pharmacoanalytical approaches for Galantamine 
hydrobromide/Pymadine, Docosahe-xaenoic acid, aminoacids, Curcumine, Ol. 
Ocimum basilicum L., Extr. Clinopodium vulgare L., Extr. Echium vulgare L. have 
been developed and validated. 
Corresponding author: Prof. Danka Obreshkova, Dsci; tel.: 0898486767,  
e-mail: phddanka@yahoo.com  
 
 
WATER-EXTRACTABLE POLYSACCHARIDE FROM PLANTAGO 
MEDIA L. LEAVES – STRUCTURAL CHARACTERIZATION AND 
BIOLOGICAL ACTIVITY  
Lukova P.1*, Nikolova M.2, Delattre C.3, Gardarin C.3, Petit E.4, Michaud P.3,      
Iliev I.2 
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Aim: The aim of the present study was to characterize the chemical content of water-
extractable polysaccharides (WEPs) from Plantago media L. leaves and evaluate 
their antioxidant and prebiotic activity.  
Materials and methods: The neutral sugars, uronic acid, total phenolic and protein 
content were analyzed spectrophotometrically. The monosaccharide composition of 
WEPs was studied by HPAEC and FT-IR. The molecular weight was estimated by 
SEC-MALLS. Lactobacillus plantarum strains (S26, S27, S30) were used to examine 
the prebiotic activity of the enzymatically hydrolysed WEPs. The antioxidant activity 
was evaluated by DPPH and FRAP assays.  
Results: The HPAEC analysis showed that galacturonic acid (67.36%) was the main 
monosaccharide of WEPs followed by galactose (11.89%), rhamnose (7.77%), 
glucose (6.22%) and small amounts of arabinose, xylose and fructose. FT-IR study 
indicated a strong characteristic absorption peak at 1552 cm-1 corresponding to the 
vibration of COO- group of the galacturonic acid. The molecular weight of WEPs was 
estimated to 3.9x105. Results gave evidence that WEPs exhibited DPPH (40.08 ± 
1.75%) and FRAP (132.40 ± 2.11μM Trolox equivalent) antioxidant activity. WEPs 
hydrolyzates stimulated successfully the production of α-galactosidase, α-
glucosidase and β-xylosidase activity in the investigated probiotic strains.  
Conclusion: The presented results suggested that P. media WEPs have been 
composed of ramified rhamnogalacturonan I and have the potential of biological 
active natural compounds with antioxidant and prebiotic applications. 
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QUANTIFICATION OF FLAVONOIDS IN IN VITRO CULTURES OF 
ASTRAGALUS GLYCYPHYLLOS L. 
Popova P., Zarev Y., Shkondrov A., Krasteva I., Ionkova I. 
Department of Pharmacognosy, Faculty of Pharmacy, Medical University of Sofia, 2 
Dunav str., 1000 Sofia, Bulgaria 
 
Aim of the study: The aim was to determine the total flavonoid content of 
ethylacetate extracts from callus cultures of A. glycyphyllos cultivated on media with 
different concentrations of Mg2+ and Ca2+. In addition, to determine rutin and 
camelliaside A quantity in shoots, callus and suspension cultures grown on 
Murashige & Skoog‟s medium (MS), supplemented with plant hormones. 
Materials and methods: Callus cultures of A. glycyphyllos grown in MS media, 
supplemented with casein, 2,4-dichlorophenoxyacetic acid, kinetin and indole-3-
acetic acid with different concentrations of Mg2+ and Ca2+ were used. Cultures grown 
on these media were used for determination of total flavonoids content.  
Secondly, rutin and camelliaside A were determined in cultures cultivated either on 
classical MS or on modified ones both in light and in dark regimen.  
Flavonoid content in both groups of samples was quantified by LC/MS. 
Results: The highest flavonoids content was observed in callus cultures grown on 
modified medium with twice the amount of Ca2+, while only a little was achieved in 
callus cultures cultivated on the same medium with twice reduced amount of Mg2+. 
Camelliaside A and rutin were determined in the highest quantity in shoots. 
Conclusion: Flavonol production in in vitro cultures can be enhanced by varying the 
components of culture medium. These findings suggest that in vitro cultivated A. 
glycyphyllos could serve as a source of pharmaceutically important metabolites.  
Acknowledgement: Financial support from the Council of Medicinal Science at 
Medical University of Sofia, contract № D-80/2019 is acknowledged. 
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